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Role Of Type Ii Phosphatidylinositol 4-Kinases In Endosomal Tubule Dynamics
During Melanosome Biogenesis
Abstract
Melanosomes are pigment cell-specific lysosome-related organelles (LROs) in which melanin pigments
are synthesized and stored. Melanosome maturation requires biosynthetic delivery of melanogenic
enzymes (e.g. TYRP1), transporters (e.g. OCA2), and SNAREs (e.g. VAMP7) from early endosomes (EEs).
One essential pathway requires the multisubunit complex, BLOC-1, on EEs to generate tubular transport
carriers to deliver cargos to melanosomes. The molecular mechanisms by which BLOC-1 facilitates
tubule formation are not entirely known, but several studies suggest that
phosphatidylinositol-4-phosphate (PtdIns4P) and the type II PtdIns-4-kinases, PI4KIIα and PI4KIIβ, may
play a role. Moreover, PI4KIIα and PI4KIIβ interact respectively with AP-3 and AP-1, both of which control
BLOC-1-dependent cargo sorting. We hypothesized that type II PtdIns-4-kinases support
BLOC-1-dependent tubule formation via PtdIns4P to regulate melanosome biogenesis. We found that
depletion of either PI4KIIα or PI4KIIβ in melanocytes reduced melanin content and impaired the
melanosomal localization of TYRP1, OCA2, and VAMP7 by immunofluorescence microscopy (IFM) and
bright-field microscopy. TYRP1 was largely mislocalized to late endosomes/lysosomes in PI4KIIα- or βdepleted cells, and not exclusively to EEs as observed in BLOC-1-/- melanocytes. This suggested that type
II PtdIns-4kinases are not absolutely required for BLOC-1-dependent cargo exit from EEs but function
downstream of BLOC-1. Consistently, depletion of PI4KIIα or PI4KIIβ in BLOC-1-deficient cells did not
affect TYRP1 accumulation in EEs by IFM, and depletion of PI4KIIα or PI4KIIβ in wild-type melanocytes
did not affect BLOC-1 association with membranes by subcellular fractionation. Rescue studies revealed
that enzymatic activity and AP-binding abilities of both PI4KIIα and PI4KIIβ are necessary for TYRP1
localization to melanosomes. Live cell imaging showed that PI4KIIα associates with tubules from the
onset of tubule formation, whereas PI4KIIβ accumulates after the tubule has formed, suggesting that
PI4KIIα acts earlier than PI4KIIβ. Depletion of either PI4KIIα or PI4KIIβ reduced PtdIns4P on endosomal
tubules and impaired tubule elongation. These data together suggest that PI4KIIα and PI4KIIβ function
sequentially and non-redundantly downstream of BLOC-1 by generating PtdIns4P on endosomal tubules
during tubule elongation and that both isoforms are necessary for efficient melanosome contact and
content delivery to melanosome. Our study demonstrates the important roles of PtdIns4P and both type II
PtdIns-4-kinases in BLOC-1-dependent tubular cargo transport for melanosome biogenesis and extends
the cohort of effectors required for LRO biogenesis.
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ABSTRACT

ROLE OF TYPE II PHOSPHATIDYLINOSITOL 4-KINASES IN ENDOSOMAL TUBULE
DYNAMICS DURING MELANOSOME BIOGENESIS
Yueyao Zhu
Michael S. Marks

Melanosomes are pigment cell-specific lysosome-related organelles (LROs) in which melanin
pigments are synthesized and stored. Melanosome maturation requires biosynthetic delivery of
melanogenic enzymes (e.g. TYRP1), transporters (e.g. OCA2) and SNAREs (e.g. VAMP7) from
early endosomes (EEs). One essential pathway requires the multisubunit complex, BLOC-1, on
EEs to generate tubular transport carriers to deliver cargos to melanosomes. The molecular
mechanisms by which BLOC-1 facilitates tubule formation are not entirely known, but several
studies suggest that phosphatidylinositol-4-phosphate (PtdIns4P) and the type II PtdIns-4-kinases,
PI4KIIα and PI4KIIβ, may play a role. Moreover, PI4KIIα and PI4KIIβ interact respectively with AP3 and AP-1, both of which control BLOC-1-dependent cargo sorting. We hypothesized that type II
PtdIns-4-kinases support BLOC-1-dependent tubule formation via PtdIns4P to regulate
melanosome biogenesis. We found that depletion of either PI4KIIα or PI4KIIβ in melanocytes
reduced melanin content and impaired the melanosomal localization of TYRP1, OCA2 and VAMP7
by immunofluorescence microscopy (IFM) and bright field microscopy. TYRP1 was largely
mislocalized to late endosomes/lysosomes in PI4KIIα- or β-depleted cells, and not exclusively to
EEs as observed in BLOC-1-/- melanocytes. This suggested that type II PtdIns-4kinases are not
absolutely required for BLOC-1-dependent cargo exit from EEs but function downstream of BLOC1. Consistently, depletion of PI4KIIα or PI4KIIβ in BLOC-1-deficient cells did not affect TYRP1
accumulation in EEs by IFM, and depletion of PI4KIIα or PI4KIIβ in wild-type melanocytes did not
affect BLOC-1 association with membranes by subcellular fractionation. Rescue studies revealed
that enzymatic activity and AP-binding abilities of both PI4KIIα and PI4KIIβ are necessary for

v

TYRP1 localization to melanosomes. Live cell imaging showed that PI4KIIα associates with tubules
from the onset of tubule formation, whereas PI4KIIβ accumulates after the tubule has formed,
suggesting that PI4KIIα acts earlier than PI4KIIβ. Depletion of either PI4KIIα or PI4KIIβ reduced
PtdIns4P on endosomal tubules and impaired tubule elongation. These data together suggest that
PI4KIIα and PI4KIIβ function sequentially and non-redundantly downstream of BLOC-1 by
generating PtdIns4P on endosomal tubules during tubule elongation and that both isoforms are
necessary for efficient melanosome contact and content delivery to melanosome. Our study
demonstrates important roles of PtdIns4P and both type II PtdIns-4-kinases in BLOC-1-dependent
tubular cargo transport for melanosome biogenesis and extends the cohort of effectors required for
LRO biogenesis.
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CHAPTER 1: INTRODUCTION

1.1 Lysosome-related organelles
The endo-lysosomal system is a dynamic network of intracellular membrane-bound compartment
that plays an essential role in nutrient uptake, signaling, metabolism, and pathogen life cycle
(Huotari and Helenius, 2011; Klumperman and Raposo, 2014). In some cell types, the endolysosomal system is additionally adapted to create specialized subcellular compartments termed
lysosome-related organelles (LROs) for specific physiological functions (Bowman et al., 2019;
Delevoye et al., 2019). LROs are termed as such because, similarly to lysosomes, they are derived
from the endosomal system and share some common features with conventional lysosomes. For
instance, LRO membranes and some of their luminal contents derive from both endosomal and
secretory organelles. In addition, LROs possess a cohort of lysosomal resident proteins such as
LAMPs (Lysosome-Associated Membrane Proteins) and acid hydrolases, and most LROs have an
acidic phase during their life cycle (Marks et al., 2013; Raposo et al., 2007). However, LROs are
distinguished from conventional lysosomes by their distinct morphologies and physiological
functions due to their unique cell type-specific contents. These unique LRO contents define the
special features of their host cells. For example, by electron microscopy (EM) lysosomes usually
appear as spherical membrane-bound organelles with electron-dense contents and often
multilamellar membrane whorls, whereas cell type-specific LROs have distinct morphologies and
shapes that are determined by the macromolecular composition of the limiting membranes and
intraluminal contents. Proper regulation of LRO formation, maturation, and secretion is necessary
for normal physiological function, and gene mutations that result in LRO deficiencies cause various
genetic disorders including the Hermansky-Pudlak syndromes (HPS), the Chediak-Higashi
syndrome (CHS), and the Griscelli syndromes (GS) (Huizing et al., 2008). Each of these disorders
associates with abnormalities of a group of LROs in diverse physiological systems such as
pigmentation, hemostasis, immunity, neurology, and others. This thesis addresses molecular
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mechanisms of LRO biogenesis and their relationship to the products of genes that are disrupted
in HPS. In particular, the research described herein establishes roles for two lipid kinases in the
maturation of one LRO type, the melanosome of pigment cells, as a model for how they function in
other LRO-containing cell types. In this section, some relevant classical LROs, associated
disorders, and responsible protein complexes will be discussed in detail. We will then discuss
pathways by which contents are delivered to LROs, the role of HPS-associated gene products in
these pathways, and the roles of specific lipids in membrane transport pathways.

1.1.1 Types of lysosome-related organelles
LROs are defined as cell type-specific structures whose contents are derived at least in part from
the endosomal system (Delevoye et al., 2019). They are highly diverse, although among their
contents most LROs harbor the tetraspanin, CD63, which some consider as a “LRO marker”
(Delevoye et al., 2019). Most LROs function as regulated secretory organelles, much like classical
secretory granules (Arvan and Castle, 1998), and in fact at least some secretory granules are now
recognized to harbor features of LROs (Delevoye et al., 2019; Sirkis et al., 2013). Here I introduce
some key LROs that will be discussed later in the context of my research (Figure 1.1).
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Figure 1.1

Figure 1.1 Examples of LROs.
(A) Dense granules (arrows) in a human platelet observed by whole mount EM (Chen et al., 2018).
(B) A WPB in a human umbilical vein endothelial cell shown by transmission EM (Valentijn et al.,
2008). (C) Glue granules (Gr, pointed by arrow) in L3 salivary glands observed by transmission EM
(Burgess et al., 2011). Electron-dense material (arrowhead) becomes prominent near the granule
membrane during Gr maturation. (D) A phagosome containing Mycobacterium avium in a mouse
bone marrow-derived macrophage observed by transmission EM (de Chastellier et al., 2009).
Lysosomes (Ly) are labeled with bovine serum albumin-gold and indicated by gold particles. (EiEiv) Four developmental stages of melanosomes in MNT-1 human melanoma cells analyzed by
transmission EM of samples preserved by high pressure freezing: melanosome stages I (Ei), II (Eii),
III (Eiii) and IV (Eiv). Images are adapted from (Raposo and Marks, 2007).
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1.1.1a Platelet Dense granules
Dense granules (also called delta granules) are a subtype of LROs that are generated within
platelets, a specialized type of blood cell that initiates blood clot formation to stop bleeding upon
vascular injury. Dense granules contain primarily small molecules including calcium, serotonin,
ADP, and ATP (Sharda and Flaumenhaft, 2018). The high concentration of calcium makes the
dense granule appear electron-dense by EM analyses of intact unstained platelets (Fig. 1.1A)
(Sharda and Flaumenhaft, 2018). Secretion of dense granules and release of their intraluminal
constituents upon platelet activation at sites of vascular damage play a critical role in effective
hemostasis and thrombosis (Sharda and Flaumenhaft, 2018).

Dense granule formation initiates in late stages of megakaryocyte maturation into platelets (Hanby
et al., 2017) and continues in circulating platelets (Sharda and Flaumenhaft, 2018). Dense granules
appear to derive primarily from the endosomal system rather than from the TGN and may share
some features with conventional lysosomes. Electron microscopy data have been interpreted to
suggest that dense granules may derive from multivesicular bodies (MVBs) (Youssefian and
Cramer, 2000), but other evidence indicates that early endosomes contribute to their maturation
and function (Meng et al., 2012). Dense granules possess an acidic luminal environment that
requires the vacuolar ATPase (v-ATPase) (Dean et al., 1984). While some authors have suggested
that CD63 and LAMP2 are enriched on DGs based on immunoelectron microscopy (Youssefian
and Cramer, 2000), these data suffer from the lack of a solid definition of dense granules in fixed
thin sections of platelets and thus potential confusion with classical multivesicular late endosomes
or lysosomes. Although MVBs have been suggested to be the precursors of lysosomes, dense
granules, and alpha granules -– another type of platelet granule important for hemostasis (Joshi
and Whiteheart, 2017), how MVBs can give rise to these three types of organelles is not understood.
This process likely requires specialized molecular machineries that strictly control protein sorting
and endosomal transport and will be discussed further in section 1.2.
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1.1.1b Weibel-Palade bodies
Weibel-Palade bodies (WPBs) are cigar-shaped LROs of endothelial cells (Fig. 1.1B) – the cells
that form the inner lining of blood vessels, act as an active interface between circulating blood and
tissue, and maintain vascular homeostasis (Nass et al., 2021). The hemostatic functions of
endothelial cells are conferred by two major bioactive molecules that are stored in WPBs: von
Willebrand factor (vWF) and P-selectin. These two molecules together play an essential role in
hemostasis upon vascular damage by adhering, activating and aggregating platelets at the injury
site. P-selectin additionally initiates the recruitment of leukocytes to areas of injury, thus promoting
inflammation, angiogenesis, and wound healing (Hannah et al., 2002).

WPBs, unlike dense granules, are primarily derived from the TGN. The biosynthesis of vWF is a
prerequisite for WPB biogenesis and dictates their unusual cigar-like shape (Ferraro et al., 2014);
in fact, WPB-like organelles can be detected even in non-endothelial cells upon the expression of
vWF (Wagner et al., 1991). VWF is synthesized in the ER where it dimerizes and is then transported
to TGN where vWF dimers rearrange themselves to assemble into a rod-like ‘stalk’ (Springer, 2014).
These stalks stack into tubules and incorporate into coated vesicles that bud off from TGN as
immature WPBs (Nass et al., 2021; Springer, 2014). Clathrin and the AP-1 adaptor are essential
for the formation of early-stage WPBs from the TGN but are not necessary to maintain the cigarlike shape once they are completely formed (Lui-Roberts et al., 2005). Packing of vWF tubules
occurs in the TGN preceding or concomitant with WPB budding, yielding the highly elongated cigarshaped organelles (Ferraro et al., 2014). Immature WPBs released from the TGN acquire additional
contents, including CD63 and P-selectin, from the endo-lysosomal system for maturation. In sum,
WPB maturation in endothelial cells requires a complex system involving protein and membrane
acquisition from the Golgi and endo-lysosomes, cargo transport between endo-lysosomes and
nascent WPBs, and morphological alterations that eventually generate the unique cigar-shaped
organelle containing the tubulated highly multimeric vWF. This shape is essential for platelet
capture upon secretion (Ferraro et al., 2016).
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1.1.1c Drosophila secretory glue granules
LROs are also found in invertebrates. Secretory glue granules (SGs) are a type of secretory
granules formed within epithelial cells of Drosophila third-instar larval salivary glands (Fig. 1.1C).
They store mucin-like “glue” proteins that, upon secretion, adhere the larvae onto a solid surface
for pupation and metamorphosis (Biyasheva et al., 2001). SGs share many similarities with WPBs
in terms of formation and maturation. Like WPBs, SGs originate and then bud off from the TGN
with the help of clathrin and AP-1 adaptor at the site where cargos are clustered (Burgess et al.,
2011). SGs then mature by acquiring components including CD63 from endosomal compartments
(Azouz et al., 2014; Klein et al., 2017; Ma et al., 2020; Mizuno et al., 2007). SGs are representative
of mammalian secretory granules, several of which have been shown to acquire endosomal
material during their maturation (Asensio et al., 2010; Sirkis et al., 2013; Suckow et al., 2010).

1.1.1d Phagosomes
Phagosomes are membrane-bound organelles in phagocytes (e.g., dendritic cells, neutrophils,
macrophages, and retinal pigment epithelial cells) that store and degrade phagocytosed large
particles, such as microorganisms, apoptotic cells, and debris (Fig. 1.1D). A nascent phagosome
is formed around particles that are adhered to the plasma membrane by actin-dependent extension
of membrane and fusion of the membrane around these particles (Swanson, 2008). Phagosomes
mature by the acquisition of unique contents from the endolysosomal system (Fairn and Grinstein,
2012), and thus can be considered as “inducible” LROs. The maturation process involves a series
of sequential fusions of phagosomes with early endosomes, late endosomes, and lysosomes,
ultimately changing phagosomal protein composition and luminal pH and increasing phagosomal
degradative capacity. Thus, phagosomes acquire some lysosomal proteins, such as LAMP1 and
LAMP2, from late endosomes and lysosomes. Acidification of the phagosomal lumen is essential
to initiate the degradation of phagocytosed particles, and is mediated by the recruitment of the vATPase from the TGN, early endosomes, lysosomes, and/or plasma membrane (Nguyen and
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Yates, 2021). Ultimately, phagosomes fuse with lysosomes to form phagolysosomes, augmenting
the degradative capacity by the acquisition of hydrolytic enzymes such as cathepsins (Sun-Wada
et al., 2009). Through this maturation mechanism, phagocytes of the innate immune system, such
as macrophages and dendritic cells, eventually eliminate invading pathogens and present antigens
to T cells to initiate adaptive immune responses. Therefore, phagosomes in these cell types serve
as a platform to bridge innate and adaptive immunity.

1.1.1e Melanosomes
This thesis employs melanosomes as model LROs, and so melanosome maturation and function
will be discussed in more detail.

Melanosomes generated within pigment cells are major sites of synthesis and storage of melanins.
In mammals, melanins are the primary determinant of the color of skin, hair, and eyes. For example,
the range of skin and eye coloration of humans attribute to differing ratios of two types of melanins:
brown-black eumelanins and red-yellow pheomelanins (Ito and Wakamatsu, 2003). Darker color is
relatively enriched in eumelanin, whereas red or yellow color is relatively enriched in pheomelanin.
In addition to coloration of skin and hair, melanins also provide protection against harmful effects
of sunlight by absorbing, scattering, photo-oxidizing and scavenging free radicals to prevent
damage to DNA, proteins, and cell membrane lipids in the skin (Costin and Hearing, 2007). Patients
with reduced or absent melanins are more vulnerable to the harmful effects of UVR and more
susceptible to develop skin cancers, particularly squamous cell carcinoma and basal cell carcinoma
(Marcon and Maia, 2019; Montoliu et al., 2014). Melanin synthesis in the retinal pigment epithelium
and underlying choroidal melanocytes of the eye is critical to ensure proper vision by supporting
retinal development (Jeffery, 1998), scattering or blocking light of deleterious wavelength, and
deactivating reactive oxygen species (Hu et al., 2008). Hence, mutations resulting in defective
melanin synthesis and melanosome biogenesis result in albinism, a relatively rare (~1 in 10,00020,000 live births in caucasians (Montoliu et al., 2014)), heterogeneous disorder characterized by
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hypopigmentation of the skin, hair, and eyes. Albinism can be categorized into two general forms:
non-syndromic albinism and syndromic albinism. In non-syndromic albinism, only pigmented cell
types are affected due to mutations in pigment cell-specific genes, most of which encode
melanosome-specific contents such as melanogenic enzymes and transporters; the types of nonsyndromic albinism identified so far are ocular albinism type 1 (OA1) and oculocutaneous albinism
types 1-8 (OCA1-OCA8) (Marcon and Maia, 2019; Mártinez-García and Montoliu, 2013; Pennamen
et al., 2020b). In syndromic albinism, gene mutations not only cause impairment of the packaging
of melanin in pigment cells but also lead to LRO defects in non-pigmented cell types that cause
additional systemic disorders. These will be discussed in section 1.1.2.

The melanosomes that harbor primarily pheomelanins in the skin and hair have not been carefully
characterized and differ substantially from those harboring eumelanins (Jimbow et al., 1983; Moyer,
1966). By contrast, melanosomes that harbor primarily eumelanins have been well-studied. Here,
all remaining discussion is limited to melanosomes that make primarily eumelanins.

Melanosome maturation involves two sequential but independent processes: functional amyloid
fibril formation and melanin pigment synthesis. The dynamic progression of amyloid fibril formation
and melanin deposition respectively determines the shape and pigment content of melanosomes.
Melanosome maturation has been characterized into four progressive morphologically-defined
developmental stages from stage I to stage IV (Fig. 1.1Ei-Eiv) (Seiji et al., 1961). Stage I
melanosomes (Fig. 1.1Ei) are vacuolar early endosomes that lack pigment, are accessible to
endocytic cargos, and contain intraluminal vesicles (ILVs), but are distinguished from early
endosomes in other cell types in that they contain PMEL, a pigment cell-specific protein that forms
amyloid fibrils upon which melanins will ultimately deposit (Raposo et al., 2001). PMEL is an integral
membrane protein that accesses stage I melanosomes following internalization from the plasma
membrane (Robila et al., 2008; Theos et al., 2006a), and then undergoes proteolytic processing to
the amyloidogenic form (Berson et al., 2001; Berson et al., 2003), concomitant with accumulation
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of the amyloidogenic fragment on ILVs (Berson et al., 2001; Theos et al., 2006b; van Niel et al.,
2011). The nascent fibrils begin to form and elongate in association with the ILVs (Hurbain et al.,
2008). As the fibrils continue growing, the ILVs are “pushed” to the periphery of the stage I
melanosome. At the same time, these fibrils assemble into sheets, generating a striated
appearance in cross- or transverse-section by electron microscopy and distending the melanosome
into an ellipsoid shape (Hurbain et al., 2008). Ellipsoidal melanosomes that are enriched in sheetlike fibrils but still lack pigment are referred as stage II melanosomes. At this stage, the
melanosomes are no longer accessible to the endocytic pathway. The stage II melanosomes (Fig.
1.1Eii) then mature to stages III and IV by the delivery of melanogenic enzymes, such as tyrosinase
(TYR) that catalyzes the limiting steps in melanin synthesis, and of transporters, such as the
melanosomal chloride channel oculocutaneous albinism type 2 (OCA2) and the copper transporter
ATP7A, both of which modify the luminal environment of melanosomes to facilitate enzyme function
in melanin production (Le et al., 2021). Stage III melanosomes (Fig. 1.1Eiii) are pigmented
because melanin is synthesized and deposited on matured amyloid fibrous sheets upon delivery of
enzymes and transporters, thickening and darkening the fibrils as detected by electron microscopy
(Raposo et al., 2001). As melanin pigments continue to accumulate, they fill the entire lumen of the
organelle, masking the underlying sheet-like structure. Melanosomes that are filled with melanin
are referred to as stage IV. Stage IV melanosomes (Fig. 1.1Eiv) accumulate the small GTPase
Rab27a, and in skin and hair melanocytes are recruited to the cell periphery by Myosin Va motility
along peripheral actin filaments (Hume et al., 2002; Hume et al., 2001; Hume et al., 2006; Seabra
and Coudrier, 2004; Seabra et al., 2002; Strom et al., 2002). They then are transferred to
keratinocytes to provide the skin and hair with their characteristic color.

Melanosomes, like many other LROs, coexist with the classical organelles of the endosomal
system, including lysosomes. Whereas most lysosomal proteins are properly delivered
biosynthetically to lysosomes via one of several routes (Saftig and Klumperman, 2009), a small
proportion of lysosomal proteins such as Lysosomal Associated Membrane Protein (LAMP)-1,
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LAMP-2, and CD63 are detected in melanosomes (Orlow, 1995; Raposo et al., 2001). In addition,
some of these proteins, as well as lysosomal hydrolases, are likely missorted as the stage I
melanosomes mature into stage II and classical late endosomes. Indeed, some content of
lysosomal hydrolases are necessary for the PMEL fibrils to form sheets that serve as the platform
on which melanin pigments ultimately deposit (Ho et al., 2016).

1.1.2 Disorders of lysosome-related organelles
Abnormalities in LROs are associated with symptoms of human genetic diseases such as the
Chediak-Higashi Syndromes (CHS), Griscelli Syndromes (GS), and the Hermansky-Pudlak
Syndromes (HPS). Patients with these syndromes suffer from one or more of the following
symptoms: decreased pigmentation of the skin, hair and eyes (oculocutaneous albinism); bleeding
diathesis; lung fibrosis; compromised immune system; hyperinflammation; and neurological
disorders. Some of these symptoms are directly caused by dysfunction of particular LROs in
associated physiological processes – e.g., melanosomes in pigment cells, dense granules in
platelets, and lamellar bodies in alveolar type 2 cells of the lung. In some cases, defects in multiple
organelles contribute to pathology in a single physiological system. For example, the
immunodeficiencies in HPS type 2 and CHS are manifested by defects in cytolytic granules of
cytotoxic T cells (CTLs) and in phagosomes and specialized LROs of antigen presenting cells.
Neurological disorders may encompass a wide range of defective sorting and trafficking events
during the formation of a subset of synaptic vesicles (Danglot and Galli, 2007; Newell-Litwa et al.,
2007). The following sections summarize the main clinical symptoms of these syndromic diseases
and the relevant impaired LROs.

1.1.2a The Chediak-Higashi Syndrome
CHS is a very rare autosomal recessive disorder clinically manifested by partial oculocutaneous
albinism, immunodeficiency, bleeding tendency and progressive neurological dysfunction. At the
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cellular level, a characteristic feature of CHS is the abnormal large appearance of lysosomes
(Spicer et al., 1981) and some LROs including melanosomes (Zhao et al., 1994), MHC class II
compartments of antigen presenting cells (Faigle et al., 1998), lytic granules of CTLs and natural
killer (NK) cells (Baetz et al., 1995), and azurophilic granules of neutrophils (Kjeldsen et al., 1998).
Platelet-dense granules, on the other hand, are either absent or reduced in number (Kaplan et al.,
2008). The underlying genetic defects in CHS patients are inactivating mutations in the lysosomal
trafficking regulator (LYST) gene [or Chediak-Higashi syndrome (CHS1) gene], the protein product
of which is thought to either promote fission of endo-lysosomal organelles or prevent their fusion
(Bowman et al., 2019). The CHS1 protein product is extremely large (~4000 amino acids) and is a
member of the BEACH domain-containing protein family, but its function is not understood
(Cullinane et al., 2013). Hence, the mechanism by which LYST impacts LRO biogenesis is still
unclear.

1.1.2b The Griscelli Syndrome
GS is a group of rare autosomal recessive disorders characterized by pigment dilution of the skin
and hair, variable immunodeficiency, and in some cases severe neurological defects. Three types
of human GS (GS1-3) have been identified, all of which display hypopigmentation of hair and skin.
They are caused by mutations in genes respectively encoding three components of a complex
required for melanosome positioning within skin melanocytes: the processive actin-based motor
myosin Va (MYO5A), the Rab GTPase Rab27a (RAB27A) and a linker between them, melanophilin
(MLPH) (Van Gele et al., 2009). Myosin Va is recruited by Rab27a on mature melanosomes via
the linker MLPH, and promotes the peripheral distribution and motility of melanosomes along
peripheral actin filaments (Fukuda et al., 2002; Hume et al., 2002; Hume et al., 2001; Provance et
al., 2002; Strom et al., 2002; Wu et al., 2001; Wu et al., 2002a; Wu et al., 2002b). Defects in any of
these components result in the accumulation of melanosomes around the microtubule-organizing
center rather than at the plasma membrane, consequently leading to failed transfer of melanin from
melanocytes to keratinocytes for normal pigmentation (Ménasché et al., 2003; Ménasché et al.,
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2000; Pastural et al., 1997). Patients of GS type 1 also suffer from neurological defects because
mutations in MYO5A impairs neuronal development, axonal transport, dendritic spine structure,
and synaptic plasticity (Hammer and Wagner, 2013). Immunodeficiency observed in GS type 2 is
due to deficient Rab27a-mediated cytolytic granule secretion from cytotoxic T cells and NK cells
(Haddad et al., 2001; Stinchcombe et al., 2001).

1.1.2c The Hermansky-Pudlak Syndromes
HPS is group of autosomal recessive disorders characterized by OCA, a bleeding diathesis, and,
in some patients, pulmonary fibrosis, granulomatous colitis, and/or immunodeficiency. HPS is rare
in the general population (incidence estimated at 1:1,000,000) but has a high frequency in
northwestern Puerto Rico (1 in 1,800) due to genetic founder effects (Seward and Gahl, 2013).
Mutations in eleven different genes (HPS1, AP3B1, HPS3, HPS4, HPS5, HPS6, BLOC1S8,
BLOC1S3, BLOC1S6, AP3D1, and BLOC1S5) have been identified to associate with eleven HPS
subtypes (HPS1-HPS11) in humans (Li et al., 2022). These genes encode subunits of four cytosolic
obligate multisubunit protein complexes: adaptor protein (AP)-3, biogenesis of lysosome related
organelles complex (BLOC)-1, BLOC-2, and BLOC-3 (see detailed discussion in 1.1.3). All
mutations identified in HPS patients thus far inactivate the gene encoding a subunit of one of these
complexes, resulting in instability of the remaining subunits and loss of the complex (Huizing et al.,
2020). The loss of either of these complexes disrupts intracellular membrane and protein trafficking
pathways that are essential for the biogenesis of selected LROs (see detailed discussion in 1.2).

All HPS patients exhibit some degree of oculocutaneous albinism that results from defective
melanosome maturation and reduced melanin synthesis. Hence, the hair color of patients ranges
from white to brown and can occasionally darken with age, and the skin color can vary but is
typically lighter than that of non-HPS relatives. The eye color can also vary, but iris transillumination
is readily apparent, indicating defective pigmentation in the retina as in all OCA patients, and
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associated foveal hypoplasia causes poor visual acuity (Schneier and Fulton, 2013; Summers et
al., 1988).

The bleeding diathesis is another consistent clinical symptom found in all HPS patients. Affected
individuals suffer from spontaneous bruising, epistaxis, menorrhagia, and excessive bleeding that
could be life-threatening in some cases, such as childbirth. These bleeding disorders in HPS
patients primarily stem from the absent or severely deficient platelet dense granules (Seward and
Gahl, 2013). Other factors, such as abnormal release of contents from alpha granules and of
protein disulfide isomerase from “T granules” in platelets of HPS mouse models (Meng et al., 2015;
Sharda et al., 2015), and defective exocytosis of WPBs from patient-derived endothelial cells
(Karampini et al., 2019; Ma et al., 2016; Sharda et al., 2020), might also contribute to excessive
bleeding.

In addition to hypopigmentation and bleeding, some HPS subtypes suffer from additional
complications. HPS1, 2, and 4 patients invariably develop pulmonary fibrosis that is lethal without
treatment by the fourth to fifth decade of life (Seward and Gahl, 2013). The initiating factor for this
lung disorder appears to be the deficient biogenesis of lamellar bodies, a type of LRO in alveolar
type II (AT2) cells that is responsible for the production and secretion of pulmonary surfactant – a
key component necessary for the maintenance of normal lung homeostasis and compliance
(Atochina-Vasserman et al., 2011; Guttentag et al., 2005; Young et al., 2012).

A small subset of HPS1 and HPS4 patients also suffer from severe granulomatous colitis, the cause
of which is still unknown (Seward and Gahl, 2013). HPS2 and HPS10 patients, who lack AP-3,
manifest with recurrent viral and bacterial infections, which are due to impaired formation of LROs
in a number of innate and adaptive immune cell types including conventional dendritic cells,
plasmacytoid dendritic cells, cytotoxic T cells, and NK cells (Clark et al., 2003; Enders et al., 2006;
Fontana et al., 2006; Wenham et al., 2010). Individuals with HPS10 also have neurological
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disorders (Ammann et al., 2016; Mohammed et al., 2019) due to a loss of AP-3 from the central
nervous system.

1.1.3 HPS-associated protein complexes
Our current understanding of LROs is largely attributable to the discoveries of the cell biology of
human and animal models of HPS in which subsets of LROs are dysfunctional. The dysfunction of
LROs in these diseases arises primarily from impaired vesicular and membrane trafficking required
for LRO formation due to the loss of BLOC-3, BLOC-2, BLOC-1, or AP-3. In this section, these four
protein complexes will be discussed in detail (Figure 1.2).
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Figure 1.2

Figure 1.2 HPS-associated protein complexes
(A-D) Schematic representation of the assembly of HPS gene products into protein complexes.
Indicated are the subunit names and, for those subunits with distinct names, the HPS variant
associated with its genetic mutation. Red, subunits encoded by genes associated with HPS in both
humans and mice. Yellow, subunits associated with HPS only found in rodents. Subunits that are
known to be phosphorylated are indicated by P. BLOC-3 functions as a guanine nucleotide
exchange factor (GEF) for Rab32 and Rab38; the latter is mutated in a rat model of HPS. Figure is
adapted from (Di Pietro and Dell'Angelica, 2005)
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1.1.3a BLOC-3
BLOC-3 consists of two subunits, HPS1 and HPS4, that are encoded by the HPS1 and HPS4
genes (Fig. 1.2A). Mutations in these genes are responsible for HPS1 and HPS4 in humans, and
mutations in the corresponding mouse Hps1 and Hps4 genes underlie the mouse HPS models pale
ear and light ear, respectively (Bowman et al., 2019). HPS1 and HPS4, which are clinically similar
and the most severe forms of HPS, have relatively severe oculocutaneous albinism and bleeding
problems (Chiang et al., 2003; Martina et al., 2003; Nazarian et al., 2003). Particularly, HPS1
accounts for the prevalent form in northwestern Puerto Rico — one in twenty-one individuals in this
area carry a mutation in the HPS1 gene – and 50% of HPS cases outside of Puerto Rico. In addition
to OCA and bleeding diathesis, HPS1 and HPS4 patients and HPS1 mice present symptoms of
progressive pulmonary fibrosis, and some HPS1 and HPS4 patients additionally have
granulomatous colitis, a debilitating form of inflammatory bowel disease (Guttentag et al., 2005;
Seward and Gahl, 2013; Young et al., 2007). BLOC-3 is identified as the GEF for Rab32 and Rab38,
both of which have been shown to play a role in the biogenesis of several LROs (Bultema et al.,
2012; Gerondopoulos et al., 2012; Lopes et al., 2007; Wasmeier et al., 2006). Although loss of
Rab38 in rats causes an HPS-like disorder (Oiso et al., 2004), in other cell types, including
melanocytes, these two GTPases are partially redundant - hence, the Rab38-deficient chocolate
mice have a milder phenotype than HPS1 pale ear mice.

Pale ear and light ear mice have intact pigmentation in the hair, and melanosomes in the hair bulb
are normally dark but enlarged (Gardner et al., 1997; Nguyen et al., 2002; Suzuki et al., 2002). By
contrast, pigment dilution is found in the skin and eyes in which melanosomes are small, poorly
pigmented and largely depleted (Gardner et al., 1997; Nguyen and Wei, 2007; Suzuki et al., 2002).
Why do different pigmentation phenotypes co-exist in BLOC-3-deficient mice? Does defective
function of either Rab38 or Rab32 account for the hypopigmentation in patients and animal models
lacking HPS1 and HPS4? Although symptoms of Rab38 or Rab32 deficiency are quite similar to
BLOC-3 deficiency, the hair color of pale ear and light ear mice contrasts with that of chocolate
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mice. This might reflect two phenomena. First, Rab38 and Rab32 might be at least partially
redundant in some cell types; for example, in immortalized epidermal melanocytes, depletion of
both Rab38 and Rab32 is needed to observe a dramatic defect in melanosome biogenesis
(Wasmeier et al, 2006). Another potential explanation is that not all pigment cells are created equal;
it is possible that the pigment cells of the hair bulb in BLOC-3-deficient mice express a redundant
GEF for Rab38 and/or Rab32 that compensates for the loss of BLOC-3. More critical experiments
are needed to test this idea and perhaps search for an additional GEF for Rab38 and/or Rab32.
The enlarged and pigmented phenotype of BLOC-3-deficient melanosomes in some pigment cell
types might reflect a primary deficiency in retrograde transport from melanosomes and not in
anterograde melanosomal cargo transport (Dennis et al., 2016); this will be discussed further in
section 1.2.2c.

Pulmonary fibrosis and inflammatory bowel disease of HPS1 and HPS4 patients may result from
impaired physiological processes mediated by BLOC-3-dependent activation of Rab38/32. Like
pale ear mice, both the chocolate mice and the Rab38-mutant rats, Ruby, show abnormalities in
both lamellar bodies of AT2 cells and lung surfactant secretion (Guttentag et al., 2005; Osanai et
al., 2010; Osanai et al., 2008). Inflammatory bowel disease reflects an increased susceptibility of
HPS patients to environmental stimuli. This sensitivity is usually associated with innate immune
defects that often mirror the reduced ability of macrophages and monocytes to restrict bacterial
infection. It is reported that Rab32, which is highly expressed in macrophages and monocytes
(Gurkan et al., 2005), accumulates on the phagosomes or vacuoles containing pathogenic bacteria
following phagocytosis. This appears to be necessary for the restriction of certain bacteria, such as
Salmonella typhi (Spano and Galan, 2012). Overexpression of a dominant negative form of Rab32
compromises cathepsin D recruitment to phagosomes (Hoffmann et al., 2014; Seto et al., 2011;
Spano and Galan, 2012). Together, these data suggest that Rab32 may promote the fusion of
phagosomes with lysosomes for bacterial killing in macrophages. It is possible that the
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inflammatory bowel disease in HPS1 and HPS4 patients might reflect an impaired BLOC-3/ Rab32
axis in macrophages and monocytes.

1.1.3b BLOC-2
BLOC-2 is comprised of three subunits, HPS3, HPS5 and HPS6, and gene mutations found in
these subunits give rise to human HPS subtypes 3, 5, and 6, respectively, as well as to the
corresponding cocoa, ruby-eye 2, and ruby-eye HPS mouse models (Fig. 1.2B) (Bowman et al.,
2019). Patients with BLOC-2 deficiency display mild oculocutaneous albinism, but some HPS5 and
HPS6 patients and their mouse models show more severe bleeding disorders (Anikster et al., 2001;
Huizing et al., 2001a; Huizing et al., 2004; Huizing et al., 2009; Ringeisen et al., 2013; Stephen et
al., 2017; Zhang et al., 2003). The bleeding problem in these patients and mouse models might be
exacerbated by defects in WPB maturation and secretion due to the apparently unique role of
BLOC-2, and not other HPS complexes, in this process (Ma et al., 2016; Sharda et al., 2015;
Sharda et al., 2020). Thus, besides the absence of dense granules, HPS6 patients may have
impaired WPB function that worsens the bleeding disorder. BLOC-2-deficient patients and mouse
models lack the lung and hyperinflammatory phenotypes observed in BLOC-3-deficient patients.

The role of BLOC-2 in LRO biogenesis is not entirely characterized, but some of its functions have
been identified. In pigment cells, BLOC-2 functions in one pathway of cargo transport to
melanosomes for melanin synthesis; melanocytes lacking BLOC-2 mistarget a set of melanosome
cargoes to the Golgi, plasma membrane and endosomes (Dennis et al., 2015). In endothelial cells,
BLOC-2 is reported to facilitate trafficking of the v-ATPase to the WPB membrane and thus
maintain the acidic luminal pH of the WPB, which is critical for the formation of vWF tubules (Lu et
al., 2021). Additional data suggest that BLOC-2 mediates endosomal input to WPBs for vWF
maturation (Ma et al., 2016; Sharda et al., 2020).
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1.1.3c BLOC-1
BLOC-1 contains eight subunits: BLOS1, BLOS2, BLOS3, BLOS4 (a.k.a. Cappuccino), BLOS5
(a.k.a. muted), BLOS6 (a.k.a. Pallidin), BLOS7 (a.k.a. snapin), and BLOS8 (a.k.a. dysbindin) (Fig.
1.2C). These subunits in humans are encoded by the BLOC1S1-8 genes, respectively (Bowman
et al., 2019). Mutations in the BLOC1S3, BLOC1S5, BLOC1S6 and BLOC1S8 genes have been
identified in patients with HPS8 (Cullinane et al., 2012; Morgan et al., 2006), HPS11 (Pennamen et
al., 2020a), HPS9 (Cullinane et al., 2011), and HPS7 (Bryan et al., 2017; Li et al., 2003; Lowe et
al., 2013), respectively. Individuals with BLOC-1 deficiency tend to have mild HPS symptoms
including incomplete OCA (less obvious than other HPS subtypes) and a moderate bleeding
diathesis, and no pulmonary disease or immunodeficiency is observed. Five HPS mouse models
of BLOC-1 deficiency (BLOS3: reduced pigmentation; BLOS4: cappuccino; BLOS5: muted; BLOS6:
pallid; BLOS8: sandy) display similar features but their hypopigmentation phenotypes are the most
severe among all HPS models (Bowman et al., 2019). The BLOS1, BLOS2 and BLOS7 subunits
are shared with another complex called BORC that functions ubiquitously to maintain lysosome
positioning in all cell types (Pu et al., 2015). Defects in these genes have not been associated with
HPS, which might reflect a more central, and perhaps essential, function of BORC.

The function of BLOC-1 in melanosome biogenesis has been well studied. In melanocytes, BLOC1 is an essential component of a transport pathway responsible for delivering a cohort of
transmembrane protein cargos to melanosomes (Le et al., 2021; Sitaram and Marks, 2012). BLOC2, AP-3, and other cytoskeleton factors also function in this pathway. Platelets in BLOC-1-deficient
mice also have the most severe bleeding deficiency (Novak and Swank, 1984; Meng et al 2015),
suggesting a central role in platelet dense granule biogenesis. However, our understanding of the
role of BLOC-1 in regulating other LROs that impact HPS patients is very limited.
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1.1.3d AP-3
AP-3 belongs to a family of heterotetrameric adaptor protein complexes (AP) that recognize and
bind to sorting signals of cargo proteins, recruit clathrin and/or other accessory proteins to the site
to generate transport carriers, and then concentrate the cargo proteins into the carriers for delivery
to targeted organelles (Park and Guo, 2014). AP-3 consists of four subunits: δ, β3 (isoform β3A or
β3B), μ3 (isoform μ3A or μ3B) and σ3 (isoform σ3A or σ3B) (Fig. 1.2D). In mammals, the A isoforms
and both σ3 isoforms are ubiquitously expressed in almost all tissues and cells, whereas the B
isoforms of μ3 and β3 are specifically expressed in neuronal cells (Dell'Angelica et al., 1997). The
μ3 subunits recognize cargos via cytoplasmically-exposed tyrosine-based sorting signals that
conform to the YxxΦ motif (Mardones et al., 2013; Ohno et al., 1998), while the interface between
σ3 and δ subunits binds to cytoplasmically-exposed dileucine-based sorting signals that fits the
consensus motif (D/E)xxxL(L/I). Both types of motifs can be also recognized by AP-1 and AP-2
(Janvier and Bonifacino, 2005; Janvier et al., 2003; Kelly et al., 2008), but variations in the nonessential residues contribute to specificity for one or more of the adaptors (Ohno et al., 1998;
Sitaram et al., 2012). The AP3B1 gene encoding β3 and the AP3D1 gene encoding δ are mutated
in humans with HPS2 (Dell'Angelica et al., 1999; Huizing et al., 2002; Jung et al., 2006) and HPS10
(Ammann et al., 2016; Kantheti et al., 1998), respectively, and the corresponding genes are
mutated in pearl and mocha mice, respectively (Dell'Angelica et al., 1999; Kantheti et al., 1998).
These gene mutations result in AP-3 instability and consequent defects in LRO biogenesis and
protein cargo sorting to lysosomes (Dell'Angelica, 2009), causing symptoms that include
oculocutaneous albinism (mild in humans compared to individuals with BLOC-3 deficiency),
prolonged bleeding, lung disease (Hengst et al., 2018), and recurrent bacterial and viral infections
due to impaired immune responses (Ammann et al., 2016; Chiang et al., 2010; Fontana et al., 2006;
Huizing et al., 2002; Jung et al., 2006; Wenham et al., 2010). HPS10 individuals and mocha mice,
but not HPS2 individuals and pearl mice, additionally display neuronal deficiencies because of
impaired AP-3-dependent synaptic vesicle formation in neurons (Ammann et al., 2016; Nakatsu et
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al., 2004; Newell-Litwa et al., 2009; Salazar et al., 2004); this reflects the loss of the single AP-3δ
chain that functions in both ubiquitous and neuron-specific AP-3 complexes.

In melanocytes, AP-3 facilitates the sorting of multiple melanogenic cargoes to melanosomes for
melanin synthesis. These cargoes include TYR, which catalyzes the limiting steps in melanin
synthesis, and the melanosomal chloride channel oculocutaneous albinism type 2 (OCA2) that
regulates melanin synthesis by modulating melanosome pH (Bellono et al., 2014). Both cargoes
are recognized by AP-3 via dileucine-based sorting signals (Sitaram et al., 2012; Theos et al.,
2005a)

The exact role of AP-3 in dense granule biogenesis is not clear so far but is believed to mediate
cargo sorting to dense granules to ensure proper function. One such cargo might be SLC35D3, a
member of the nucleotide sugar transporter family. An inactivating mutation in Slc35d3 in mice
underlies the platelet dense granule defect in the ashen-Roswell strain of mice (Chintala et al.,
2007), indicating that SLC35D3 function is critical for dense granule biogenesis. SLC35D3 harbors
2 potential YxxØ consensus sorting signals that might engage AP-3, and protein levels of SLC35D3
are down-regulated in AP-3-deficient pearl mice (Meng et al., 2012) – which have a dramatic loss
of morphologically identifiable dense granules and content (Novak et al., 1984) – suggesting that
AP-3 might be responsible for targeting SLC35D3 to dense granules. Two studies suggest that a
putative serotonin transporter, vesicular monoamine transporter 2 (VMAT2), might localize to
dense granules via an AP-3-depenent dileucine-like (KEEKMAIL) sorting motif (Ambrosio et al.,
2012; Asensio et al., 2010), but currently there is no solid published evidence to document the AP3-dependent interaction and localization to bona fide dense granules. Preliminary data from the
Marks laboratory suggest that the sorting signals in SLC35D3, but not in VMAT2, can engage AP3 in vitro (Hanby, 2017).
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As indicated earlier, WPB maturation in endothelial cells requires the delivery of CD63 from
endosomes. This process requires AP-3-dependent recognition of a tyrosine-based sorting signal
in the CD63 cytoplasmic domain (Harrison-Lavoie et al., 2006). Thus, defective WPBs in
endothelial cells might contribute to the bleeding tendency of HPS2 and HPS10 patients and their
mouse models. While WPB maturation also requires P-selectin delivery from endosomes, Pselectin is recruited to WPBs in endothelial cells by an AP-3-independent mechanism that requires
sorting information within both its cytoplasmic and luminal domains (Harrison-Lavoie et al., 2006).

The recurrent bacterial and viral infections in HPS2 and HPS10 patients and their mouse models
reflect a variety of AP-3-dependent functions in innate and adaptive immune cells. In CTLs and
presumably in NK cells, AP-3 is required for proper mobilization of cytolytic granules along
microtubules towards the immunological synapse; hence, AP-3-deficient CTLs and NK cells are
unable to effectively kill target cells (Clark et al., 2003; Fontana et al., 2006; Jung et al., 2006;
Wenham et al., 2010). The lipid antigen-presenting molecules, human CD1b and mouse CD1d,
require AP-3 for trafficking to late endosomal/ lysosomal compartments for efficient antigen
presentation; hence, AP-3-deficient cells fail to properly present critical lipid antigens to NK T cells
(Briken et al., 2002; Cernadas et al., 2003; Elewaut et al., 2003; Sugita et al., 2002). In dog
neutrophils, AP-3 is required for the delivery of elastase to azurophilic granules, and impaired
elastase delivery in AP-3-deficient cells might contribute to the cyclical neutropenia observed in
HPS2 patients (Meng et al., 2010). In plasmacytoid dendritic cells, AP-3 is necessary for trafficking
of the nucleic acid-binding TLR9 and TLR7 to specialized LROs that facilitate critical steps in
activating interferon signaling, likely resulting in impaired immunity to viruses and extracellular
bacteria (Blasius et al., 2010; Sasai et al., 2010). In conventional dendritic cells, AP-3 is required
for TLR4 sorting and/or retention on maturing phagosomes, where it stimulates MyD88-dependent
signaling to enhance proinflammatory responses and bacterial antigen presentation to CD4+ T cells
(Mantegazza et al., 2012). This process also requires the recruitment of the lipid kinase PI4KIIα to
generate local phosphatidylinositol-4-phosphate to stabilize MyD88 on the phagosome membrane
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(López-Haber et al., 2020b). Thus, AP-3 plays many important roles in multiple cell types to
regulate adaptive and innate immunity.

1.2 Cargo trafficking pathways
As discussed earlier, LRO biogenesis and function require specialized trafficking routes that exploit
unique molecular machineries to segregate tissue-specific contents from classical endo-lysosomal
compartments and specifically to LROs of host cells. Although they are ubiquitously expressed,
HPS associated complexes (AP-3 and BLOCs) function in cell type-specific manners, perhaps in
conjunction with cell type-specific components, to organize a dedicated transport system to
spatiotemporally control cargo sorting and transport. Melanosome biogenesis in skin melanocytes
has served as the primary model system for studying LRO trafficking mechanisms, and studies to
date have provided much insight into how cells accurately transport cargo proteins to nascent LROs.
This section will discuss the trafficking pathways mediated by HPS-associated complexes during
melanosome biogenesis (Figure 1.3).
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Figure 1.3

Figure 1.3 Cargo transport pathways to and from melanosomes.
① AP-3-dependent vesicular transport. The melanogenic enzyme TYR is sorted by AP-3 into
vesicular carriers that eventually traffic to and fuse with maturing melanosomes. ② BLOC-1dependent tubular transport. Cargos such as TYRP1, ATP7A, and OCA2 are sorted by AP-1
(TYRP1 and ATP7A) or AP-3 (OCA2) into endosome-derived tubular carriers for melanosomebound transport. These tubules require BLOC-1 for initiation and elongation through coordination
with the microtubule motor protein KIF13A and its adaptor AP-1. Fusion of the tubules with the
melanosome membrane requires BLOC-2, and is mediated by the vSNARE VAMP7 complexing
with an unknown tSNARE complex on the melanosome membrane. VAMP7 is sorted into the
tubules likely as a cis-SNARE complex with STX13 and unknown Qabc SNARE helices via a
mechanism in which VAMP7 is engaged by AP-3δ (δ) within the AP-3 complex and STX13 is
engaged by the Pallidin (P) subunit of BLOC-1 within an AP-3–BLOC-1 super-complex. The
disassembly of this cis-SNARE complex frees VAMP7 to engage with the melanosomal tSNARE.
③ Rab6-mediated vesicular transport. Melanosomal proteins (e.g., DCT and MART-1) are
transported by vesicular carriers to maturing melanosomes directly from the Golgi via a Rab6ELKS-dependent pathway. ④ BLOC-3-dependent retrograde tubular transport from melanosomes.
Non-resident proteins (e.g., VAMP7) are recycled via melanosome-derived tubular carriers that in
a process that requires BLOC-3 — a GEF for Rab32/28 — and VARP – an effector for Rab32/38.
Figure adapted from (Bowman et al., 2019; Bowman et al., 2021)
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1.2.1 Golgi-derived pathway
Currently, two melanogenic proteins [dopachrome tautomerase (DCT) and melanoma-associated
antigen 1 (MART-1)] have been shown to be transported directly from the TGN to melanosomes
by vesicular carriers that are dependent on Rab6, a small GTPase of the Rab family, and its effector,
ELKS (Patwardhan et al., 2017) (Fig. 1.3, see ③). Interestingly, Rab6 and ELKS are also required
for the conventional secretory route from the Golgi to the plasma membrane (Grigoriev et al., 2007).
In melanocytes, Rab6 is required for the formation of Golgi-derived secretory vesicles that are
loaded with melanogenic cargos, and then facilitates the transport of these vesicles towards
melanosomes. ELKS then functions to restrict targeting and docking of these cargos to
melanosomes. How the Rab6-ELKS-dependent pathway determines the direction of transport —
either to the plasma membrane or to melanosomes — is not clear.

1.2.2 Endosome-derived pathways
The majority of known melanogenic cargos including TYR, TYRP1, OCA2, ATP7A, and likely
SLC45A2 use endosome-derived anterograde pathways to reach melanosomes by two different
types of transport carriers: vesicular and tubular. A retrograde pathway from melanosomes is also
needed to ensure that those membrane proteins that participate in the forward trafficking pathways
are recycled to endosomes and available for another round of anterograde transport. In this section,
I will discuss how AP-3 and BLOCs coordinate with other necessary factors, including the AP-3like complex AP-1 and the microtubule-based motor protein KIF13A, to construct the endosomederived transport pathways.

1.2.2a AP-3-dependent vesicular transport
AP-3 is required for anterograde vesicular transport from endosomes to melanosomes. In this
transport pathway, AP-3 localizes to early endosomes, where it recognizes TYR via its dileucinebased sorting signal and accumulates TYR into an AP-3-coated patch (Fig. 1.3, see ①). AP-3,
together with clathrin, facilitates the formation of TYR-loaded vesicular carriers that are then
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targeted to melanosomes by poorly understood mechanisms to initiate melanin synthesis (Theos
et al., 2005a). The small GTPase Rab4A might play a role in this process (Nag et al 2018). In
melanocytes that lack AP-3, TYR is depleted from melanosomes and accumulates in vacuolar
endosomes and MVBs (Theos et al., 2005a). However, a small cohort of TYR is still properly sorted
to melanosomes in melanocytes from AP-3-deficient mice such as the Ap3b1-deficient pearl mouse
and the Ap3d1-deficient mocha mouse. In these cells, TYR is likely instead sorted by AP-1 to
melanosomes, as these cells harbor an increased quantity of AP-1-coated TYR-containing vesicles
in close proximity to melanosomes (Theos et al., 2005a). This may explain the remaining pigment
in pearl melanosomes (Theos et al., 2005a), and also suggests a parallel route that might engage
AP-1. The existence of a parallel route that is regulated by AP-1 is supported by the transport of
TYRP1, which contains a dileucine-based sorting signal that is recognized by AP-1 but not by AP3 and is at least partially localized to melanosomes in AP-3-deficient melanocytes (Delevoye et al.,
2009; Huizing et al., 2001b; Theos et al., 2005a). It turns out that the parallel route is a BLOC-1dependent pathway.

1.2.2b BLOC-1-dependent tubular transport
BLOC-1 plays an essential role in the tubular transport pathway from endosomes to melanosomes.
This pathway uniquely requires BLOC-1 to generate recycling-endosome-like tubular transport
carriers from early sorting endosomes that ultimately fuse with melanosomes, delivering cargoes
such as TYRP1, OCA2, and ATP7A (Delevoye et al., 2016; Delevoye et al., 2009; Setty et al., 2008;
Setty et al., 2007; Sitaram et al., 2012) (Fig. 1.3, see ②). BLOC-1 plays at least two roles in
generating the tubules. First, BLOC-1 has a curvilinear structure, like a banana, that favors binding
to curved membranes and stabilizes a membrane bud as it emerges from a vacuolar early
endosome (Delevoye et al., 2016; Jani et al., 2021; Lee et al., 2012). Second, it binds to the kinesin3 microtubule motor, KIF13A, and facilitates the activity of this motor in pulling the tubules from the
endosome along microtubules (Delevoye et al., 2016; Delevoye et al., 2014). KIF13A is recruited
to the membrane in a manner requiring AP-1 (Delevoye et al., 2016; Delevoye et al., 2009;
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Nakagawa et al., 2000). In addition, BLOC-1 is required for the recruitment to the bud neck of
Annexin A2 (AnxA2), an activator of Arp2/3-dependent polymerization of branched actin filaments;
both AnxA2 and Arp2/3 activity are required to stabilize the tubule, perhaps to form a pedestal
against which KIF13A can exert force (Delevoye et al., 2016). In other cell types, the Wiskott Aldrich
Syndrome protein and scar homologue (WASH) complex fulfills a similar role in activating actin
polymerization in conjunction with BLOC-1 (Ryder et al., 2013). As the tubule is forming,
melanogenic cargos are sorted by either AP-1 [e.g. for TYRP1 (Delevoye et al., 2009) and likely
ATP7A (Holloway et al., 2013; Yi and Kaler, 2015)] or AP-3 [e.g. for OCA2 (Sitaram et al., 2012)]
onto the tubule for transport and delivery to melanosomes.

Once the tubule is formed, it is extended by KIF13A along microtubules and targeted to maturing
melanosomes. Tubule stability and targeting to melanosomes requires BLOC-2, although its
mechanism of action is not known (Dennis et al., 2015). Transient fusion with the melanosome is
mediated by the vSNARE VAMP7 (Dennis et al., 2016), which in other cells facilitates fusion of late
endosomes with lysosomes and autophagosomes (Advani et al., 1999; Takats et al., 2013; Ward
et al., 2000). VAMP7 is sorted onto the tubules in complex with the Qa-SNARE (tSNARE subunit)
syntaxin 13 (STX13), likely within a four helix cis-SNARE complex, by a redundant mechanism in
which VAMP7 can directly bind to AP-3 and STX13 binds to BLOC-1 (Bowman et al., 2021; Ghiani
et al., 2010; Huang et al., 1999; Moriyama and Bonifacino, 2002) (Appendix Fig. 1). In order to
mediate fusion with melanosomes, the VAMP7-STX13 complex must ultimately be dissociated to
release free VAMP7; the fusion then results in VAMP7 delivery with cargo to the maturing
melanosome. Live cell imaging analyses suggest that fusion is transient, and that the tubule retracts
back to the endosome after cargo delivery (Dennis et al., 2015). VAMP7 is recycled back to the
membrane of origin in a process requiring BLOC-3 (see below) to mediate additional rounds of
cargo trafficking.
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1.2.2c BLOC-3-dependent tubular retrograde transport
Melanosome size is maintained at a constant level as melanosomes mature from stage II to stage
IV. Thus, any forward membrane traffic must be balanced by retrograde transport from
melanosomes to remove excess membrane. Moreover, the trafficking and fusion machineries, such
as VAMP7, must be recycled to early endosomes to promote additional rounds of forward transport.
VAMP7 is recycled from melanosomes via tubular transport carriers from melanosomes by a
mechanism that requires BLOC-3 (Fig. 1.3, see ④). It is worth noting that these melanosomederived tubules are devoid of melanosomal proteins, such as TYRP1 and OCA2, consistent with
the notion that only unneeded proteins are recycled from melanosomes. How does BLOC-3
regulate retrograde pathway to recycle VAMP7? BLOC-3 serves as the GEF to activate Rab38 and
Rab32 and promotes the recruitment of these Rab proteins to melanosomes (Gerondopoulos et al.,
2012); the activated Rab38 and/or Rab32 recruits its effector VARP to melanosomes where VARP
interacts with VAMP7 and likely recruits retromer complex, which has been shown to play an
important role in membrane tubule formation (Purushothaman et al., 2017), to generate tubules
(Dennis et al., 2016; Tamura et al., 2009). The tubules contain VAMP7 as well as Rab38, and are
severed from the tubules by a mechanism that requires the actin-based motor myosin VI and actin
nucleation, respectively (Dennis et al., 2016; Ripoll et al., 2018). The function of BLOC-3 in
retrograde transport may explain in part the enlarged melanosome phenotype in pale ear and light
ear mouse melanocytes.

However, some evidence suggests that BLOC-3, Rab32, and Rab38 play a direct role in
anterograde cargo transport to melanosomes. Rab32 and Rab38 are found to collaboratively
regulate trafficking of melanogenic enzymes, e.g., TYR and TYRP1, to melanosomes (Bultema et
al., 2012; Wasmeier et al., 2006). Additional depletion of Rab32 in melanocytes of Rab38-deficient
chocolate mice causes further pigment loss, mature melanosome depletion and missorting/
degradation of TYR and TYRP1 (Wasmeier et al., 2006). Similarly, retinal pigment epithelia (RPE)
from Rab38-deficient chocolate mice display fewer melanosomes and TYR mislocalization (Lopes
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et al., 2007). Knockdown of either HPS1 or HPS4 in MNT-1 melanoma cells by siRNA also causes
TYRP1 mistargeting, pigment dilution, mature melanosome depletion, and non-pigmented early
stage melanosome accumulation (Gerondopoulos et al., 2012). These data might reflect a direct
role for BLOC-3, Rab32, and Rab38 in anterograde traffic. However, these data might also be
interpreted as an indirect role of these proteins in recycling VAMP7, which is needed in the forward
pathway. A failure to recycle VAMP7 would cause the entrapment of VAMP7 on melanosomes and
consequently would deplete VAMP7 from early endosomes, disrupting anterograde trafficking as
seen with VAMP7 knockdown (Dennis et al., 2016; Jani et al., 2015; Tamura et al., 2011). The role
of BLOC-3 and Rab38 in retrograde transport is consistent with both melanosomal localization of
Rab32 and Rab38 (Bultema et al., 2012; Gerondopoulos et al., 2012) and their presence on
tubulovesicular membranes (Wasmeier et al., 2006) that might correspond to retrograde transport
intermediates.

1.3 Membrane deformation and membrane tubule-based cargo transport
1.3.1 Mechanisms of membrane deformation
Membrane and cargo trafficking between compartments of the secretory and endosomal systems
typically require the generation from a donor compartment of transport carriers that incorporate
specific donor cargoes, the movement of these transport carriers towards the target compartment,
and then engagement and fusion with the target compartment to deliver the cargoes. Transport
carriers can be in the form of membrane tubules or vesicles. The generation of transport carriers
requires membrane deformation driven by a complex interplay between lipid molecules within the
membrane bilayers and proteins that are associated with the membrane. This section will discuss
the mechanisms by which lipids and proteins effect membrane deformation.

1.3.1a Lipid-mediated effects on membrane deformation
Membrane lipids primarily consist of a hydrophilic head group and lipophilic regions that are
embedded in the bilayer. The head groups can range in size from a single proton (e.g., in
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cholesterol or phosphatidic acid) to large and complex oligosaccharide chains (e.g., on
glycosphingolipids). For glycerophospholipids and sphingolipids, the lipophilic regions consist of
acyl chains that can be of various length and saturation, and thus can occupy different volumes
within the bilayer. Hence, membrane lipids can vary substantially in size and shape (Bruce Alberts
et al., 2014).

The selective lipid transfer between leaflet can induce and/or support membrane curvature (Fig.
1.4, see ①). The lipid molecules in cell membranes are in a disordered liquid state and they can
diffuse and, under some conditions, mix between bilayer leaflets (Singer and Nicolson, 1972).
Selective transfer of lipids from one leaflet to the other can promote spontaneous membrane
deformation by inducing surface-area asymmetry between leaflets (Farge and Devaux, 1992;
Farge et al., 1999).

The shape of lipid molecules has a major impact on the ability of the lipid to induce and/or support
membrane curvature (Fig. 1.4, see ②). The asymmetry between bilayer leaflets can also stem
from distinct geometries of lipid molecules owing to different physico-chemical properties of lipid
headgroups or tails. For example, lysophosphatidylcholine promotes positive membrane curvature
due to its “cone”-like shape based on the geometry of its large head group and narrower tail; by
contrast, phosphatidylethanolamine and ceramide, both of which tend to have an inverted “cone”like structure, possibly help to generate negative membrane curvature because a row of aligned
lipids tends to invaginate to bend the membrane (Burger, 2000; Chernomordik, 1996; Fuller and
Rand,

2001).

Enzymatic

changes

to

lipid

headgroups,

such

as

phosphorylation

of

phosphatidylinositols, or to the acyl chains, such as through the activity of phospholipases, can
cause inducible changes to membrane curvature required for vesicle or tubule initiation.

The insertion of cholesterol in one leaflet of the membrane bilayer can also facilitate membrane
curvature (Fig. 1.4, see ③). Cholesterol-mediated membrane deformation may reflect two possible
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scenarios: on one hand, the selective enrichment of cholesterol in one leaflet may change the
relative surface area between bilayers and thus create asymmetry between them; on the other
hand, the accumulation of cholesterol could decrease membrane rigidity and minimize the energy
needed for deforming the membrane by preserving hydrophobic and van der Waals forces between
the leaflets (Baba et al., 2001; Brown et al., 2001b; Brown et al., 2002).
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Figure 1.4

Figure 1.4 Lipid-mediated effects on membrane deformation.
① Selective transfer of lipid molecules from one leaflet to the other could promote spontaneous
membrane curvature by inducing surface-area asymmetry between leaflets. Black arrowheads
indicate the transferred lipids. ② Lipid molecules with distinct geometries of head groups could
play a role in generating either positive or negative membrane curvature. Black arrowheads indicate
lipid molecule with either large (cone-like shape) or small (inverted cone-like shape) head groups.
③ Cholesterol insertion into one leaflet could facilitate membrane deformation by introducing a
bilayer surface-area discrepancy and decreasing membrane rigidity. Black arrowheads indicate
cholesterol insertion. Figure is adapted from (Farsad and De Camilli, 2003)

32

1.3.1b Protein-mediated effects on membrane deformation
Studies over the last 20 years or so have implicated various roles for cytosolic proteins in inducing
and/or stabilizing membrane deformation upon recruitment to the membrane. Partial or full insertion
of proteins into membrane bilayers can induce membrane bending (Fig. 1.5). For instance, the
insertion of an amphipathic helix or hydrophobic domain into one leaflet of the bilayer, which has
been observed for the active GTP-bound form of the Sar1 GTPase (Lee et al., 2005) that can result
in increased positive membrane curvature by generating asymmetry (Fig. 1.5A). The hydrophobic
residues of amphipathic helices can insert into the hydrophobic phase of an individual leaflet; this
insertion can displace local lipid headgroups and reorient acyl chains, leading to not only surface
asymmetry but also a reordering of the lipids in one leaflet, inducing a bend (Ford et al., 2002; Peter
et al., 2004) (Fig. 1.5A). This mechanism explains the membrane deformation induced by the
ENTH domain of epsin (Fig. 1.5A) (Ford et al., 2002) or amphiphysin (Fig. 1.5B) (Peter et al., 2004),
both of which possess amphipathic helices, during clathrin-mediated endocytosis. In addition to
amphipathic helix insertion, some transmembrane proteins with unique wedge-like shapes can also
introduce curvature by their transmembrane domains (Fig. 1.5C). For example, the dopamine
transporter (DAT) (Fig. 1.5C) is thought to have a wedge shape (Penmatsa et al., 2013), and the
targeting of DAT to filopodia allows for locally concentrated DAT to induce an outward membrane
bending (Caltagarone et al., 2015). Some transmembrane proteins or lipids without “curved”
shapes can contribute to membrane deformation by self-clustering (Fig. 1.5D). For example,
clustering of glycosphingolipids by bound Shiga toxin drives membrane invagination by inducing
asymmetry in the external leaflet of the membrane (Fig. 1.5D) (Romer et al., 2007). The clustering
of transmembrane proteins also couples with the lipid reorganization (Escriba et al., 2008).
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Figure 1.5

Figure 1.5 Mechanisms of protein partial or full insertion into membrane bilayers for
membrane deformation.
(A) Some curvature-inducing proteins insert an amphipathic helix or hydrophobic domain into one
leaflet of the bilayer to deform the membrane. (B) Insertion of an amphipathic helix on a protein
into the membrane can induce curvature and cooperate with another domain of the same protein
that scaffolds the curvature. (C) Proteins with a wedge-like shape can introduce curvature via their
transmembrane domains. (D) An individual transmembrane protein without a curved shape can
bend the membrane via self-clustering coupled with lipid reorganization. Figure is adapted from
(Jarsch et al., 2016).
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Some peripheral binding proteins deform the membrane by self-oligomerization to act as scaffold.
For example, coat proteins such as clathrin, COPI and COPII impact membrane remodeling by
orderly oligomerizing into curved structures that can be seen as exoskeletons to scaffold
membranes (Fig. 1.6C) (Antonny et al., 2003; Nossal, 2001). Their function requires interaction
with membrane-embedded proteins rather than a direct association with the lipid bilayer. In addition
to oligomerization of ordered proteins, intrinsically disordered proteins such as Epsin1 and AP180
can also oligomerize to drive membrane curvature (Fig. 1.6E) (Busch et al., 2015). The disordered
domains have large hydrodynamic radii, and a high density of disordered proteins such as Epsin1
and AP180 can occupy a highly crowded membrane surface, generating steric pressure that drives
membrane bending (Fig. 1.6E) (Busch et al., 2015). Recent studies suggest that this might be
facilitated by phase transition of the concentrated disordered domains (Yuan et al., 2021). Protein
crowding can not only deform but in some cases can sever membranes (Snead and Stachowiak,
2018; Stachowiak et al., 2012). Even proteins unrelated to membrane curvature, such as green
fluorescent protein (GFP) (Fig. 1.6E), can bend membranes when sufficiently concentrated
(Stachowiak et al., 2012).

Proteins with a concave shape, such as proteins possessing a Bin-Amphiphysin-Rvs (BAR) domain,
can either produce membrane curvature directly or sense and stabilize membrane curvature (Fig.
1.6A and B). BAR domain proteins are usually dimers that possess lipid binding properties on their
concave surface, and preferentially bind to curved membranes, as shown by their interaction with
artificial liposomes that have similar curvature to that of the BAR domain (Peter et al., 2004). Some
BAR domains, referred to as N-BAR domains, associate with N-terminal amphipathic helices to
induce membrane bending and stabilize the curvature (Figs. 1.5B and 1.6A). N-BAR domains are
found in amphiphysin, endophilin and BRAP1/Bin2, all of which facilitate endocytosis and
endosomal trafficking (Boucrot et al., 2015; Ge and Prendergast, 2000; Wigge et al., 1997). Both
the banana-shaped FCH-BAR (F-BAR) and N-BAR domains produce positive curvature (Fig. 1.6A),
whereas cigar-shaped Inverse-BAR (I-BAR) domains generate negative curvature (Simunovic et
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al., 2015) (Fig. 1.6B). Other proteins can polymerize into helical structures on the membrane
surface to deform the membrane (Fig. 1.6D). The ESCRT-III proteins constitute one family of
protein complexes whose subunits polymerize into filaments that assemble into different
architectures; the dynamic transition between conical spirals and cylindrical helices drives
membrane deformation (Pfitzner et al., 2021).
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Figure 1.6

Figure 1.6 Mechanisms by which peripheral binding proteins deform membranes.
(A, B) Intrinsically curved proteins, such as the BAR domain protein superfamily, can either induce
membrane curvature directly or sense and stabilize membrane curvature. F-BAR and N-BAR
domains produce positive curvature (A), whereas I-BAR domains generate negative curvature (B).
(C) Ordered protein oligomerization into a curved structure, such as on coat proteins like clathrin,
can act as a scaffold that promotes or stabilizes membrane deformation. (D) Protein oligomerization
into a helical structure, as in ESCRT-III proteins, induces membrane invagination. (E) Protein
crowding, such as is observed in endocytic regulators, generates steric pressure that drives
membrane bending. Figure is adapted from (Jarsch et al., 2016).
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Cytoskeletal elements play a critical role in not only providing tracks for membrane traffic but also
participating in membrane remodeling (Fig. 1.7). They can directly associate with membranes to
exert an external force to deform the membrane in several ways. The polymerization of cytoskeletal
elements such as actin can push the membrane to enforce a protrusion; outward pushing by
polymerizing actin filaments is important for generating structures such as filopodia and
lamellipodia at the plasma membrane (Fig. 1.7A) (Krause and Gautreau, 2014; Mattila and
Lappalainen, 2008), whereas actin polymerization from the plasma membrane on invaginating
membranes can promote endocytosis (Fig. 1.7B) (Collins et al., 2011). For example, in vitro
reconstitution of the actin filament network on the surface of giant unilamellar vesicles in vitro
generates local filopodium-like protrusions by pushing the membrane with forces exerted by actin
polymerization (Fig. 1.7A) (Liu et al., 2008). On the other hand, cytoskeletal elements outside the
membrane compartment, with the help of motor proteins, can exert distinct forces on a membrane
to constrict the neck of a membrane bud (Fig. 1.7B) or pull out a tubule from the membrane
compartment (Fig. 1.7C). For example, myosin motor activity on membrane-associated actin
filaments can constrict and elongate the membrane neck to drive membrane fission (Fig. 1.7B)
(Ripoll et al., 2018; Sun et al., 2006). As another example, membrane-associated microtubule
motors can pull a membrane tubule from a membrane compartment along microtubule tracks (Fig.
1.7C); this type of active tubule formation is observed during the generation of recycling endosomes
from early sorting endosomes through the activity of the kinesin 3 motor, KIF13A (Delevoye et al.,
2016; Delevoye et al., 2009; Du et al., 2016; Nakagawa et al., 2000).
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Figure 1.7

Figure 1.7 Mechanisms by which cytoskeleton and associated regulators and motors induce
membrane deformation.
(A-C) Cytoskeletons in collaboration with their associated regulators can push on membranes to
enforce a protrusion (A), invaginate the membrane by pushing on the membrane neck (B), or pull
a tubule from the membrane with the help of motor proteins (C). Figure is adapted from (Jarsch et
al., 2016).
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1.3.2 Mechanism of formation of tubular transport carriers
Intracellular transport is essential to ensure that newly synthesized or endocytosed protein cargos
are delivered to their appropriate destinations within the secretory and endosomal systems. As
indicated above, delivery of protein cargos to membrane-bound organelles requires transport
carriers in either vesicular or tubular form. Recently, tubular transport carriers (TCs) have gained
particular attention for their roles in sorting and transport events throughout the endocytic system
(Bonifacino and Rojas, 2006). In some cases, TCs may have advantages over vesicular transport
carriers (VCs). For example, when a mass of cargos needs to be transported over a relatively long
distance, such as from the TGN to the plasma membrane (Bard and Malhotra, 2006; Stephens and
Pepperkok, 2001), TCs rather than VCs can be loaded with multiple cargos at a time, steadily move
along microtubules, and target the cargoes to their destination simultaneously. By contrast, VCs
would require multiple rounds of transport to deliver the same payload.

TCs generally form in three key steps (Fig. 1.8) (Polishchuk et al., 2009): a) membrane budding,
which requires a machinery to bend the donor membrane to generate a highly curved protrusion
and must be coordinated with cargo sorting (Fig. 1.8A, see ①); b) tubule elongation and/or
stabilization, which is coupled with cargo loading into the carriers and is driven by motor proteindependent pulling force on the membrane bud (Fig. 1.8A, see ②); c) tubule fission, which is
facilitated by fission factors and releases the TCs for eventual fusion with the acceptor membrane
compartment (Fig. 1.8A, see ③; Fig. 1.8B, see ①). In some rare cases, TC fission from the donor
compartment does not happen (Fig. 1.8B, see ②); the TCs transiently fuse with the acceptor
membrane compartment while still attached to the donor membrane compartment and then retract
back (Dennis et al., 2015). This particular type of fusion event establishes a tubular channel
connecting two membrane compartments to allow continuous protein and lipid exchange. This
section will discuss several classical TCs and mechanisms of formation.
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Figure 1.8

Figure 1.8 Steps in the formation of tubular transport carriers (TCs).
(A) Three key steps to form a TC. ① TC formation begins with the budding of the donor membrane
by membrane-bending molecules. ② The membrane bud is pulled into a tubule along cytoskeletal
elements by motor proteins. The tubule can be stabilized by specific coat and/or scaffold proteins.
③ Fission factors release the TC from the donor membrane. (B) Two different TCs. ① The TC
dissociates from the donor membrane and fuses with the acceptor membrane. ② The growing
tubule can fuse with the acceptor membrane while still connected to the donor membrane. This
fusion event establishes a tubular channel that connects two membrane compartments, which
allows for continuous protein and lipid exchange. Figure is adapted from (Polishchuk et al., 2009).
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1.3.2a Post Golgi-derived tubular transport carriers
Golgi-derived TCs have been well studied in post-Golgi trafficking from the TGN to the plasma
membrane or to the endo-lysosomal system. This is a critical juncture in which TCs play a role in
segregating, sorting and directing newly synthesized proteins to their correct destinations. PostGolgi TCs are heterogeneous in size and shape, in contrast to clathrin-coated VCs that are
generally constrained by the clathrin lattice (Polishchuk et al., 2003). Notably, post-Golgi TCs that
travel from the TGN to the plasma membrane appear to lack a coat (Polishchuk et al., 2003). Thus,
how the tubular shape is maintained is still a mystery. Despite many years of study, no clear
consensus exists for the molecular mechanism of post-Golgi TC formation. It is generally thought
that they are formed by “breaking up” of the terminal Golgi or TGN cisternae following removal of
cargo in retrograde or anterograde VCs (Bonifacino and Glick, 2004). How they are pulled along
microtubule tracks is still incompletely understood. There are, however, a number of candidate
components that play a role in this process.

Arf1, a heavily studied small GTPase of the Arf family at the Golgi, plays a central role in the
formation of Golgi-derived TCs by driving membrane deformation and by recruiting binding partners
that also support TC formation and stability. Arf1 at the Golgi plays many important roles; perhaps
its best understood role is in the formation of COPI coated vesicles that mediate retrograde
transport throughout the Golgi stacks and to the endoplasmic reticulum (Hsu et al., 2009). Arf1 in
its GTP-bound (Arf1-GTP) form can form a dimer that induces positive membrane curvature,
whereas an Arf1 mutant that cannot dimerize lacks this membrane-bending ability and fails to
generate COPI vesicles (Beck et al., 2008). Besides dimerization, Arf1-GTP can further facilitate
membrane deformation through the insertion of an amphipathic helix into the membrane (Lundmark
et al., 2008). Thus, both Arf1 dimerization and amphipathic helix insertion are necessary for
curvature generation on Golgi-derived membrane. Once the curvature is generated, other proteins
such as coats [e.g. clathrin coat (Bonifacino and Glick, 2004)] and lipid modifying enzymes [e.g.
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the PtdIns-4-kinase PI4KIIIβ (Godi et al., 1999)] are recruited by Arf1 to further deform the
membrane into tubules.

Other Golgi-associated proteins likely have a role in membrane tubulation. Although no Arf1associated motor protein to drive tubulation has been identified, two Arf1-effectors that play a role
in tubule formation are four-phosphate adaptor protein 1 and 2 (FAPP1 and FAPP2). Both FAPP1
and FAPP2 bind specifically to phosphatidylinositol 4-phosphate (PtdIns4P) through their
pleckstrin-homology (PH) domain, localize to the Golgi where PtdIns4P is enriched, and control
TGN-to-plasma membrane transport (Dowler et al., 2000; Godi et al., 2004). Notably,
overexpression of the FAPP-PH domain induces very long Golgi-derived membrane tubules that
elongate at a speed consistent with microtubule-based motility but do not pinch off; this suggests
that FAPP1 and FAPP2 may stabilize elongating tubules (Godi et al., 2004). Purified FAPP2 in
solution forms a dimer with a curved shape of 30 nm in length, and is able to form tubules from
membrane sheets in vitro; this activity requires PtdIns4P-binding activity via its PH domain. These
data suggest that FAPP2 may have a direct function in tubulation (Cao et al., 2009). Further
structural analysis shows that the insertion of a hydrophobic wedge into the bilayer (see section
1.3.1b) by the FAPP1-PH domain may be responsible for initiating membrane tubule formation
(Lenoir et al., 2010). Therefore, taken together, FAPP1, FAPP2, and PtdIns4P likely function
together to shape membrane tubules emerging from the Golgi.

A machinery for membrane fission is recruited by Arf1 to release the tubule from the Golgi after the
tubule has formed. Some evidence suggests that cortactin, an actin-binding protein, and dynamin2, a large GTPase of the dynamin family, may constitute such a machinery and may be recruited
by activated Arf1 to the site of tubule fission (Cao et al., 2005). Cortactin promotes and stabilizes
Arp2/3 complex-induced actin branching that generates the force to push the membrane at the
tubule neck (Weaver et al., 2001). Concomitantly, dynamin-2 oligomerizes to form a helical
structure surrounding the neck of the tubule membrane, constricting the neck to sever the
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membrane upon consuming the energy from GTP hydrolysis (Hinostroza et al., 2020; Morlot et al.,
2012). The pushing and constricting forces together contribute to membrane fission and tubule
release.

Lipids play a critical role in membrane deformation (see 1.3.1a). One of the major lipids in the
formation of Golgi-derived tubules is PtdIns4P. PtdIns4P is highly enriched on Golgi membranes
(Godi et al., 1999; Wang et al., 2003) and as mentioned previously, PtdIns4P is required for FAPP1
and FAPP2 binding to the Golgi for shaping membrane tubules. This suggests that PtdIns4P has
a critical function in membrane deformation. In addition to FAPP1 and FAPP2, PtdIns4P is required
for the recruitment of other curvature-inducing proteins to the TGN. One example is
GOLPH3/VPS74, which induces membrane curvature by inserting a hydrophobic loop into the
cytoplasmic leaflet of the bilayer in the presence of PtdIns4P (Rahajeng et al., 2019). Purified
GOLPH3 can extend tubules from liposomes, suggesting a role of GOLPH3 in tubule formation
(Rahajeng et al., 2019). In summary, PtdIns4P can recruit an array of specific binding proteins that
contribute to generating membrane curvature and tubules.

1.3.2b Endosome-derived tubular transport carriers
The early endosome is a crucial sorting station to deliver membrane-associated proteins and lipids
to various destinations, including the Golgi, the plasma membrane, other endosomal compartments,
and LROs. Whether cargo transport utilizes VC or TC depends on the molecular machinery
employed for the specific sorting/ targeting event. The best-known machinery for TC transport from
endosomes is the retromer complex.

The retromer complex was first biochemically characterized in the yeast, Saccharomyces
cerevisiae. Yeast retromer complex is composed of five proteins that can be categorized into two
subcomplexes (Horazdovsky et al., 1997; Seaman et al., 1997; Seaman et al., 1998). One
subcomplex contains a heterodimer of the Vps5 (SNX1/2 in mammalian cells) and Vps17 (SNX5/6
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in mammalian cells) sorting nexins, which possess BAR domains (referred to as SNX-BAR) that
bind to membranes and shape the tubular morphology of the transport carrier (Carlton et al., 2004;
van Weering et al., 2012). The other subcomplex, now known as the retromer subcomplex
(hereafter referred to as retromer), consists of Vps26, Vps29, and Vps35, which do not have an
inherent ability to bind to membranes. The retromer requires interaction with either Vps5-Vps17
(SNX1/2-SNX5/6 in mammalian cells) (Haft et al., 2000; Seaman et al., 1998) or the SNX-PX family
member, SNX3 (Harrison et al., 2014; Harterink et al., 2011; Strochlic et al., 2007), to bind to early
endosomes, or alternatively the small Rab GTPase Ypt7 (Liu et al., 2012) [or the mammalian
homolog, Rab7, to late endosomes (Harrison et al., 2014; Rojas et al., 2008; Seaman et al., 2009)]
to bind to maturing early/ late endosomes. The retromer is thought to be primarily responsible for
cargo recognition and selection (Fjorback et al., 2012; Nothwehr et al., 2000), although recent
evidence suggests that the sorting nexins also play a role in this process (Simonetti et al., 2017;
Yong et al., 2020). Together with the SNX-BAR, the retromer confines cargos into TC rather than
VC (van Weering et al., 2012). A key difference between the mammalian and yeast retromer
complex is that two subcomplexes do not form a stable heteropentamer in mammals as they do in
yeast (Swarbrick et al., 2011) but transiently associate with each other, allowing them to function
in cargo trafficking independently in some cases (Burd and Cullen, 2014; Kvainickas et al., 2017;
Nisar et al., 2010; Prosser et al., 2010; Simonetti et al., 2017). This also allows mammalian retromer
and SNX-BAR to engage other binding partners on endosomes to synergize in particular trafficking
events (Gokool et al., 2007; McGough et al., 2014; Wassmer et al., 2009). This section will discuss
the role of individual subcomplexes and their cooperative actions in TC formation.

The SNX-BAR proteins associate with endosomal membranes independently of retromer through
binding to phosphatidylinositol 3-phosphate (PtdIns3P) by the phox-homology (PX) domain, a
domain that is found on every member of the SNX protein family (Chandra et al., 2019). SNX-BAR
proteins form heterodimers in mammalian cells. In particular, SNX1 or SNX2 dimerizes with SNX5
or SNX6 via their BAR domains; each one has a limited capacity to from a homodimer (see 1.3.1b)
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(Gallon and Cullen, 2015). As discussed previously, BAR domains sense curved membranes and
can drive membrane curvature. Curvature generation is driven by inserting amphipathic helices into
the cytoplasmic leaflet of the endosome membrane to induce bilayer asymmetry (van Weering et
al., 2010). Concomitantly, curvature is stabilized by helical arrays of SNX-BAR domains around the
membrane that act as scaffolds and maintain the curved or tubular shape (van Weering et al., 2010).
To initiate endosomal tubule formation, SNX-BAR proteins are recruited to PtdIns3P-enriched
endosomes where they dimerize and oligomerize to generate the curved membrane. This in turn
favors more SNX-BAR protein binding to stabilize the curvature (van Weering et al., 2010). The
tubules are further pulled along microtubules by the minus-end-directed microtubule motor dynein.
This is mediated through the SNX-BAR-dependent recruitment of dynactin, via the p150 glued subunit,
to activate dynein; dynein generates a pulling force on the tubule and thus sustains membrane
tubulation (Hong et al., 2009; Wassmer et al., 2009).

Concomitant with SNX-BAR-dependent membrane tubule formation, the retromer is recruited to
stabilize the SNX-BAR oligomers (Kendall et al., 2020; Kovtun et al., 2018) and to select cargo for
sorting. The retromer subcomplex also engages additional effectors to promote tubule formation.
Two such effectors are the WASH complex (Gomez and Billadeau, 2009; Jia et al., 2012; McGough
et al., 2014) and Eps15 homology domain-containing protein-1 (EHD1) (Gokool et al., 2007). As
mentioned earlier, WASH is related to the WASP complex and initiates branched actin
polymerization by recruiting Arp2/3 to actin filaments (Seaman et al., 2013). WASH is recruited
through the interaction of the Vps35 subunit of retromer with the L-F-[D/E]3-10-L-F motif (hereafter
referred as LFa motif) on the tail of the FAM21 subunit of WASH (Jia et al., 2012). This interaction
occurs in vivo only when Vps35 is associated with Vps29 (Helfer et al., 2013), suggesting that
WASH is engaged by a “working” retromer. FAM21 has 21 LFa motifs, and thus it is likely that a
single FAM21 binds to several retromer complexes on the endosome membrane (Gomez and
Billadeau, 2009; Jia et al., 2012). Thus, WASH might not only participate in tubule generation by
promoting the formation of branched actin networks to stabilize the SNX-BAR-induced tubule, but
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it also might help cluster retromer-associated cargos at the tubule sites by concentrating multiple
retromers. Moreover, WASH-driven actin branching on endosome membranes may also constrain
cargos within a region that is decorated by actin patches (Puthenveedu et al., 2010). This may
further ensure that cargos are loaded into TCs rather than VCs. The dynamin family member, EHD1,
interacts with Vps26 and Vps35 on curved endosomal membranes, and this interaction is required
to stabilize SNX-BAR-induced tubules (Gokool et al., 2007). EHD1, like other EHD proteins, forms
a dimer on curved membranes; upon ATP hydrolysis, the dimer further oligomerizes into a ring-like
structure that scaffolds the highly curved tubular membrane (Daumke et al., 2007; Deo et al., 2018).

Once cargos have been captured, the retromer mediates the “handover” of cargos to SNX-BARinduced tubules for transport. When the tubule is sufficiently loaded with cargos, the tubule must
undergo scission for cargo transport and delivery to the destination. The SNX-BAR-associated
dynein activity along microtubules likely provides a pulling force to strain the tubule attachment site
on endosomes (Hong et al., 2009; Wassmer et al., 2009), while actin branching initiated by the
Vps35-recruited WASH complex likely generates a pushing force on the membrane (Gomez and
Billadeau, 2009), coupling with EHD1-dependent tubule constriction to promote membrane scission
(Daumke et al., 2007; Deo et al., 2018; Gokool et al., 2007).

In summary, the retromer/SNX-BAR complexes in mammals localize to PtdIns3P-enriched
endosome membrane where they control TC formation by 1) SNX-BAR inducing membrane
curvature and tubule formation; 2) recruiting dynein for elongating and sustaining tubulation; 3)
associating with WASH and EHD1 for stabilizing and ultimately severing the tubule with the help of
dynein.

Besides tubulation driven by the retromer and SNX-BAR, it is highly likely that additional effectors
of endosomal tubulation exist in cells. For example, the EHD family member EHD3 can induce
tubule formation apparently independent of SNX-BAR proteins (Bahl et al., 2016). The small
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GTPase Arf6 regulates endocytosis and endocytic recycling independent of classical clathrindependent pathways and generates tubules that are enriched in phosphatidylinositol-(4,5)bisphosphate [PtdIns(4,5)P2] (Brown et al., 2001a); how these tubules are generated and stabilized
is not understood. Importantly, BLOC-1 has been shown to drive the formation of recycling
endosome tubules from early endosomal vacuoles in HeLa cells (Delevoye et al., 2016). This
dissertation builds on paradigms established from our understanding of the retromer/SNX-BAR
system to assess the role of phosphoinositides in the generation of BLOC-1-dependent tubules,
and to understand the function of these tubules in melanosome biogenesis.

1.4 Dissertation Aims
Previous studies on melanosome biogenesis have indicated that BLOC-1 plays an essential role
in a tubular transport pathway through which melanogenic proteins are delivered to maturing
melanosomes. In this pathway, BLOC-1 coordinates with the microtubule motor KIF13A and actin
polymerization to generate recycling endosome-like tubular transport carriers that emanate from
early endosomes, extend along microtubules, and transiently fuse with maturing melanosomes to
deliver melanosomal cargos (Delevoye et al., 2016; Delevoye et al., 2009). While there are several
identified components of this pathway, their temporal requirements during tubule formation and
extension are not yet understood. For example, negative stain electron microscopy analysis of
recombinant BLOC-1 shows that BLOC-1 adopts a banana-shaped structure similar to that of BAR
domains, suggesting that BLOC-1 may have a BAR-like capacity to sense and stabilize curved
membranes (Lee et al., 2012). If this were true, then by analogy to BAR domains and other
membrane curvature-inducing proteins, there may be a lipid requirement for BLOC-1 binding.
Although BLOC-1 is indeed needed to stabilize nascent tubules emerging from early endosomes
(Delevoye et al., 2016), it is not clear if a particular lipid is involved in BLOC-1 binding to support
tubule formation.
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Which lipid might be involved in BLOC-1-dependent tubule formation and stabilization during
melanosome biogenesis? Among lipids, phosphoinositides are good candidates to regulate BLOC1-dependent tubule formation. Phosphoinositides function in determining membrane identity,
regulating of membrane trafficking spatially and temporally, and regulating membrane remodeling,
often by binding proteins that induce or stabilize membrane deformation as described in section
1.3 (Balla, 2013; Suetsugu et al., 2014). Among phosphoinositides, PtdIns4P is the best lipid
candidate to participate in BLOC-1-dependent tubule formation. PtdIns4P has been shown in
several studies to control the formation of membrane tubules derived from the endolysosomal
system (McGrath et al., 2021; Rahajeng et al., 2019). Moreover, PtdIns4P participates in generating
membrane tubules that have an important role in LRO maturation (Ma et al., 2020) and function
(Levin-Konigsberg et al., 2019; López-Haber et al., 2020b). For example, PtdIns4P is required
during Weibel-Palade body maturation in endothelial cells (Lopes da Silva et al., 2016), and is
required to form tubules during phagolysosome resolution in macrophages (Levin-Konigsberg et
al., 2019), phagosome signaling in dendritic cells (López-Haber et al., 2020b), and secretory
granule maturation in Drosophila melanogaster larval salivary glands (Ma et al., 2020). These
findings suggest that PtdIns4P may have a general role in LRO biogenesis and thus is likely to be
involved in melanosome biogenesis.

If PtdIns4P participates in melanosome biogenesis, how and where is it generated? PtdIns4P is
generated by the phosphorylation of PtdIns by either type II or type III PtdIns-4-kinases (Fig. 1.9A)
(Balla and Balla, 2006). Type III PtdIns-4-kinases are localized primarily to the Golgi complex
(PI4KIII), the endoplasmic reticulum (PI4KIIIα), and the plasma membrane (PI4KIIIα) at steady
state in most cells, and are thus responsible for the major pools of PtdIns4P at these sites (Fig.
1.9B) (Balla and Balla, 2006). By contrast, the type II PtdIns-4-kinases, PI4KIIα and PI4KII,
contribute primarily to the generation of PtdIns4P on endo-lysosomes (Fig. 1.9B) (Balla and Balla,
2006; Minogue, 2018) and on LROs (Levin-Konigsberg et al., 2019; Lopes da Silva et al., 2016;
López-Haber et al., 2020b; Ma et al., 2020). Importantly, early endosomes are the source of BLOC-
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1-dependent tubules (Delevoye et al., 2016; Setty et al., 2007), placing PI4KIIα and/or PI4KII in
the right place to participate in this process. Of note, PI4KIIα binds directly to AP-3 (Craige et al.,
2008; Salazar et al., 2005) and indirectly to BLOC-1 (Salazar et al., 2009), likely within the AP-3BLOC-1 super-complex, and requires AP-3 for targeting to lysosomes and LROs in other cell types
(López-Haber et al., 2020b; Salazar et al., 2005; Salazar et al., 2009). Similarly, PI4KIIβ binds
directly to AP-1 (Wieffer et al., 2013), which, as discussed earlier, functions both in cargo sorting
and KIF13A recruitment during BLOC-1-dependent tubular cargo transport. Moreover, our
collaborators have shown that BLOC-1 binds to PtdIns4P and other phosphoinositides on tubular
membranes in vitro, and requires type II PtdIns-4-kinases to initiate recycling endosome formation
in HeLa cells (Jani et al., 2021).
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Figure 1.9

Figure 1.9 PtdIns4P synthesis and PtdIns-4-kinase localization.
(A) Metabolic switch between PtdIns and PtdIns4P. The red arrow indicates the phosphorylation
by PtdIns-4-kinases and black arrow indicates the dephosphorylation by Sac1 or Sac2. (B)
Localization of distinct type II and type III PtdIns-4-kinases within cells. Figure is adapted from
(Balla and Balla, 2006).
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Based on the evidence presented above, I hypothesized that PI4KIIα and/or PI4KII generates
PtdIns4P on BLOC-1-dependent endosome-derived tubules to facilitate tubule formation and
support tubular transport pathway during melanosome biogenesis. I used gene silencing in
pigmented mouse melanocytes, together with fluorescence microscopy and biochemical
approaches, to test this hypothesis. My results in Chapter 2 show that PtdIns4P is present on
BLOC-1-dependent endosomal tubules and is produced by both PI4KIIα and PI4KII which are
also present on the tubules. Both PI4KIIα and PI4KII are required non-redundantly for BLOC-1dependent cargo transport to melanosomes. Notably, while both PI4KIIα and PI4KII on endosomal
vacuoles likely participate in a redundant manner to generate a pool of PtdIns4P to recruit BLOC1 for tubule initiation (Jani et al., 2021), in their non-redundant roles, both kinases function
downstream of BLOC-1 and sequentially, with PI4KIIα acting earlier than PI4KIIβ during tubule
elongation/stabilization. The PI4KIIα- and PI4KII-dependent pools of PtdIns4P correlate with
tubule length and with the efficiency of cargo delivery to melanosomes. My results contribute to a
more comprehensive mechanistic understanding of BLOC-1-dependent tubule formation.
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CHAPTER 2

TYPE II PHOSPHATIDYLINOSITOL 4-KINASES FUNCTION SEQUENTIALLY IN CARGO
DELIVERY FROM EARLY ENDOSOMES TO MELANOSOMES

This chapter appeared as a peer-reviewed article titled “Type II phosphatidylinositol 4-kinases
function sequentially in cargo delivery from early endosomes to melanosomes” by Yueyao Zhu,
Shuixing Li, Alexa Jaume, Riddhi Atul Jani, Cédric Delevoye, Graça Raposo, and Michael S. Marks.
Journal of Cell Biology, 2022.
DOI: 10.1083/jcb.202110114.
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2.1 Abstract
Melanosomes are pigment cell-specific lysosome-related organelles in which melanin pigments are
synthesized and stored. Melanosome maturation requires delivery of melanogenic cargoes via
tubular transport carriers that emanate from early endosomes and that require BLOC-1 for their
formation. Here we show that phosphatidylinositol-4-phosphate (PtdIns4P) and the type II PtdIns4-kinases (PI4KIIα and PI4KIIβ) support BLOC-1-dependent tubule formation to regulate
melanosome biogenesis. Depletion of either PI4KIIα or PI4KIIβ with shRNAs in melanocytes
reduced melanin content and misrouted BLOC-1-dependent cargoes to late endosomes/lysosomes.
Genetic epistasis, cell fractionation, and quantitative live-cell imaging analyses show that PI4KIIα
and PI4KIIβ function sequentially and non-redundantly downstream of BLOC-1 during tubule
elongation towards melanosomes by generating local pools of PtdIns4P. The data show that both
type II PtdIns-4-kinases are necessary for efficient BLOC-1-dependent tubule elongation and
subsequent melanosome contact and content delivery during melanosome biogenesis. The
independent functions of PtdIns-4-kinases in tubule extension are downstream of likely redundant
functions in BLOC-1-dependent tubule initiation.

2.2 Introduction
The endolysosomal system is a dynamic network of intracellular membrane-bound compartments
that plays an essential global role in nutrient uptake, signaling, metabolism, and pathogen life cycle
(Huotari and Helenius, 2011; Klumperman and Raposo, 2014). In some cell types, the
endolysosomal system is additionally adapted to create specialized subcellular compartments
termed lysosome-related organelles (LROs) for specific physiological functions (Bowman et al.,
2019; Delevoye et al., 2019). LROs share some features with conventional lysosomes but possess
distinct morphological and functional characteristics that are conferred largely by cell type-specific
contents (Bowman et al., 2019; Delevoye et al., 2019). Many LROs share common origins, and
abnormalities in LRO biogenesis in several cell types underlie the pathology of the Hermansky–
Pudlak syndromes (HPS), a group of inherited multisystem disorders characterized by
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oculocutaneous albinism, bleeding diathesis, and other variable symptoms. HPS symptoms reflect
defective biogenesis of melanosomes in pigment cells, dense granules in platelets, and additional
LROs in other cell types (Bowman et al., 2019; De Jesus Rojas and Young, 2020). How the
products of HPS-associated genes and their interactors orchestrate LRO biogenesis is only
beginning to be understood.

The genes that are defective in HPS encode essential subunits of four protein complexes – adaptor
protein-3 (AP-3) and biogenesis of lysosome-related organelles complex (BLOC)-1, -2 and -3 –
that regulate membrane dynamics essential for the biosynthetic delivery and/or recycling of
components to or from maturing LROs (Bowman et al., 2019; Di Pietro and Dell'Angelica, 2005).
BLOC and AP-3 functions in LRO biogenesis are best understood for melanosome maturation in
epidermal melanocytes (Le et al., 2021). Melanosomes mature from nonpigmented stage I and II
precursors to pigmented stage III and IV organelles through the delivery of melanogenic enzymes
and transporters (Novikoff et al., 1968; Raposo et al., 2001; Seiji et al., 1961) via three district
pathways: one from the Golgi (Patwardhan et al., 2017) and two from early endosomes that are
dysregulated in HPS (Bowman et al., 2019). One of these pathways uniquely requires BLOC-1 to
generate recycling-endosome-like tubular transport intermediates from early sorting endosomes
that ultimately fuse with melanosomes, delivering cargoes such as tyrosinase-related protein-1
(TYRP1) and the melanosomal chloride channel (Bellono and Oancea, 2014; Sitaram et al., 2009)
oculocutaneous albinism type 2 (OCA2) (Delevoye et al., 2009; Setty et al., 2008; Setty et al., 2007;
Sitaram et al., 2012). BLOC-1 coordinates with the microtubule motor KIF13A and actin
polymerization to generate the tubules (Delevoye et al., 2016; Delevoye et al., 2009) and may
directly stabilize them (Jani et al., 2021; Lee et al., 2012). Adaptor protein-1 (AP-1) and a BLOC-1associated cohort of AP-3 sorts cargoes and SNARE proteins (including the vSNARE, VAMP7) into
the melanosome-bound tubules (Bowman et al., 2021; Delevoye et al., 2009; Dennis et al., 2015;
Theos et al., 2005a). AP-1 also binds to and might recruit KIF13A to the tubules (Delevoye et al.,
2009; Delevoye et al., 2014; Nakagawa et al., 2000). Despite these advances, the field lacks a
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comprehensive mechanistic understanding of BLOC-1-dependent tubule formation. In particular,
roles for lipids in the process are unknown.

Among lipids, phosphoinositides are good candidates to regulate BLOC-1-dependent tubule
formation. Phosphoinositides function in determining membrane identity, spatio-temporal
regulation of membrane trafficking, and membrane remodeling, often by binding proteins that
induce or stabilize membrane deformation (Balla, 2013; Suetsugu et al., 2014). In particular,
phosphatidylinositol 4-phosphate (PtdIns4P) controls membrane curvature associated with
membrane tubules in the endolysosomal system (Levin-Konigsberg et al., 2019; López-Haber et
al., 2020b; Ma et al., 2020; McGrath et al., 2021; Rahajeng et al., 2019). The cellular distribution of
PtdIns4P is governed by the balanced activities of PtdIns4P-generating kinases and
phosphoinositide phosphatases (D'Angelo et al., 2008; Tan and Brill, 2014). The endosomal
PtdIns4P pool is largely produced by the type II PtdIns-4-kinases, PI4KIIα and PI4KII (Balla and
Balla, 2006; Minogue, 2018). Type II PtdIns-4-kinases and PtdIns4P are required for Weibel-Palade
body maturation in endothelial cells (Lopes da Silva et al., 2016) and to form tubules during
phagolysosome resolution in macrophages (Levin-Konigsberg et al., 2019), phagosome signaling
in dendritic cells (López-Haber et al., 2020b), and secretory granule maturation in Drosophila
melanogaster larval salivary glands (Burgess et al., 2012; Ma et al., 2020). These findings suggest
a general role for type II PtdIns-4-kinases and PtdIns4P in LRO biogenesis.

Their association with membrane tubules suggests that PtdIns4P and PtdIns-4-kinases might
function in BLOC-1-dependent transport during LRO biogenesis. Accordingly, PI4KIIα binds directly
to AP-3 (Craige et al., 2008; Salazar et al., 2005) and indirectly to BLOC-1 (Salazar et al., 2009),
and requires AP-3 for targeting to lysosomes and LROs in other cell types (Craige et al., 2008;
López-Haber et al., 2020b). Similarly, PI4KIIβ binds directly to AP-1 (Wieffer et al., 2013). Moreover,
BLOC-1 binds to PtdIns4P and other phosphoinositides on tubular membranes in vitro, and
requires type II PtdIns-4-kinases to initiate recycling endosome formation in HeLa cells (Jani et al.,
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2021). Here, we used gene silencing together with imaging and biochemical approaches to test
whether PI4KIIα and/or PI4KII function in BLOC-1-dependent cargo transport to melanosomes by
generating PtdIns4P on endosomal tubules. While PI4KIIα and PI4KIIβ likely function redundantly
in BLOC-1-dependent tubule initiation (Jani et al., 2021), we show that they play additional nonredundant roles in generating PtdIns4P on the tubular carriers in melanocytes. This is necessary
for tubule stability and for cargo delivery to melanosomes.

2.3 Results
2.3.1 Type II PtdIns4-kinases are required for melanosomal localization of BLOC-1dependent cargos.
The biosynthetic delivery of TYRP1 to melanosomes from early endosomes in melanocytes
requires BLOC-1 (Setty et al., 2007). Thus, to determine if type II PtdIns-4-kinases function in
BLOC-1-dependent cargo transport, we first tested whether depletion of PI4KIIα or PI4KIIβ impacts
TYRP1 localization. Darkly pigmented immortalized wild-type (WT) melan-Ink4a mouse
melanocytes (Sviderskaya et al., 2002) were transduced with lentiviruses to co-express puromycin
resistance and shRNA for PI4KIIα (shPI4KIIα), PI4KIIβ (shPI4KIIβ), the core Pallidin subunit of
BLOC-1 (shPallidin), or a non-target control (shNC), and puromycin-resistant cells were selected
for 7-9 d. Two distinct shRNAs per target each effectively reduced target expression but not other
proteins analyzed (Fig. 2.2A-C). TYRP1 steady state localization was assessed by confocal
immunofluorescence microscopy (IFM) relative to pigment granules visualized by bright field
microscopy (Fig. 2.1A-C); quantitative colocalization analyses excluded the crowded nuclear and
perinuclear regions in which individual compartments could not be distinguished. As in untreated
cells (Raposo et al., 2001; Setty et al., 2007; Vijayasaradhi et al., 1995), the majority of peripheral
TYRP1 in shNC cells (Fig. 2.1Aa-c, 2.1B, 2.1C) surrounded pigment granules, apparent by IFM
as fluorescent “donuts” filled with black melanin (white arrows) and representing localization to the
membrane of mature melanosomes (Raposo et al., 2001). In contrast, TYRP1 in shPI4KIIα (Fig.
2.1Ad-f) or shPI4KIIβ cells (Fig. 2.1Ag-i) localized to punctate structures that largely did not
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overlap with pigment granules (yellow arrowheads), reducing peripheral melanosome localization
of TYRP1 by ~50% (Fig. 2.1B). Moreover, many shPI4KIIβ and particularly shPI4KIIα cells were
hypopigmented (Fig. 2.1Ab, Ae, Ah), most apparent by 14 d after transduction (Fig. 2.3A) and
confirmed by a quantitative melanin content assay (Fig. 2.1F; the low pigmentation induced by
shPI4KIIα-2 may reflect an off-target effect because it also slowed cell growth and depleted PI4KIIα
less effectively than shPI4KIIα-1). Nevertheless, the fraction of remaining melanosomes labeled by
TYRP1 in shPI4KIIα and shPI4KIIβ cells was reduced by ~50% relative to shNC cells (Fig. 2.1C).
These effects were specific to PI4KIIα and PI4KIIβ, as depletion of the type III PtdIns4P kinase,
PI4KIIIβ, did not affect TYRP1 localization or pigmentation (Fig. 2.2D-G). Impaired TYRP1
localization is also observed in mouse melanocytes lacking BLOC-1 subunits (Setty et al., 2007);
indeed, in highly depigmented BLOC-1-deficient shPallidin cells, TYRP1 overlap with remaining
pigment granules was similar to that of shPI4KIIα or shPI4KIIβ cells (Figs. 2.1Aj-l, 2.1B, 2.2B,
2.2C). Thus, like BLOC-1, both PI4KIIα and PI4KIIβ but not PI4KIIIβ are required for TYRP1
localization to melanosomes and optimal pigmentation.

We considered generating PI4KIIα and PI4KIIβ gene knockouts, but in shPI4KIIα and shPI4KIIβ
melanocytes at 30 d post-infection, TYRP1 localization to melanosomes was largely restored to
control levels despite consistent target protein depletion (Fig. 2.3B, white arrows; Figs. 2.3C, D).
This likely reflects functional compensation for the loss of each kinase over time. All subsequent
analyses were thus performed on cells expressing shRNAs for 7-9 d.

To test whether PI4KIIα or PI4KIIβ depletion impacts other BLOC-1-dependent melanosome
cargoes (Dennis et al., 2016; Sitaram et al., 2012), we analyzed the localization of transiently
expressed, epitope-tagged forms of OCA2 and VAMP7 relative to melanosomes in shPI4KIIα and
shPI4KIIβ cells. Compared with shNC cells in which HA-tagged OCA2 (OCA2-HA; Figs. 2.1Da-c,
2.1E) and GPF-tagged VAMP7 (GFP-VAMP7; Fig. 2.4Aa-c, 2.4B) largely overlapped with pigment
granules (white arrows), localization of both cargoes to melanosomes was impaired in shPI4KIIα
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and shPI4KIIβ cells (Figs. 2.1Dd-i, 2.1E, 2.4Ad-i, 2.4B). Like TYRP1, mislocalized OCA2-HA and
GFP-VAMP7 accumulated in punctate structures throughout the cytoplasm (Figs. 2.1D, 2.4A,
yellow arrowheads). Thus, both type II PtdIns-4-kinases in melanocytes are required for effective
BLOC-1-dependent cargo delivery.
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Figure 2.1
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Figure 2.1 Depletion of either PI4KIIα or PI4KIIβ by shRNA in WT melanocytes impairs
localization of BLOC-1-dependent cargoes to melanosomes.
WT melan-Ink4a melanocytes were transduced with lentiviruses to express shNC or the indicated
shRNAs to PI4KIIα, PI4KIIβ, or the Pallidin subunit of BLOC-1 and selected for 7-9 d (A-E) or 14 d
(F). Cells in D, E were additionally transiently transfected to express HA-tagged OCA2 (OCA2-HA)
2 d prior to analysis. (A and D) Cells were analyzed by IFM for TYRP1 (A; green, left and right
panels) or HA (D; left and right panels), and by bright field microscopy (BF) for pigment granules
(middle; pseudocolored magenta at right). White arrows, pigment granules surrounded by TYRP1
or overlapping with OCA2-HA; yellow arrowheads, TYRP1 or OCA2-HA not associated with
pigment granules. Boxed regions are magnified 5-fold in insets. Scale bars: main panels, 10 μm;
insets, 2 μm. (B, C and E) Quantification of TYRP1 (B) or HA-OCA2 (E) overlap with melanosomes
or melanosome coating by TYRP1 (C). Data from three independent experiments each were
analyzed by Kruskal-Wallis (B and C) or Welch’s ANOVA (E); ****, p<0.0001; NS, not significant.
(F) shRNA-treated melan-Ink4a cells or HEK293T cells as a negative control were analyzed by
quantitative melanin content assay. Data are presented as mean ± SD of five independent
experiments as a percentage of the signal from shNC-treated cells, and were analyzed by Welch’s
ANOVA relative to shNC-treated cells; ****, p<0.0001; *, p<0.05; NS, not significant.
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Figure 2.2

Figure 2.2 Target protein levels after 7-9d shRNA treatment and TYRP1 localization to
melanosomes in cells depleted of PI4KIIIβ.
WT melan-Ink4a melanocytes were transduced with lentiviruses expressing the indica ted shRNAs
to PI4KIIα, PI4KIIβ, PI4KIIIβ, or the Pallidin subunit of BLOC-1, or control non-coding shRNA (shNC)
and selected for 8 d. (A, B, F) Whole-cell lysates from cells treated with the indicated shRNAs were
analyzed by SDS/PAGE and immunoblotting for PI4KIIα, PI4KIIβ, PI4KIIIβ, or Pallidin and for γ-
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Tubulin as a loading control. Positions of the 25 and 50 kDa molecular weight (MW) markers (A, B)
or the 75 and 50 kDa MW markers (F) are indicated. Note that PI4KIIβ migrates as 2-3 distinct
bands, all of which are depleted upon treatment with specific shRNA. (C and G) Quantification of
band intensities (mean ± SD) for the indicated components normalized to γ-Tubulin from three
independent experiments each, and analysis by one-way ANOVA with repeated measures. NS,
not significant; *, p<0.05; **, p<0.01; ***, p<0.005. (D) Cells at 9 days post infection with either of
two distinct shRNAs to PI4KIIIβ were analyzed for endogenous TYRP1 by IFM (green, left and right
panels) and for pigment granules by bright field microscopy (BF; middle panels and pseudocolored
magenta in the merged images on the right). White arrows, examples of TYRP1 surrounding
pigment granules; boxed regions are magnified 5-fold in the insets. Scale bars: main panels, 10
μm; insets, 2 μm. (E) Quantification of TYRP1 overlap with melanosomes. Data from three
independent experiments each were analyzed by ordinary one-way ANOVA; NS, not significant.
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Figure 2.3
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Figure 2.3 Pigmentation of cells after 14 d treatment with shRNAs to PI4KIIα, PI4KIIβ, or
Pallidin and TYRP1 localization to melanosomes following 30 d PI4KIIα or PI4KIIβ shRNA
treatment.
(A) WT melan-Ink4a melanocytes were transduced with lentiviruses expressing the indicated
shRNAs to PI4KIIα, PI4KIIβ, PI4KIIIβ, or the Pallidin subunit of BLOC-1, or control non-coding
shRNA (shNC) and selected for 14 d as in Fig. 1F. Fixed cells were labeled with Hoechst 33342
dye and analyzed by fluorescence (for Hoechst; pseudocolored yellow) and bright field microscopy
(for pigment). Shown are representative images documenting the pigmentation status of the cells.
Scale bars, 20 μm. (B-D) WT melan-Ink4a melanocytes were transduced with the indicated
shRNAs to PI4KIIα or PI4KIIβ and analyzed 30 d post-infection. (B) Cells were analyzed for
endogenous TYRP1 by IFM (green, left and right panels) and for pigment granules by bright field
microscopy (BF; middle panels and pseudocolored magenta in the merged images on the right).
White arrows, examples of TYRP1 surrounding pigment granules; Boxed regions are magnified 5fold in the insets. Scale bars: main panels, 10 μm; insets, 2 μm. (C) Whole-cell lysates from cells
treated with the indicated shRNAs were analyzed by SDS/PAGE and immunoblotting for PI4KIIα,
PI4KIIβ, or Pallidin and for γ-Tubulin as a loading control. Positions of the 25 and 50 kDa molecular
weight (MW) markers are indicated. Note that PI4KIIβ migrates as 2-3 distinct bands, all of which
are depleted upon treatment with specific shRNA. (D) Quantification of band intensities (mean ±
SD) for the indicated components normalized to γ-Tubulin from two independent experiments.

65

Figure 2.4

Figure 2.4 Depletion of either PI4KIIα or PI4KIIβ by shRNA in WT melanocytes impairs
localization of GFP-VAMP7 to melanosomes.
WT melan-Ink4a melanocytes were transduced with lentiviruses expressing the indicated shRNAs
to PI4KIIα, PI4KIIβ, or control non-coding shRNA (shNC) and selected for 7 to 9 d. (A) After shRNA
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transduction, cells were transiently transfected with GFP-VAMP7 and analyzed for GFP-VAMP7
by IFM (green, left and right panels) and for pigment granules by bright field microscopy (BF; middle
panels and pseudocolored magenta in the merged images on the right). White arrows, examples
of GFP-VAMP7 surrounding pigment granules; yellow arrowheads, examples of mislocalized GFPVAMP7 not associated with pigment granules. Boxed regions are magnified 5-fold in the insets.
Scale bars: main panels, 10 μm; insets, 2 μm. (B) Quantification of the overlap of GFP-VAMP7 with
pigment granules in cells treated with the indicated shRNAs. Data from three independent
experiments were analyzed by ordinary one-way ANOVA. ****, p<0.0001; ns, not significant.
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2.3.2 TYRP1 is largely mislocalized to late endosomes and lysosomes in cells depleted of
either PI4KIIα or PI4KIIβ.
BLOC-1 is required for TYRP1 and other cargoes to exit vacuolar endosomes into tubules destined
for maturing melanosomes, and thus these cargoes are trapped in enlarged early endosomes in
BLOC-1-deficient melanocytes (Delevoye et al., 2016; Dennis et al., 2016; Setty et al., 2008; Setty
et al., 2007; Sitaram et al., 2012). To determine whether PI4KIIα and PI4KIIβ function at the same
step as BLOC-1, shNC, shPI4KIIα, shPI4KIIβ, and shPallidin cells were fixed, immunolabeled for
TYRP1 and the pan-early endosomal t-SNARE syntaxin-13 (STX13), and analyzed by IFM.
Whereas STX13 and TYRP1 overlapped minimally in shNC cells (Fig. 2.5Aa-c, white arrows; Fig.
2.5B), they overlapped extensively in the periphery of shPallidin cells (Fig. 2.5Aj-l, yellow
arrowheads; Fig. 2.5B) as expected for cells lacking BLOC-1 subunits (Setty et al., 2007). Although
the overlap of TYRP1 with STX13 (yellow arrowheads) in shPI4KIIα and shPI4KIIβ cells was higher
than in shNC cells, it was not as high as in shPallidin cells (Fig. 2.5Ad-i; Fig. 2.5B). These results
suggest that while depletion of either PI4KIIα or PI4KIIβ partially traps TYRP1 in early endosomes,
consistent with a redundant requirement for either kinase to initiate BLOC-1-dependent cargo
export from endosomes (Jani et al., 2021), neither alone is absolutely required for BLOC-1dependent cargo exit from early sorting endosomes.

To determine where most TYRP1 accumulated in shPI4KIIα and shPI4KIIβ cells, we conducted
additional IFM analyses. Notably, whereas overlap of peripheral TYRP1 with the late endosomal/
lysosomal membrane protein, LAMP2, is minimal in shNC cells (Fig. 2.5Ca-c, white arrows; Fig.
2.5D) – as also observed in untreated WT or BLOC-1-deficient cells (Setty et al., 2007) – LAMP2
overlap was substantially increased (yellow arrowheads) in shPI4KIIα and shPI4KIIβ cells (Fig.
2.5Cd-i; Fig. 2.5D). These data indicate that upon knockdown of PI4KIIα or PI4KIIβ, a cohort of
TYRP1 exits early endosomes but is then mistargeted to late endosomes and lysosomes. Thus,
both type II PtdIns4-kinases have non-redundant functions in cargo delivery to melanosomes in a
separate step from BLOC-1.
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Figure 2.5
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Figure 2.5 TYRP1 is mislocalized to early endosomes and late endosomes/ lysosomes in
WT melanocytes depleted of either PI4KIIα or PI4KIIβ.
Melan-Ink4a melanocytes were transduced with lentiviruses to express shNC or the indicated
shRNAs to PI4KIIα, PI4KIIβ, or the Pallidin subunit of BLOC-1, and selected for 7 to 9 d. (A and C)
Cells were analyzed by IFM for TYRP1 (green, left and right panels) relative to STX13 to mark early
endosomes (A) or LAMP2 to mark late endosomes and lysosomes (C) (magenta, middle and right
panels). White arrows, TYRP1 not associated with STX13 or LAMP2; yellow arrowheads, TYRP1
overlapping with STX13 or LAMP2. Boxed regions are magnified 5-fold in the insets. Scale bars:
main panels, 10 μm; insets, 2 μm. (B and D) Quantification of TYRP1 overlap with STX13 (B) or
LAMP2 (D). Data from three independent experiments were analyzed by ordinary one-way ANOVA
(B) or Welch’s ANOVA (D); ****, p<0.0001; ns, not significant.
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2.3.3 PI4KIIα and PI4KIIβ functions in TYRP1 trafficking require their lipid kinase activity and
binding to adaptor proteins.
To ensure that cargo mislocalization in shPI4KIIα and shPI4KIIβ cells reflected target depletion, we
assessed whether TYRP1 localization to melanosomes was restored by overexpressing shRNAresistant PI4KIIα or PI4KIIβ. WT mouse melan-Ink4a melanocytes were transduced with
retroviruses encoding GFP-tagged human WT PI4KIIα or PI4KIIβ, selected for stable integration
for at least two weeks, and then depleted of the endogenous target protein by mouse-specific
shPI4KIIα or shPI4KIIβ. Cells were analyzed 7-9 d later by IFM and bright field microscopy.
Whereas TYRP1 overlapped minimally with pigment granules in melanocytes expressing shPI4KIIα
or shPI4KIIβ alone (yellow arrowheads, Figs. 2.6B, 2.7B), co-expression of PI4KIIα-WT-GFP with
shPI4KIIα-1 (Fig. 2.6C) or of PI4KIIβ-WT-GFP with shPI4KIIβ-2 (Fig. 2.7C) restored a WT pattern
of TYRP1 around pigment granules in a significant fraction of cells (compare white arrows in Fig.
2.6A with 2.6C and Fig. 2.7A with 2.7C; Figs. 2.6G, 2.7G). Immunoblotting showed that the
shRNAs efficiently reduced target expression even in the presence of correctly expressed excess
human GFP-tagged transgenes (Figs. 2.6H, 2.7H). Thus, the impaired TYRP1 localization in
shPI4KIIα and shPI4KIIβ cells was a direct result of target protein depletion. The failure of GFPtagged PI4KIIα-WT and PI4KIIβ-WT to fully restore TYRP1 localization might reflect partial
interference with kinase activity by the C-terminal GFP fusion or a consequence of kinase
overexpression.

Surprisingly, overexpression of either PI4KIIβ-WT-GFP in shPI4KIIα cells or of PI4KIIα-WT-GFP in
shPI4KIIβ cells restored TYRP1 localization to the same degree as re-expression of the targeted
kinase (white arrows, Figs. 2.6F, G, I; Figs. 2.7F, G). This likely reflects cross-compensation by
overexpressed PtdIns-4-kinase activity in adjacent endosomal domains (see Figs. 2.10-2.13
below).
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We next tested if the PI4KIIα and PI4KIIβ roles in melanosome cargo transport require their kinase
activities and respective binding to AP-3 or AP-1. Kinase-dead [PI4KIIα-D308A and PI4KIIβ-D304A;
(Balla et al., 2002)] and AP binding-deficient mutants [PI4KIIα-L61, 62A and PI4KIIβ-L29, 30A;
(Craige et al., 2008; Wieffer et al., 2013)] were expressed stably in WT mouse melanocytes, and
the corresponding endogenous mouse kinase was depleted by shRNA for 7-9 d prior to analyses.
IFM (Fig. 2.6D, E; Fig. 2.7D, E) and immunoblotting (Figs. 2.6H, 2.7H) showed that all mutants
were effectively expressed. However, neither the kinase dead nor AP binding mutants of either
PI4KIIα or PI4KIIβ restored TYRP1 localization to pigment granules in shPI4KIIα and shPI4KIIβ
cells (yellow arrowheads; Figs. 2.6G, 2.7G). Moreover, whereas WT (Figs. 2.6Ci, 2.7Ci) and
kinase-dead (Fig. 2.6Dm, 2.7Dm) variants of PI4KIIα-GFP and PI4KIIβ-GFP localized
predominantly to cytoplasmic puncta (PI4KIIα) and to the perinuclear region or a few cytoplasmic
puncta (PI4KIIβ), PI4KIIα-L61,62A-GFP (Fig. 2.6Eq) and PI4KIIβ-L29,30A-GFP (Fig. 2.7Eq) were
predominantly cytoplasmic. These data suggest that (1) both PI4KIIα and PI4KIIβ require both their
kinase activity (and hence PtdIns4P generation) and their interaction with APs to promote TYRP1
localization, and (2) recruitment to endolysosomal membranes requires binding of PI4KIIα to AP-3
and of PI4KIIβ to AP-1.
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Figure 2.6

Figure 2.6 PI4KIIα function in TYRP1 trafficking requires its lipid kinase activity and binding
to adaptor AP-3.
Melan-Ink4a melanocytes were untransduced (A, B) or transduced with retroviruses to express
GFP-tagged human PI4KIIα-WT (C), kinase-dead mutant PI4KIIα-D308A (D), AP-3-bindingdeficient mutant PI4KIIα-L61,62A (E) or PI4KIIβ-WT (F), selected with hygromycin for at least two
weeks, and then transduced with lentiviruses to express shNC or shPI4KIIα-1. (A-F) 7 to 9 d later,
cells were analyzed by IFM for GFP (white; left panels) and TYRP1 (green; middle left and right
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panels) and by bright field microscopy for pigment granules (BF; middle right panels;
pseudocolored magenta at right). White arrows, TYRP1 surrounding pigment granules; yellow
arrowheads, TYRP1 not overlapping with pigment granules. Boxed regions are magnified 5-fold in
the insets. Scale bars: main panels, 10 μm; insets, 2 μm. (G) Quantification of TYRP1 overlap with
melanosomes from at least three independent experiments, with analyses by Welch’s ANOVA; ****,
p<0.0001; ns, not significant. (H, I) Whole-cell lysates from cells in A-E (H) or panel F and Fig. 2.7F
(I) were analyzed by SDS/PAGE and immunoblotting for PI4KIIα (H) or both PI4KIIα and PI4KIIβ
(I) and γ-Tubulin as a loading control. Left, positions of molecular weight markers (MW).
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Figure 2.7

Figure 2.7 PI4KIIβ function in TYRP1 trafficking requires its lipid kinase activity and binding
to adaptor AP-1.
Melan-Ink4a cells were untransduced (A, B) or transduced with retroviruses to express GFP-tagged
human PI4KIIβ-WT (C), kinase-dead mutant PI4KIIβ-D304A (D), AP-1-binding-deficient mutant
PI4KIIβ-L29,30A (E) or PI4KIIα-WT (F), selected for at least two weeks, and then transduced with
lentiviruses expressing shNC or shPI4KIIβ-2 shRNA to PI4KIIβ. (A-F) 7 to 9 d after shRNA
transduction, cells were analyzed by IFM for GFP (white; left panels) and TYRP1 (green; middle
left and right panels) and by bright field microscopy for pigment granules (BF; middle right panels
and pseudocolored magenta at right). White arrows, TYRP1 surrounding pigment granules; yellow
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arrowheads, TYRP1 not overlapping with pigment granules. Boxed regions are magnified 5-fold in
the insets. Scale bars: main panels, 10 μm; insets, 2 μm. (G) Quantification of TYRP1 overlap with
pigment granules from at least three independent experiments and analysis by Welch’s ANOVA;
****, p<0.0001; ns, not significant. (H) Whole-cell lysates from cells in A-E were analyzed by
SDS/PAGE and immunoblotting for GFP, PI4KIIβ and γ-Tubulin as a loading control (note, the
L28,29A mutant is not recognized by the anti-PI4KIIβ antibody). Left, positions of molecular weight
markers (MW). Immunoblotting for PI4KIIα in cells (F) is shown in Figure 2.6.
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2.3.4 PI4KIIα and PI4KIIβ independently function downstream of BLOC-1 in tubular transport
to melanosomes.
Because TYRP1 was trapped less in early endosomes upon PI4KIIα or PI4KIIβ depletion than upon
BLOC-1 depletion/ knockout, we hypothesized that while either PI4KIIα or PI4KIIβ can collaborate
with BLOC-1 to facilitate cargo exit from early sorting endosomes (Jani et al., 2021), each
additionally promotes an ensuing step in tubule stabilization and/or targeting towards melanosomes.
If so, then TYRP1 should remain trapped in early endosomes and not progress to late endosomes/
lysosomes upon PI4KIIα or PI4KIIβ depletion in BLOC-1-deficient cells. To test this, BLOC-1deficient (BLOC-1-/-) melanocytes that lack the Pallidin (Bloc1s6) subunit and thus fail to assemble
BLOC-1 (Falcon-Perez et al., 2002; Starcevic and Dell'Angelica, 2004) were treated with shNC,
shPI4KIIα, or shPI4KIIβ. They were then analyzed by triple labeling IFM for TYRP1, either PI4KIIα
or PI4KIIβ (not shown) to validate protein depletion, and transferrin receptor (TfR) to identify early
sorting and recycling endosomes [TfR was used instead of STX13 to allow for triple labeling, and
at steady state overlaps with STX13 but not TYRP1 in WT cells or with both STX13 and TYRP1 in
BLOC-1-/- cells (Fig. 2.8)]. Consistent with published data (Delevoye et al., 2016; Setty et al., 2008;
Setty et al., 2007) and Fig. 2.5A, TYRP1 in BLOC-1-/- cells treated with shNC localized largely to
early endosomes as shown by overlap with TfR (arrowheads, Fig. 2.9Aa-c, 2.9B). Knock down of
PI4KIIα or PI4KIIβ in these cells with either of two shRNAs each did not alter the degree of TYRP1/
TfR overlap (yellow arrowheads, Fig. 2.9Ad-i, 2.9B). Thus, TYRP1 is trapped in early endosomes
in BLOC-1-deficient cells regardless of the expression of PI4KIIα or PI4KIIβ, indicating that PI4KIIα
and PI4KIIβ have unique functions downstream of BLOC-1 in cargo transport to melanosomes.

PI4KIIα and PI4KIIβ could potentially generate a pool of PtdIns4P to recruit or stabilize BLOC-1 or
other effectors of tubular transport on membranes, as suggested by in vitro studies (Jani et al.,
2021). Because validated fluorescent forms of BLOC-1 do not exist to assess membrane
association by live cell microscopy in which intact tubules can be visualized, we instead used
subcellular fractionation. Membrane and cytosolic fractions were prepared from homogenates of
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WT melanocytes treated with shNC, shPI4KIIα, or shPI4KIIβ, and the relative association of BLOC1, AP-1, and AP-3 with each fraction was assessed by immunoblotting for the Pallidin, AP-1γ, and
AP-3μ subunits, respectively (Fig. 2.9C, D). Depletion of PI4KIIα or PI4KIIβ neither substantially
nor significantly reduced BLOC-1 membrane association (Fig. 2.9C, D; the decrease caused by
shPI4KIIα-2 likely reflects an off-target effect as discussed earlier). Similarly, neither shPI4KIIα nor
shPI4KIIβ affected the membrane association of AP-1 or AP-3 (Fig. 2.9C, D). We therefore
conclude that neither type II PtdIns4-kinase is uniquely required for the association of BLOC-1, AP3 or AP-1 with membranes.
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Figure 2.8

Figure 2.8 Validation of TfR as an early endosomal marker.
WT melanocytes (upper panels) and BLOC-1-/- melanocytes from pallid mice (lower panels) were
fixed and analyzed by triple label IFM for endogenous TfR (white and green in single and merged
panels, respectively) relative to STX13 and TYRP1 (white and magenta in single and merged
panels, respectively). Cyan arrows, examples of TfR overlap with STX13 but not TYRP1; yellow
arrowheads, examples of TfR overlap with both STX13 and TYRP1. Boxed regions are magnified
5-fold in the insets. Scale bars: main panels, 10 μm; insets, 2 μm.
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Figure 2.9

Figure 2.9 Type II PtdIns4-kinases are required after BLOC-1 function in tubular transport to
melanosomes.
BLOC-1-/- melan-pa (A and B) or melan-Ink4a (C and D) melanocytes were transduced with
lentiviruses to express shNC, shPI4KIIα, or shPI4KIIβ for 7 to 9 d. (A) BLOC-1-/- cells were analyzed
by IFM for TYRP1 (green; left and right panels), TfR to mark early endosomes (magenta, middle
and right panels), and either PI4KIIα or PI4KIIβ (not shown); only cells with minimal PI4KIIα or
PI4KIIβ signal are shown. Yellow arrowheads, TYRP1 overlapping with TfR. Boxed regions are
magnified 5-fold in the insets. Scale bars: main panels, 10 μm; insets, 2 μm. (B) Quantification of
TYRP1 overlap with TfR from three independent experiments and analysis by ordinary one-way
ANOVA. (C, D) Indicated melan-Ink4a cells were homogenized and fractionated to yield
postnuclear membrane (M) and cytosolic (C) fractions. Identical cell equivalents of membrane and
cytosolic fractions were fractionated by SDS-PAGE and analyzed by immunoblotting using
antibodies to the indicated subunits of BLOC-1, AP-1, and AP-3. (C) Representative blots. Left,
positions of molecular weight (MW) markers. (D) Quantification of the percentage (mean ± SD of 4
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independent experiments) of each protein associated with the membrane fraction relative to the
total cellular content. Analysis, ordinary one-way ANOVA. ns, not significant.
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2.3.5 PI4KIIα and PI4KIIβ function sequentially to enrich PtdIns4P on tubular endosomal
domains
If PI4KIIα and PI4KIIβ each directly regulate cargo transport downstream of BLOC-1, then they and
their product, PtdIns4P, should be present on early endosomes and the tubular carriers through
which BLOC-1-dependent cargoes travel. By IFM analysis of fixed cells, endogenous PI4KIIα and
PI4KIIβ and overexpressed GFP-tagged PI4KIIα and PI4KIIβ localized in the cell periphery to only
a small fraction of early endosomes labeled by TfR (yellow arrowheads, Fig. 2.10A, B) or STX13
(yellow arrowheads, Fig. 2.10C, D), respectively (note also extensive localization of PI4KIIβ to the
Golgi region). Similarly small fractions of endogenous PI4KIIα and PI4KIIβ colocalized with TfR [as
seen in other cell types (Craige et al., 2008; Wieffer et al., 2013), but a larger fraction of GFPtagged forms colocalized with STX13 – suggesting that PI4KIIα and PI4KIIβ in the cell periphery
both predominantly localize to a small subset of early endosomal structures that are more enriched
in STX13 than TfR.

To better assess localization to the fixation-sensitive tubules, we utilized live-cell microscopy to
visualize GFP-tagged PI4KIIα, PI4KIIβ or a PtdIns4P probe relative to mCherry-tagged STX13,
which labels the entire early endosomal network including the tubular carriers (Bowman et al., 2021;
Delevoye et al., 2016; Dennis et al., 2015). To detect PtdIns4P, we used P4C-SidC (P4C), a
PtdIns4P-binding domain derived from the secreted SidC effector protein of Legionella
pneumophila (Dolinsky et al., 2014; Weber et al., 2018; Weber et al., 2014) [GFP-P4M-SidMx2 –
containing a tandem repeat of the PtdIns4P binding domain of SidM from L. pneumophila
(Hammond et al., 2014) – did not efficiently label Golgi, endosomes, or tubules in our cells, and
thus was not used in our analyses]. GFP-tagged proteins were transiently expressed in WT
melanocytes stably expressing mCherry-STX13, and cells were analyzed the next day by dualview live-cell spinning disk microscopy (Kinosita et al., 1991) to simultaneously detect mCherryand GFP-tagged components. Still images from image streams show that GFP-tagged PI4KIIα,
PI4KIIβ, and P4C each labeled punctate structures and tubules that largely overlapped with
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mCherry-STX13 (yellow arrowheads in insets, Fig. 2.10A-C), consistent with previous studies
(Balla et al., 2002; Craige et al., 2008; Dong et al., 2016; Jovic et al., 2014; Ma et al., 2020; Wieffer
et al., 2013). Since the majority of STX13-labeled tubules in melanocytes are BLOC-1-dependent
(Delevoye et al., 2016), the tubules decorated by both mCherry-STX13 and PI4KIIα-GFP, PI4KIIβGFP, or GFP-P4C likely corresponded to the BLOC-1-dependent tubular carriers. Additional
tubules were labeled only by PI4KIIα-GFP, PI4KIIβ-GFP, or GFP-P4C (data not shown), suggesting
that type II PtdIns4-kinases associate with tubules from multiple origins in melanocytes. As
expected, P4C also labeled the plasma membrane and the Golgi area (Fig. 2.10C; see also Fig.
2.12Aa-c). The data suggest that PI4KIIα, PI4KIIβ, and their product PtdIns4P are present on early
endosomal tubules that ferry cargo to melanosomes as well as on other tubules that lack STX13.
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Figure 2.10
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Figure 2.10 Type II PtdIns4-kinases and PtdIns4P are present on endosomal tubular carriers.
(A-D) Melan-Ink4a cells that were untransfected (A, B) or that stably expressed PI4KIIα-GFP or
PI4KIIβ-GFP (C, D) were fixed and analyzed by IFM for either endogenous TfR with PI4KIIα or
PI4KIIβ (A, B) or endogenous STX13 with GFP-tagged PI4KIIα or PI4KIIβ (C, D). Shown are
representative individual and merged images (A, C) and quantification of the percentage of area of
overlap of both contents (mean ± SD from three experiments) relative to the total area labeled by
either protein alone (B, D). (E-G) Melan-Ink4a cells stably expressing mCherry-STX13 (magenta,
middle and right panels) were transiently transfected with GFP-tagged PI4KIIα (E), PI4KIIβ (F) or
P4C (G; green, left and right panels) and then analyzed by dual-view live cell-spinning disk
microscopy. Shown are the individual labels and merged image from a frame of a representative
cell emphasizing tubular structures; two boxed regions are magnified 5-fold in the insets. Yellow
arrowheads, tubular structures containing both mCherry-STX13 and either PI4KIIα-GFP, PI4KIIβGFP, or GFP-P4C-SidC. Scale bars: main panels, 10 μm; insets, 2 μm.
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Since both PI4KIIα and PI4KIIβ associated with membrane tubules, we asked whether the
requirement for both enyzmes in cargo delivery to melanosomes reflects their sequential activity.
To test this, we analyzed the dual-view image streams for the temporal association of PI4KIIα-GFP
or PI4KIIβ-GFP relative to the onset of tubule formation from round STX13-containing early
endosomes. For image streams in which the source endosome and a nascent tubule were
visualized, PI4KIIα-GFP was consistently present both on the body of mCherry-STX13-containing
endosomes prior to tubule formation (Fig. 2.11A, white arrowheads) and on the nascent mCherrySTX13-labeled tubule, starting with the appearance of a small protrusion (Fig. 2.11A, yellow
arrowhead, 0s) and continuing during tubule extension (Fig. 2.11A, yellow arrowheads, 0.4-4s).
This indicated that PI4KIIα is sorted into the tubular carriers during their formation. By contrast,
PI4KIIβ-GFP was not detected on the nascent mCherry-STX13-labeled tubules (Fig. 2.11B; tubule
initiates at white arrowhead), but rather consistently appeared as the tubule extended and
accumulated along its length (Fig. 2.11B, 1.6-2.4s between white and yellow arrowheads). In cases
where PI4KIIβ-GFP was detected on the source endosome prior to tubulation, it was typically
present in a subdomain (Fig. 2.11B, white arrowheads) and became more enriched on the tubules.
These results indicate that PI4KIIβ, unlike PI4KIIα, associates with established tubules, and
suggest that PI4KIIβ functions at a later step of tubule dynamics than PI4KIIα.

Consistent with the combined distribution of PI4KIIα-GFP and PI4KIIβ-GFP on the tubules, their
product, PtdIns4P (visualized with GFP-P4C), was present throughout the lifetime of the mCherrySTX13-positve tubules from the onset of tubule formation through tubule extension (Fig. 2.11C, all
panels from white arrows to yellow arrowheads). Additional tubules labeled by GFP-P4C but not
mCherry-STX13 were observed moving towards the plasma membrane and likely represent Golgiderived carriers (Graham and Burd, 2011; Highland and Fromme, 2021; Stalder and Gershlick,
2020).
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Figure 2.11

Figure 2.11 PI4KIIα and PI4KIIβ associate with tubules with distinct kinetics and together
generate PtdIns4P throughout the lifetime of the tubule.
As in Fig. 2.6E-G, melan-Ink4a cells stably expressing mCherry-STX13 and transiently transfected
to express GFP-tagged PI4KIIα (A), PI4KIIβ (B) or P4C (C) were analyzed by dual-view live-cell
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spinning-disk microscopy. Shown are a montage of individual and merged image sequences from
the indicated insets from Fig. 2.10E-G emphasizing the successive extension of STX13-containing
tubules from a source endosome. White arrowheads, sources of tubules; yellow arrowheads, tips
of tubules; time from onset of tubule formation is indicated in seconds. GFP-PI4KIIα was present
on nascent tubules in 22 out of 24 instances (as in A; n=6 cells, 3 independent experiments) and
GFP-PI4KIIβ joined pre-formed tubules in 20 out of 26 instances (as in B, n=9 cells, 3 independent
experiments) in which the source endosome and a nascent tubule were visible and distinguishable
in the same plane of focus. Scale bars: 2 μm.
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2.3.6 PI4KIIα and PI4KIIβ are both required to maintain the endosomal PtdIns4P pool.
To test whether PI4KIIα and PI4KIIβ activity was responsible for PtdIns4P on vacuolar endosomes
and endosomal tubules, we assessed the distribution of PtdIns4P in shPI4KIIα and shPI4KIIβ cells
using GFP-P4C. To avoid the heterogeneity of transient expression, GFP-P4C was expressed
stably from a recombinant retrovirus in WT melanocytes prior to expression of shNC, shPI4KIIα, or
shPI4KIIβ from recombinant lentiviruses. Cells were then transiently transfected to express
mCherry-STX13 prior to live-cell microscopy. As in transient transfections (Fig. 2.10), GFP-P4C
expressed stably in shNC cells localized to the plasma membrane, Golgi, and perinuclear and
peripheral tubular and punctate compartments (Fig. 2.12Aa). Depletion of PI4KIIα or PI4KIIβ
resulted in an apparent diminution of GFP-P4C-labeled puncta in the periphery and an
accumulation in the perinuclear region (Fig. 2.12Ad, g); unlike in cells that did not express P4C
(Fig. 2.5A), this was accompanied by perinuclear accumulation of STX13-labeled endosomes (Fig.
2.12Ae, h), perhaps due to exacerbation of altered endosomal dynamics by shielding of remaining
PtdIns4P. Concomitantly, compared to shNC cells, fewer tubular structures that were labeled by
GFP-P4C (Fig. 2.12Aa,d, g; Fig. 2.12B) or doubly labeled by both GFP-P4C and mCherry-STX13
(yellow vs. white arrowheads; Fig. 2.12Ac, f, i; Fig. 2.12C) were observed in shPI4KIIα and
shPI4KIIβ cells. Moreover, the percentage of mCherry-STX13-containing tubules that also labeled
for GFP-P4C was dramatically reduced (Fig. 2.12D). The impact of PI4KIIα- and PI4KIIβ-depletion
was specific for PtdIns4P, since the number of puncta and the general distribution of the PtdIns3P
probe GFP-2XFYVE (Gillooly et al., 2000) were similar in cells expressing shNC, shPI4KIIα, or
shPI4KIIβ (Fig. 2.13). These data show that both PI4KIIα and PI4KIIβ contribute to PtdIns4P pools
on membrane tubules emanating from early endosomes, as well as from other compartments.
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Figure 2.12

Figure 2.12 PI4KIIα and PI4KIIβ are both required to maintain PtdIns4P on endosomal
tubules.
Melan-Ink4a cells stably expressing GFP-P4C (P4C) were transduced with lentiviruses encoding
shNC or the indicated shRNAs to PI4KIIα or PI4KIIβ, selected for 7 to 9 d, and then transiently
transfected with mCherry-STX13 (STX13) and analyzed by live-cell spinning-disk microscopy. (A)
Still images from image streams of cells treated with shNC (Aa-c) shPI4KIIα (Ad-f) or shPI4KIIβ
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(Ag-i) showing P4C (green, left panels), STX13 (magenta, middle panels), and their overlap
(merged images on the right). Yellow arrowheads, STX13-containing tubules that overlap with P4C;
white arrowheads, STX13-containing tubules that do not overlap with P4C. Boxed regions are
magnified 5-fold in the insets. Scale bars: main panels, 10 μm; insets, 2 μm. (B, C) Quantification
of the total numbers of either single P4C-positive (B) or double P4C- and STX13-positive tubules
per 100-μm2 area in each cell population. (D) Quantification of the percentage of STX13-containing
tubules that were also positive for P4C in each cell population. Data in B-D are from three
independent experiments each and were analysed by Kruskal-Wallis (B) or ordinary one-way
ANOVA (C, D). ****, p<0.0001; **, p<0.01; ns, not significant.
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Figure 2.13

Figure 2.13The distribution of PtdIns3P is not affected by depletion of PI4KIIα or PI4KIIβ.
WT melan-Ink4a melanocytes were transduced with lentiviruses expressing the indicated shRNAs
to PI4KIIα or PI4KIIβ or control non-coding shRNA (shNC) and selected for 7-9 d. Cells were then
transiently transfected to express GFP-2XFYVE and analyzed by live-cell spinning-disk microscopy
the next day. (A) Shown are representative single frame images of cells transduced with each
shRNA and harboring GFP-2XFYVE-labeled puncta. The outline of the cell is indicated. Scale bar,
10 μm. (B) Quantification of the number of puncta within each cell. Data are from three independent
experiments and were analyzed by Kruskal-Wallis test; ns, not significant.
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2.3.7 PI4KIIα and PI4KIIβ are needed to support the formation of effective tubular carriers.
Given that PI4KIIα and PI4KIIβ localization correlated with tubule formation and elongation
respectively, we next tested whether PtdIns4P production by PI4KIIα and PI4KIIβ is required for
proper tubule dynamics in melanocytes. WT melanocytes that stably expressed mCherry-STX13
were treated with shNC, shPI4KIIα, or shPI4KIIβ, and the effects on STX13-positive tubular
structures were assessed by live-cell microscopy. In shNC cells, as in untreated cells [Figs. 2.10
and 2.11 and (Bowman et al., 2021; Dennis et al., 2016; Dennis et al., 2015)], numerous long and
dynamic STX13-positive tubules were detected throughout the cytoplasm [(shown are fluorescence
(Fig 2.14Aa, b) and skeletonized images (Fig. 2.14Ac, d)]. Although shPI4KIIα and shPI4KIIβ cells
also harbored dynamic tubules, relative to shNC cells the tubules were fewer in number (Fig.
2.14Aa-d, Ba-d, Ca-d; Fig. 2.14D), less enriched in the number and percentage of longer (> 1 μm)
tubules (Fig. 2.14E, 2.14F), and shorter on average (Fig. 2.14G). Since the tubules that contact
melanosomes are typically long (Bowman et al., 2021; Dennis et al., 2015), these data suggest that
formation and extension of melanosome-bound tubules are impaired by PI4KIIα or PI4KIIβ
deficiency. The reduction in tubule number and length trended as more severe in shPI4KIIα cells
than in shPI4KIIβ cells (Fig. 2.14D-G), supporting the conclusion that PI4KIIα functions earlier than
PI4KIIβ, but was less severe than previously observed in BLOC-1-/- cells (Bowman et al., 2021;
Delevoye et al., 2016). These results indicate that PI4KIIα and PI4KIIβ are each uniquely required
sequentially in tubule elongation and/or stabilization, subsequent to BLOC-1-dependent tubule
formation.
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Figure 2.14

Figure 2.14 Depletion of either PI4KIIα or PI4KIIβ disrupts the dynamics of BLOC-1dependent tubular cargo carriers.
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A-G. Melan-Ink4a melanocytes stably expressing mCherry-STX13 (mCh-STX13) were transduced
with lentiviruses to express shNC or the indicated shRNAs to PI4KIIα or PI4KIIβ, selected for 7 to
9 d, and analyzed by live cell-spinning disk microscopy. (A-C) Still images from image streams (a
panels; boxed regions are magnified 4-fold in insets in b panels), and skeletonized images (c, d)
emphasizing the tubules. Scale bars: main panels, 12 μm; insets, 3 μm. (D-G) Quantification of the
total number of mCh-STX13-labeled tubules per 25-μm2 area (D), the total number of tubules per
25-μm2 area that were longer than 1 μm (E), the percentage of total tubules that were longer than
1 μm (F), or the length of all tubules per 25-μm2 area (G) for each cell population. Data are from
three independent experiments and were analyzed by Kruskal-Wallis (D) or ordinary one-way
ANOVA (E-G). (****, p<0.0001; ***, p<0.001; *, p<0.05; NS, not significant). (H) Working model.
PI4KIIα (pink and green) is recruited by AP-3 (blue) on the vacuolar endosome to newly forming
endosomal tubules labeled by STX13 through the interaction of AP-3, BLOC-1 (orange), and
PI4KIIα (top panel). As the tubule elongates, PI4KII (blue and green) is recruited by AP-1 (green)
– perhaps bound to the kinesin motor heavy chain KIF13A (red) – to the extended tubule (bottom
panel). Both PI4KIIα and PI4KII generate local PtdIns4P (yellow shading) to allow for effective
transport of cargos (TYRP1, OCA2 and VAMP7 as indicated) to melanosomes.
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2.4 Discussion
BLOC-1-dependent endosomal tubular carriers are essential for cargo delivery to maturing
melanosomes, but how lipids regulate tubule formation and dynamics was not known. In Chapter
2, I showed that the type II PtdIns-4-kinases, PI4KIIα and PI4KIIβ, are recruited to the tubular
endosomal carriers where they cooperate to generate local pools of PtdIns4P. While PI4KIIα and
PI4KIIβ likely play redundant roles in PtdIns4P generation on vacuolar endosomes to concentrate
BLOC-1 and initiate tubulation (Jani et al., 2021), the PtdIns4P pools produced by each kinase are
required after tubule initiation for tubule stability and ultimate cargo delivery to melanosomes.
These functions require both kinase activity and adaptor binding by PI4KIIα and PI4KIIβ. Depletion
of either PI4KIIα or PI4KIIβ impairs tubular carrier dynamics, resulting in melanosomal cargo
mistargeting – primarily to late endosomes and lysosomes – and consequent impaired melanin
production. Our results support a model in which PI4KIIα on newly generated endosomal tubules
and PI4KIIβ on the growing tubules, recruited by AP-3 and AP-1 respectively, generate local
PtdIns4P to ensure effective tubular cargo transport to melanosomes (Fig. 2.14H). This model may
have broader implications for tubule-dependent cargo transport within the endomembrane system
and for LRO biogenesis in general.

In melanocytes, BLOC-1 and the kinesin-3 heavy chain KIF13A cooperate to generate long, stable
membrane tubules that transport selected cargoes to melanosomes and constitute the majority of
STX13-containing endosomal tubules (Delevoye et al., 2016; Dennis et al., 2016; Dennis et al.,
2015). BLOC-1 cooperates with PI4KIIα in endosomal trafficking in other cell types (Gokhale et al.,
2012; Larimore et al., 2011; Salazar et al., 2009), but how PI4KIIα or PI4KII contributes to tubule
dynamics was not known. Our live-cell imaging shows that PtdIns4P is present over the entire
length and lifetime of BLOC-1-dependent tubules. PI4KIIα and PI4KII are both detected on the
tubules and the early endosomes from which they emerge, and accordingly, depletion of either
PI4KIIα or PI4KII impaired both tubule number and length. Thus, continuous PtdIns4P generation
by PI4KIIα and PI4KII coincides with and is necessary for tubule initiation, extension, and
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stabilization. PI4KIIα or PI4KII depletion impaired tubule number less dramatically than BLOC-1
depletion; we interpret this to reflect redundancy of the two type II PtdIns-4-kinases in tubule
initiation (Jani et al., 2021). Our data in melanocytes are consistent with the known association of
PtdIns4P with recycling endosomal tubules in HeLa cells (Jovic et al., 2009) and with tubules from
a variety of LROs in different cell types (Domingues et al., 2016; Levin-Konigsberg et al., 2019;
López-Haber et al., 2020b; Ma et al., 2020). How PtdIns4P promotes tubule stability or extension
is not clear. We speculate that it serves as a platform to recruit membrane bending proteins
(Kitamata et al., 2020) such as BLOC-1 itself [(Jani et al., 2021); see below], EHD1, or DRG2 (Jovic
et al., 2009; Ma et al., 2020; Mani et al., 2017). Alternatively, PtdIns4P might concentrate KIF13A
on tubules either indirectly via clustering its adaptor AP-1 (Wang et al., 2003) or directly like the
activity of PtdIns(4,5)P2 on KIF1A and KIF5B to drive membrane transport and tubulation (Du et al.,
2016; Klopfenstein et al., 2002).

Perhaps our most surprising finding is that two type II PtdIns-4-kinases are sequentially required
for extension and/or stability of the same tubular transport carriers. Depletion of either PI4KIIα or
PI4KII reduced the number and length of STX13-positive tubules and the delivery of melanosome
cargo. As in other cell types (Balla et al., 2002; Craige et al., 2008; Jovic et al., 2014; Ma et al.,
2020; Wieffer et al., 2013), both PI4KIIα and PI4KII in melanocytes localized in part to a subset of
early endosomes and derived tubules, but whereas PI4KIIα associated with the tubules during their
formation (and thus might play a prominent role in tubule initiation), PI4KII mainly accumulated on
the tubules after formation and during extension. Consistently, tubules were shorter upon depletion
of PI4KIIα than of PI4KII. Together, these data suggest that PI4KIIα and PI4KII act sequentially
to ensure that PtdIns4P levels are maintained throughout tubule elongation (Fig. 2.14H). Because
PI4KIIα function and localization required its AP-3-binding determinant, we speculate that PI4KIIα
is recruited by AP-3 on budding regions of vacuolar endosomes, where a BLOC-1-AP-3 supercomplex (Di Pietro et al., 2006; Salazar et al., 2006; Salazar et al., 2009) facilitates tubule initiation
and SNARE and cargo sorting (Bowman et al., 2021). Similarly, PI4KII function and localization
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required its AP-1-binding determinant; we thus further speculate that PI4KII is recruited to the
growing tubule by AP-1 bound to KIF13A as KIF13A extends the tubule along microtubules
(Campagne et al., 2018; Delevoye et al., 2016; Delevoye et al., 2009; Delevoye et al., 2014).
Although general membrane association of BLOC-1, AP-3, or AP-1 was not impaired by PI4KIIαor PI4KII-depletion, the pool of PtdIns4P generated by PI4KIIα or PI4KII likely feeds back to
concentrate BLOC-1 (Jani et al., 2021) and AP-1 (Wang et al., 2003), respectively, on the tubules.
Overexpression of either GFP-PI4KIIα or -PI4KII compensated for the depletion of either
endogenous PI4KII paralogue in cargo localization to melanosomes, suggesting that excess local
PtdIns4P produced by the overexpressed PI4KII likely diffuses to sites where the absent PI4KII
paralogue would normally produce a more limited pool.

While our live cell imaging data are consistent with a redundant requirement for either type II PtdIns4-kinase to concentrate BLOC-1 during recycling tubule formation from early endosomal vacuoles
(Jani et al., 2021), they reveal an independent non-redundant requirement for PI4KIIα and PI4KII
in tubule dynamics and melanosome cargo transport downstream of BLOC-1. This is supported by:
(a) the exit of BLOC-1-dependent melanosome cargoes from early endosomes in cells depleted of
PI4KIIα or PI4KII but not in cells depleted of BLOC-1; (b) the entrapment of cargo in early
endosomes in cells lacking both BLOC-1 and either PI4KIIα or PI4KII; (c) the lack of a significant
reduction in BLOC-1 recruitment to membranes in cells depleted of PI4KIIα or PI4KII; and (d) the
more modest impairment in tubule number and length in cells depleted of PI4KIIα or PI4KII relative
to BLOC-1-deficient cells (Bowman et al., 2021; Delevoye et al., 2016). The additional requirement
for PtdIns4P in the maintenance and extension of the tubules at a stage following BLOC-1dependent tubule initiation is also consistent with data in HeLa cells (Jani et al., 2021). Our efforts
to simultaneously deplete both enzymes in melanocytes were unsuccessful, but future studies
using knockout/ knockdown approaches might be used to validate a requirement for endosomal
PtdIns4P in initiating tubule formation in melanocytes.
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Both type II PtdIns-4-kinases were necessary for the ultimate delivery of BLOC-1-dependent
cargoes to melanosomes; depletion of either PI4KIIα or PI4KII resulted in mistargeting of at least
one cargo to late endosomes and lysosomes. This likely does not reflect improper sorting of cargo
or SNAREs into the nascent tubules, as sorting is mediated by AP-1, AP-3, and/or BLOC-1
(Bowman et al., 2021; Delevoye et al., 2009; Sitaram et al., 2012; Theos et al., 2005b), which were
effectively recruited to membranes in PI4KIIα- or PI4KII-depleted cells. Moreover, cargo was
retained within early endosomes in BLOC-1-deficient cells depleted of PI4KIIα or PI4KII, indicating
that missorting to late endosomes/ lysosomes required BLOC-1 activity and thus likely also tubule
initiation. Rather, the data support the conclusion that the short tubules in PI4KIIα or PI4KIIdepleted cells are sufficient for cargo exit from early endosomal vacuoles but not for ultimate cargo
delivery to melanosomes. Thus, length and lifetime likely impact the ability of tubules to fuse with
maturing melanosomes to ensure cargo delivery (Delevoye et al., 2009). This might reflect (a) the
long distance needed for cargo to travel from endosomes to peripheral melanosomes or (b) a
requirement for selective microtubule-driven processes to ensure that the cargo carriers encounter
and fuse with melanosomes prior to late endosomes or lysosomes. Future studies will be needed
to address this model.

PtdIns4P is critical in all cells to control cargo transport, membrane identity, and organelle contacts
within the endomembrane system (D'Angelo et al., 2008; Tan and Brill, 2014). Specialized cell
types specifically adapt the use of PtdIns4P on tubules to ensure the maturation of LROs, including
phagolysosomes in dendritic cells and macrophages (Levin-Konigsberg et al., 2019; López-Haber
et al., 2020b; Mantegazza et al., 2014) and secretory granules in Drosophila melanogaster salivary
glands (Ma et al., 2020). Our results extend these studies by revealing a requirement in
melanocytes for both mammalian type II PtdIns-4-kinases at distinct stages of membrane tubuledependent anterograde cargo transport from endosomes to maturing melanosomes, and are
consistent with a requirement for both PI4KIIα and PI4KII in Weibel-Palade body maturation in
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endothelial cells (Lopes da Silva et al., 2016). Together, these studies suggest that the formation
of PtdIns4P-enriched tubules is a general feature in LRO maturation.
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2.6 Materials and Methods
2.6.1 Reagents
Unless otherwise indicated, chemicals were obtained from Sigma-Aldrich or Fisher Bioreagents.
Tissue culture reagents and blasticidin were from Life Technologies/Thermo Fisher Scientific.
Puromycin was from Takara Bio. Hygromycin B and protease inhibitors were from Roche. Odyssey
Blocking Buffer was from LI-COR. Gene amplification primers were from Integrated DNA
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Technologies. Phusion polymerase, restriction enzymes, T4 DNA ligase and the Gibson Assembly
Cloning Kit were from New England Biolabs.

2.6.2 Antibodies
Primary monoclonal antibodies used and their sources (indicated in parentheses) were: mouse
anti-TYRP1 (TA99/Mel-5, American Type Culture Collection; Rockville, MD); mouse anti-γ-Tubulin
(GTU-88, Sigma); mouse anti-γ-adaptin (BD 610385); mouse anti-GFP (clones 7.1 and 13.1,
Roche); rabbit anti-AP3M1 (ab201227; Abcam); rat anti–mouse LAMP2 (GL2A7, Abcam); rat antimouse TfR (CD71, BD 553264); and rat anti-HA (3F10, Roche 11867423001). Primary polyclonal
antibodies used and their sources were: rabbit anti-STX13 (a kind gift of Rytis Prekeris, Univ. of
Colorado, Denver, CO, USA)(Prekeris et al., 1998); rabbit anti-pallidin (a kind gift of Juan
Bonifacino, National Institute of Child Health and Human Development, Bethesda, MD,
USA)(Moriyama and Bonifacino, 2002); rabbit anti-PI4KIIIβ (13247-1-AP, Proteintech); rabbit antiPI4KIIα and anti-PI4KIIβ (kind gifts of Pietro De Camilli, Yale Univ., New Haven, CT, USA) (Guo et
al., 2003); and rabbit anti-GFP (PABG1, Chromotek); Species- and/or mouse isotype–specific
secondary antibodies from donkey or goat conjugated to Alexa Fluor 488, Alexa Fluor 594, or Alexa
Fluor 640 used for IFM or to Alexa Fluor 680 or Alexa Fluor 790 for immunoblots were obtained
from Jackson ImmunoResearch Laboratories. Dilution of each antibody for immunoblot or
immunofluorescence is listed in Table 1.

2.6.3 DNA constructs
All oligonucleotides used in constructing shRNA and expression plasmids are documented in Table
2.
The pLKO.1-puromycin derived lentiviral vectors for small hairpin RNAs (shRNAs) against mouse
PI4KIIα (shPI4KIIα-1, shPI4KIIα-2), PI4KIIβ (shPI4KIIβ-1, shPI4KIIβ-2), pallidin (shPallidin-1,
shPallidin-2), PI4KIIIβ (shPI4KIIIβ-1, shPI4KIIIβ-2) and non-target control (shNC) were obtained
from the High-throughput Screening Core of the University of Pennsylvania (Supplementary
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Table1). The plasmid-based expression vectors pEGFP-N1-PI4KIIα (Balla et al., 2002), pEGFPN1-PI4KIIβ (Balla et al., 2002), pEGFP-C1-P4C-SidC (Dolinsky et al., 2014; Weber et al., 2018;
Weber et al., 2014), pEGFP-C1-VAMP7 (Dennis et al., 2016), pmCherry-STX13 (Dennis et al.,
2016; Dennis et al., 2015), pEGFP-C3-2xFYVE (Gillooly et al., 2000) and pCR-OCA2-WT-HAUTR2 (Sitaram et al., 2009) and the retroviral expression vector pBMN-mCherry-STX13-IRESHygro (X/N) (Bowman et al., 2021) have been previously described. Lentiviral packaging plasmid
psPAX2 and pMD2.G encoding the vesicular stomatitis virus glycoprotein were gifts from Didier
Trono (Univ. of Geneva) and purchased from Addgene (http://n2t.net/addgene:12260 and
http://n2t.net/addgene:12259, respectively). Plasmid pBMN-GFP-P4C-SidC was generated by
amplifying GFP-P4C-SidC from pEGFP-C1-P4C-SidC using primers 1 and 2, subcloning the
amplified fragment into the NotI restriction site of pBMN-IRES-hygro(X/N) (Setty et al., 2007), and
determining the proper insert orientation by gene amplification. The shRNA-resistant (shPI4KIIα1R) forms of PI4KIIα-WT-GFP, PI4KIIα-D308A-GFP and PI4KIIα-L61, 62A-GFP were generated by
two-step gene amplification using the previously described MiGR-PI4KIIα-WT-GFP, MiGR-PI4KIIαD308A-GFP and MiGR-PI4KIIα-L61, 62A-GFP, respectively, as templates (López-Haber et al.,
2020a). In the first step, fragments containing PI4KIIα cDNA 1-477 and PI4KIIα cDNA 459-1437
fused to GFP were separately amplified using primers 3 and 4 and primers 5 and 6, respectively.
The two PCR products contain a 19-bp region of overlap containing the shPI4KIIα-1R sequence
CAAaAATGAgGAaCCCTAT (mutagenized sites in small caps). The second step amplification
concatenated the two PCR products using primers 3 and 6 to generate the full-length products,
which were then subcloned into the NotI restriction site of pBMN-IRES-hygro(X/N) to generate
pBMN-PI4KIIα-WT-GFP, pBMN-PI4KIIα-D308A-GFP and pBMN-PI4KIIα-L61, 62A-GFP. Similarly,
the shRNA-resistant (shPI4KIIβ-2R) forms of PI4KIIβ-WT-GFP and PI4KIIβ-D304A-GFP were
generated by two-step amplification using pEGFP-N1-PI4KIIβ-WT and pEGFP-N1-PI4KIIβ-D304A
(Balla et al., 2002) as templates, respectively. In the first step, fragments containing PI4KIIβ cDNA
bp 1-1080 and PI4KIIβ bp cDNA 1063-1443 fused to GFP were separately amplified using primers
7 and 8 and primers 9 and 6, respectively. The two PCR products contain an 18-bp region of overlap
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containing the shPI4KIIβ-2R sequence GAcGAgTGGAGAGCtTAT (mutagenized sites in small
caps). The second step amplification concatenated the two PCR products using primers 7 and 6 to
generate the full-length products, which were then subcloned into the NotI restriction site of pBMNIRES-hygro(X/N) to generate pBMN-PI4KIIβ-WT-GFP and pBMN-PI4KIIβ-D308A-GFP. In all
cases, the proper orientation of inserts within the pBMN-IRES-hygro vector was determined by
gene amplification. The shPI4KIIβ-2R form of pBMN-PI4KIIβ-L29, 30A-GFP was made by Gibson
assembly using pBMN-PI4KIIβ-WT-GFP as template. Fragments containing PI4KIIβ cDNA bp 11017 and cDNA bp 987-1443 fused to GFP were amplified using primers 10 and 11, and primers
12 and 13, respectively. The two PCR products contain a 28-bp region of overlap
GAGCCGgcGgcACCGCGGATCGCCTGGG in which the codons for the two leucines of the AP-1
binding site are mutagenized to alanine codons (alanine codons in bold).

2.6.4 Cell culture and cell line generation
Immortalized melanocyte cell lines melan-Ink4a-1 (referred to here as melan-Ink4a or WT) derived
from C57BL/6J-Ink4a-Arf-/- (Cdk2a-null) mice (Sviderskaya et al., 2002) and melan-pa1 (referred to
here as melan-pa) derived from Pldn/BLOC-1-deficient C57BL/6J-Pldnpa/pa pallid mice (Setty et al.,
2007) have been described. All melanocyte cell lines were cultured at 37°C and 10% CO2 in RPMI
1640 supplemented with 10% FBS (Atlanta Biologicals), 2 mM L-glutamine and 200 nM 12-Otetradecanoylphorbol-13-acetate. Plat-E cells (Morita et al., 2000) were cultured at 37°C and 5%
CO2 in DMEM supplemented with 10% FBS (Hyclone), 2 mM L-glutamine, 1 mM sodium pyruvate
with 1 μg/mL puromycin and 10 μg/mL blasticidin to maintain selection for the murine leukemia
virus Gag and Env genes. HEK293T cells were cultured at 37°C and 5% CO 2 in DMEM
supplemented with 10% FBS (Hyclone), 2 mM L-glutamine. All cell lines were tested to be negative
for mycoplasma every 2–3 months using the MycoAlert Mycoplasma Detection Kit (Lonza).

Stable melan-Ink4a lines expressing mCherry-tagged STX13 or GFP-tagged P4C-SidC, PI4KIIα or
PI4KIIβ were generated by transducing melan-Ink4a cells with recombinant retroviruses encoding

103

the indicated genes. Retroviruses were produced by Plat-E cells that were transiently transfected
with indicated retroviral DNA constructs in the pBMN-IRES-hygro vector. Briefly, Plat-E cells were
plated at 1.5x106 cells per 35-mm well and transfected the next day with 3.5 μg plasmid DNA using
Lipofectamine 2000 (Thermo Fisher) in DMEM-containing medium according to manufacturer’s
instructions. The medium was replaced with RPMI 1640/ 10% FBS after 4-6 h, and retroviruscontaining supernatants were collected 48 h later, filtered, and added to melan-Ink4a cells seeded
the previous day (3-4x105 cells per 35-mm well). The retrovirus-containing supernatants was
replaced with fresh medium containing 400-500 μg/ml hygromycin B, and polyclonal drug-resistant
lines were selected over 14 d. Stable transfectant lines were occasionally treated with 200 µg/ml
hygromycin B for 2–3 d to maintain selective pressure for the transgene.

Lentiviruses encoding shRNAs were harvested from transfected HEK293T cells that were cotransfected with packaging plasmid psPAX2, envelope plasmid pMD2.G, and pLKO.1 lentiviral
plasmid containing the indicated shRNA insert and puromycin-resistance gene. HEK293T cells
plated at 1.5x106 cells per 35-mm well the day before were transfected with 3.5 μg pLKO.1-shRNA,
2.625 μg psPAX2, and 0.875 μg pMD2.G using Lipofectamine 2000 (Thermo Fisher) according to
the manufacturer’s instructions. Medium replacement and virus harvesting were as described
above for retroviral production. The lentivirus-containing supernatants were diluted 1:1 with fresh
medium and added to melanocytes seeded the previous day (3-4x105 cells per 35-mm well).
Transduced cells were selected using 2 μg/mL puromycin for 7-14 d or as indicated otherwise.

For transient transfection of melanocytes, cells were plated at 2.5-3x106 cells per 35-mm well on
Matrigel (BD)-coated coverslips (for OCA2-HA, GFP-VAMP7) or 35-mm glass-bottomed dishes
(Matsunami D35-14-1.5-U; for mCherry-STX13, GFP-P4C, PI4KIIα-GFP, PI4KIIβ-GFP, GFP2XFYVE) and then transfected the next day with 1 μg (GFP-P4C, GFP-2XFYVE) or 2 μg (OCA2HA, GFP-VAMP7, mCherry-STX13, PI4KIIα-GFP, PI4KIIβ-GFP) of expression plasmid using
Lipofectamine 3000 according to the manufacturer’s instructions. Cells were imaged 24 h (GFP-
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VAMP7, GFP-P4C, PI4KIIα-GFP, PI4KIIβ-GFP, GFP-2XFYVE) or 48 h (OCA2-HA, mCherrySTX13) after transfection.

2.6.5 Melanin content quantification
Quantification of melanin content by spectroscopy was performed essentially as described
(Delevoye et al., 2009). Briefly, 1.2x106 cells were seeded in 6-cm dishes in triplicate. The next day,
cells were rinsed twice with PBS, detached by incubation in PBS, 10 mM EDTA for 15-20, and
collected by centrifugation at 500 x g for 5 min. Cells were resuspended in cold 50 mM Tris-HCl,
pH 7.4, 2 mM EDTA, 150 mM NaCl, 1 mM DTT, and 1x protease inhibitor cocktail (Roche), and
then sonicated on ice using the Sonic Dismembrator Model 100 (Fisher Scientific). Sonicates were
fractionated into supernatant and pellet fractions by centrifugation at 20,000 x g for 15 min at 4°C.
Supernatants were subjected to determination of protein concentration by BCA protein
determination kit (Thermo Fisher). Melanin-containing pellets were rinsed in ethanol/diethyl ether
(1:1) and dissolved in 2 M NaOH/ 20% dimethyl sulfoxide at 60°C for 1 hour. The melanin content
of individual samples was measured by spectrophotometry as absorbance at 492 nm, and
normalized to protein concentration in each sample. Triplicate samples were analyzed for each
experimental condition in each experiment.

2.6.6 Immunoblotting
Melanocytes were cultured in 10-cm dishes, detached by incubation in PBS, 10 mM EDTA for 1520 min, and collected by centrifugation at 500 x g for 5 min. Cell pellets were resuspended in cold
50 mM Tris-HCl, pH 7.4, 2 mM EDTA, 150 mM NaCl, 1 mM DTT, and 1x protease inhibitor cocktail
(Roche), and lysed by sonication on ice using the Sonic Dismembrator Model 100 (Fisher Scientific).
Concentrated Laemmli sample buffer with 2-mercaptoethanol was added to cell lysates and heated
at 95-100°C for 10 min. Samples were then fractionated by 12% sodium dodecyl sulfate
(SDS)/polyacrylamide gel electrophoresis (PAGE) on polyacrylamide gels and transferred to
polyvinylidene difluoride membranes (Immobilon-FL, Millipore). Membranes were blocked with
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Odyssey Blocking Buffer at room temperature (RT) for 1 h, incubated with primary antibody diluted
in TBS/ 0.2% tween-20 (TBST) overnight at 4°C, washed 3 times 10 min with TBST, and then
incubated with secondary antibody conjugated with either Alexa Fluor 680 or Alexa Fluor 790,
diluted in TBST, at RT for 1 h. After washing 3 times 10 min with TBST, blots were analyzed using
a LI-COR Odyssey CLx imaging system, and images were further processed and quantified using
Fiji-ImageJ (National Institutes of Health).

2.6.7 Subcellular fractionation
Subcellular fractionation was performed essentially as described (Di Pietro et al., 2004; Di Pietro
et al., 2006) with minor modifications. All steps were performed at 4°C. To prepare cytosolic and
membrane fractions, melanocytes were homogenized at 107 cells/ml in hypotonic buffer [10 mM
HEPES, pH 7.4, 1 mM MgCl2, 1 mM EGTA, 250 mM sucrose, 2 mM DTT, 1x protease inhibitor
cocktail (Roche), 1x phosphatase inhibitor (Roche)] by passing cells through a pre-chilled 28G
needle for 25-30 cycles until 70-80% cells were disrupted as evaluated by trypan blue exclusion.
Undisrupted cells in the crude homogenate were pelleted by centrifugation at 500 x g for 1 min,
and the supernatant was then centrifuged at 5000 x g for 10 min to remove nuclei and mitochondria.
The resulting post-nuclear supernatant was fractionated into membrane pellet and cytosolic
supernatant fractions by centrifugation at 100,000 x g for 60 min. Membrane pellets were gently
washed once in hypotonic buffer to minimize contamination by cytosolic proteins and then
solubilized in hypotonic buffer containing 0.2% SDS to the same volume as the cytosol fraction. 6X
Laemmli sample buffer with 2-mercaptoethanol was added to solubilized membrane and cytosolic
fractions (to a final 1X concentration), and samples were heated at 95-100°C for 10 min. Identical
volumes of membrane and cytosolic fractions were fractionated by SDS-PAGE on 12%
polyacrylamide gels and analyzed by immunoblotting.
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2.6.8 Immunofluorescence microscopy and live-cell imaging
Immunofluorescence microscopy was performed essentially as described (Bowman et al., 2021;
Dennis et al., 2016). Briefly, melanocytes were seeded on matrigel-coated coverslips 24-48 h
before fixation. Cells were fixed with 4% formaldehyde (VWR Scientific) in PBS (RT, 15 min),
washed 5 times with PBS, incubated with primary antibody (RT, 1 h) diluted in blocking buffer (0.01%
BSA and 0.02% Saponin in PBS), washed 3 times 5 min with PBS, incubated with secondary
antibodies (RT, 30 min) diluted in blocking buffer, washed again, and mounted onto slides using
Prolong Gold (Thermo Fisher). Fixed cell images were acquired using a Leica DMI8 inverted
microscope (Leica Biosystems) equipped with a CSU-WI spinning-disk confocal scanner unit
(Yokogawa), a 100X total internal reflection fluorescence objective lens (Leica 1.47 NA) or a 63X
objective lens (Leica, 1.40 NA) a Hamamatsu Photonics ORCA-Flash 4.0 sCMOS digital camera,
and VisiView software (Visitron System). Images were further processed and analyzed using FijiImageJ.

Live-cell imaging was done essentially as described (Bowman et al., 2021). Briefly, melanocytes
were seeded onto matrigel-coated 35-mm glass-bottomed dishes, incubated in Leibovitz’s CO2independent medium without phenol red (Invitrogen) supplemented with 10% FBS in an
environmental chamber set to 37°C, and imaged using the same microscopic system. To image
tubule dynamics, z-series images spanning two to five layers separated by 0.2-μm or 0.25-μm were
captured every 0.6–1 s for a minimum of 30 s and a maximum of 90 s. To observe cellular PtdIns4P
distribution, sixteen 0.2-μm layers of z-series were acquired for further analysis. Dual-view live-cell
imaging was performed using the Hamamatsu W-VIEW GEMINI Image splitting optics, and one
to three z-series layers separated by 0.2-μm were captured every 0.4-0.5 s for a minimum of 20
s and a maximum of 80 s.
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2.6.9 Quantitative image Analysis
Colocalization analyses. The area of overlap between fluorescently labeled proteins and pigmented
melanosomes or between two fluorescently labeled proteins was quantified using Fiji-ImageJ
(Schneider et al., 2012) on fixed cell images essentially as previously described (Bowman et al.,
2021; Dennis et al., 2015). Briefly, single z-plane images were cropped around single cells, and
the nucleus and densely labeled perinuclear region were removed. The local background of
fluorescent images was subtracted using the “rolling ball” algorithm with “sliding paraboloid”
selected; the rolling ball radius was chosen based on fluorescence intensity, such that a smaller
radius was used for higher fluorescence intensity values (e.g. 2 pixels for most TYRP1, STX13,
LAMP2, OCA2-HA, and PI4KIIα images, and 5 pixels for TfR, PI4KIIβ, and PI4KIIα-GFP) and a
higher radius for lower intensity values (e.g. 10 pixels for GFP-VAMP7 and PI4KIIβ-GFP). Pigment
granules from the bright field channel were processed using either the “Invert” function first and
then “Threshold” function by ImageJ or, for Figure 1C, the plugin “Spot Detector” by Icy software
(https://icy.bioimageanalysis.org/). After background subtraction, images were converted to binary
images using either the “Threshold” function (TYRP1, STX13, LAMP2 and OCA2-HA) or the
Bernson algorithm of the “Auto Local Threshold” function with a 15-pixel radius (GFP-VAMP7,
PI4KIIα, PI4KIIβ, PI4KIIα-GFP, PI4KIIβ-GFP) or both (TfR). Structures of less than 5 pixels in area
were considered background and filtered out using the “Analyze Particles” function. To generate
an overlap image, two binary images were multiplied using the “Image Calculator” function, and the
areas of the individual and overlap binary images were calculated using the “Analyze Particles”
function. Percentage of overlap was calculated either as the percentage of the area of overlap
relative to the area of one of the individual labels or by dividing the number of TYRP1-overlapping
pigment granules by the total number of pigment granules (Fig. 2.1C).

Tubule number and percentage of STX13-positive tubules that contain PtdIns4P. Quantification of
tubules containing PtdIns4P, as labeled by the GFP-P4C-SidC (P4C) probe, was done using
ImageJ on video streams of melan-Ink4a mouse melanocytes that stably express P4C and
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transiently express mCherry-STX13 (STX13). A maximum-intensity projection was generated from
three consecutive z-series layers separated by 0.2-μm from a single frame of a video stream, and
two cytoplasmic 100-μm2 square regions were randomly selected for each single cell analysis.
Background subtraction and segmentation of both P4C and STX13 were processed using the
SQUASSH algorithm (Rizk et al., 2014) with the following parameters: rolling ball window size of
20 pixels in the Background subtractor; 0.04 for minimum object intensity channel; “Subpixel
segmentation” selected; and 0.4 for standard deviation of xy and z in the PSF model. Binary images
were generated using the “SQUASSH” algorithm, and structures in which binary P4C- and STX13containing structures overlapped were visualized using the “Image Calculator” “multiply” function.
Circular structures in binary images were removed and P4C-positive and/or P4C-STX13-positive
tubular structures were quantified using the Analyze particles function with size of 0.0625 μm 2infinity and circularity of 0-0.7. The percentage of STX13-positive tubules that overlap P4C was
calculated by dividing the number of P4C-STX13-positive tubules by the number of STX13-positive
tubules. In the graphs shown in Fig. 2.12B-D, a single dot indicates the average of two 100-μm2
regions within a single cell.

Number, percentage, and length of STX13-containing tubules. Quantification of endosomal tubules
labeled by mCherry-STX13 was performed using Fiji-ImageJ on melan-Ink4a mouse melanocytes
that stably express mCherry-STX13. Single plane images with largely in-focus STX13-positive
structures were selected from image sequences, and ten cytoplasmic 25-μm2 square regions were
randomly chosen and analyzed individually. Signal background was subtracted using the Rolling
Ball algorithm with a 10-pixel radius and Sliding Paraboloid selected. After background subtraction,
images were processed by Smooth to reduce noise and then rendered binary using the Phansalkar
algorithm of the “Auto Local Threshold” function with a 15-pixel radius, followed by the Skeletonize
function. The Analyze Skeleton function was used to calculate and document the length and
number of tubules, represented as Branches. Only branches longer than 0.25 μm were considered
as tubules. Tubule length was determined by averaging all branches longer than 0.25 μm within
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each 25-μm2 region of a single cell. In the graphs shown in Fig. 2.14D-G, a single dot represents
the average of ten 25-μm2 regions within a single cell.

Number of GFP-2XFYVE-containing puncta per cell. Quantification was done using ImageJ from
video streams of melan-Ink4a mouse melanocytes expressing shNC, shPI4KIIα, or shPI4KIIβ. A
maximum-intensity projection of selected frames was generated from three consecutive z-series
layers separated by 0.25-μm z-step, and regions covering entire cells were analyzed. Signal
background was subtracted using the Rolling Ball algorithm with a 5-pixel radius with Sliding
Paraboloid selected. After background subtraction, images were rendered binary using the
“Contrast” algorithm of the “Auto Local Threshold” function with a 15-pixel radius, followed by the
“Fill holes” and “Watershed” functions. Using the “Analyze Particles” function, structures of less
than 5 pixels were considered background and filtered out, and the number of puncta in each cell
was calculated.

2.6.10 Graphical presentation of data and statistical analyses
At least three independent replicates were performed in each experiment and sample sizes are as
indicated in each figure legend. In all graphs, results were presented as mean ± SD. Most data are
presented as “super-plots” (Lord et al., 2020) in which values from individual cells within each
experiment are indicated by a single dot, colors represent independent experiments, triangles
represent means of each experiment, and bars represent the overall mean and SD across all
experimental repeats. Statistical analyses were performed in GraphPad Prism using ordinary oneway ANOVA, Welsh’s ANOVA, or Kruskal-Wallis test with post-hoc correction as specified and
determined using GraphPad Prism by assessing each data set for normality and homoscedasticity;
Welsh’s ANOVA was used when the data set did not display homoscedasticity, and a KruskalWallis test was used if the data set did not display a normal distribution. Significance between
control or experimental samples are indicated; only p < 0.05 was considered as statistically
significant.
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Table 1 Antibody dilution used in this study
Antibody Name

Immunoblot

Mouse Anti-TYRP1 (TA99/Mel-

Immunofluorescence
1:100

5)
Mouse anti-γ-Tubulin

1:3000

Mouse anti-γ-adaptin

1:1000

Mouse anti-GFP (Clone 7.1

1:1000

1:200

and 13.1)
Rabbit anti-AP3M1

1:1000

Rat anti–mouse LAMP2

1:200

Rat anti-mouse TfR

1:200

Rat anti-HA (3F10)

1:50

Rabbit anti-STX13

1:200

Rabbit anti-pallidin

1:200

Rabbit anti-PI4KIIIβ

1:500

Rabbit anti-PI4KIIα

1:1000

1:200

Rabbit anti-PI4KIIβ

1:500

1:100

Rabbit anti-GFP (PABG1)

1:200

Alexa Fluor 488/594/640

1:400

Alexa Fluor 680/790

1:4000
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Table 2 Oligonucleotide sequences used in plasmid construction a
Oligonucleotide

Sequence 5’-3’

Use

GCGCGATAGCGCTAATAATTT

Non-mammalian shRNA target

Name
shNC

control
shPI4KIIα-1

CCCAAGAATGAAGAGCCATAT

shRNA #1 to PI4KIIα

shPI4KIIα-2

CCAGGCCCTGAAAGACAATAA

shRNA #2 to PI4KIIα

shPI4KIIβ-1

GCTGTTTGTGAAAGATTACAA

shRNA #1 to PI4KIIβ

shPI4KIIβ-2

CCTGATGAATGGCGAGCATAT

shRNA #2 to PI4KIIβ

shPallidin-1

CAGAACCAAGTTGTGTTACTA

shRNA #1 to Pallidin

shPallidin-2

ACACAGAACCAAGTTGTGTTA

shRNA #2 to Pallidin

shPI4KIIIβ-1

GCGAGAATTCATCAAGTCTTT

shRNA #1 to PI4KIIIβ

shPI4KIIIβ-2

CCTCAAAGAGAGGTTCCACAT

shRNA #2 to PI4KIIIβ

Primer 1

CTGCAGGCGGCCGCCACCATGG

Forward primer for amplification

TGAGCAAGGGCGAGGAGCTGT

of GFP-P4C-SidC or GFP-P4MSidMx2

Primer 2

Primer 3

TACGTAGCGGCCGCTCATTCCAG

Reverse primer for amplification

AGAGATGATTTCATC

of GFP-P4C-SidC

CTGCAGGCGGCCGCCACCATGG

Forward primer for amplification

ACGAGACGAGCCCACTAG

and mutagenesis of PI4KIIα
cDNA bp 1-477 or full length to
generate shRNA-resistant form

Primer 4

ATAGGGtTCcTCATTtTTGGGTTTG

Reverse primer for amplification

AAGACAGCAATGATCC

and mutagenesis of PI4KIIα
cDNA bp 1-477 to generate
shRNA-resistant form
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Primer 5

CAAaAATGAgGAaCCCTATGGGCA

Forward primer for amplification

TCTTAATCCTAAGTG

and mutagenesis of PI4KIIα
cDNA bp 459-1437 to generate
shRNA-resistant form

Primer 6

CATATGGCGGCCGCTTTACTTGT

Reverse primer from end of

ACAGCTCG

EGFP coding region for
amplification of PI4KIIα-GFP and
PI4KIIβ-GFP variants to
generate shRNA-resistant forms

Primer 7

CTGCAGGCGGCCGCCACCATGG

Forward primer for amplification

AGGATCCCTCCGAGCCCGA

of PI4KIIβ-WT or PI4KIIβ-D304
cDNA bp 1-1080 or full length to
generate shRNA-resistant forms

Primer 8

ATAaGCTCTCCAcTCgTCtGGATGT

Reverse primer for amplification

TTAAAAGGAAATGCTAGAC

of PI4KIIβ-WT or PI4KIIβ-D304
cDNA bp 1-1080 to generate
shRNA-resistant forms

Primer 9

GAcGAgTGGAGAGCtTATCCATTT

Forward primer for amplification

CACTGGGCTTGGCTTC

of PI4KIIβ-WT or PI4KIIβ-D304
cDNA bp 1063-1443 to generate
shRNA-resistant forms

Primer 10

TAGAGTCGACCCGGGCGGCCGC

Forward primer for amplification

CACCATGGAGGATCCCTCCGAGC

of shRNA-resistant PI4KIIβ-WT

CCGA

cDNA bp 1-1017 to mutagenize
codons for dileucine residues to
alanines
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Primer 11

GGGCCCAGGCGATCCGCGGTGC

Reverse primer for amplification

CGCCGGCTCC

and mutagenesis of shRNAresistant PI4KIIβ-WT cDNA bp 11017 to mutagenize codons for
dileucine residues to alanines

Primer 12

GAGCCGGCGGCACCGCGGATCGC

Forward primer for amplification

CTGGG

and mutagenesis of shRNAresistant PI4KIIβ-GFP cDNA bp
987-1443 to mutagenize codons
for dileucine residues to alanines

Primer 13

GGGCGGAATTTACGTAGCGGCC

Reverse primer for amplification

GCTTTACTTGTACAGCTCG

of shRNA-resistant PI4KIIβ-GFP
cDNA bp 987-1443 to
mutagenize codons for dileucine
residues to alanines

a In

sequences shown, introduced NotI sites are underlined, nucleotide changes for shRNA

resistance are indicated by bold lower case letters, and nucleotide changes for amino acid
changes are indicated by bold small capital letters.
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CHAPTER 3: DISCUSSION

3.1 How does depletion of either PI4KIIα or PI4KIIβ affect endocytic trafficking?
1) Depletion of type II PtdIns-4-kinase might not impair trafficking from early to late endosomes and
lysosomes.
In this study, we discovered that in melanocytes depleted of PI4KIIα or PI4KIIβ, TYRP1 is partially
retained within early endosomes as it is in cells depleted of BLOC-1, but is largely targeted from
early endosomes to late endosomes and lysosomes instead of melanosomes. The degree of
TYRP1 trafficking to these compartments is similar in cells depleted of either PI4KIIα or PI4KIIβ,
indicating that both kinases are independently required for cargo delivery to melanosomes. The
data further suggest either that endosome-to-lysosome trafficking may not require PI4KIIα or
PI4KIIβ, or that PI4KIIα and PI4KIIβ may have a redundant role in this trafficking route. However,
this conclusion contradicts other relevant studies in other cell types. One study showed that gene
silencing of PI4KIIα in fibrosarcoma cells disrupted trafficking of ligand-bound epidermal growth
factor receptors (EGFRs) to late endosomes but instead led to an accumulation of EGFRs in
vesicular carriers in close juxtaposition to plasma membrane (Minogue et al., 2006). This study
suggested that PI4KIIα is required for trafficking of ligand-bound EGFRs form early endosomes to
late endosomes and thus for subsequent EGFR degradation in lysosomes. Whether PI4KIIβ affects
EGFR trafficking was not tested. Other studies on corroborate a role of PI4KIIα-generated PtdIns4P
in the fusion of late endosomes and/or lysosomes with phagosomes and autophagosomes
(Jeschke and Haas, 2018; Jeschke et al., 2015; Wang et al., 2015). Although our imaging results
document that depletion of either PI4KIIα or PI4KIIβ in melanocytes reduces levels of endosomal
PtdIns4P, sufficient levels of PtdIns4P might remain for fusion of vesicles with late endosomes/
lysosomes. Alternatively, it is possible that early endosomal maturation to late endosomes
proceeds with melanosomal cargoes intact in cells depleted of PI4KIIα or PI4KIIβ; however, this is
contradicted by the retention of such cargoes in BLOC-1-deficient cells. To explain the discrepancy
between our study and others, we reason that extraneous stimuli, such as EGF addition, nutrient
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deprivation, or exposure to microorganisms (or particles), stimulate cells to adapt their endolysosomal trafficking to support increased transport of a bulk of material to lysosomes for
degradation or reuse, thus requiring a surge of organelle fusion with lysosomes; this fusion might
be more sensitive to PtdIns4P levels. By contrast, in our study the cells are maintained under basal
conditions where endosomal PtdIns4P levels produced by a single type II PtdIns-4-kinase might
be sufficient to sustain the fusion of mis-routed TYRP1-positive early endosomes with lysosomes.
This is supported by the retention of PtdIns4P levels on vacuolar structures in cells depleted of
either PI4KIIα or PI4KIIβ. It will be interesting to test whether simultaneous depletion of both PI4KIIα
and PI4KIIβ recapitulates the lysosome fusion defect observed in other systems.

2) Depletion of type II PtdIns-4-kinase might impair endosome-to-plasma membrane trafficking.
It has been reported that PI4KIIα and its product, PtdIns4P, have a role in sorting cargos such as
TfR at early endosomes (Henmi et al., 2016). Moreover, the conversion of local PtdIns3P to
PtdIns4P has been proposed to mark a site for recycling of TfR to the plasma membrane (Ketel et
al., 2016). These data suggest that PI4KIIα functions in the endosome-to-plasma membrane
recycling pathway in other cell types. Consistently, BLOC-1 has a minor contribution to cargo
recycling from early endosomes in melanocytes (Setty et al., 2007) and other cell types (Delevoye
et al., 2016; Jani et al., 2021) Therefore, given that PI4KIIα associates with BLOC-1 and that
PI4KIIα supports BLOC-1-dependent cargo transport (our study), depletion of PI4KIIα very likely
compromises endosomal trafficking not only to melanosomes but also to the plasma membrane. If
the endosome-to-plasma membrane route was affected by PI4KIIα depletion, then the rate of
TYRP1 recycling to the plasma membrane might be reduced, as shown in BLOC-1-deficient cells
(Delevoye et al., 2016; Jani et al., 2021; Setty et al., 2007). Testing this would require a sensitive
and quantitative flow cytometric assay for TYRP1 endosomal recycling as in other studies (Setty et
al., 2007; Truschel et al., 2009).
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The endosome-to-plasma membrane trafficking route might also be impaired by PI4KIIβ depletion.
The degree of TYRP1 mislocalization to late endosomes and lysosomes in PI4KIIβ-depleted cells
is similar to PI4KIIα-depleted cells and TYRP1 appears not to enrich on PM, suggesting that TYRP1
may not be targeted to the plasma membrane in these cells as it is in BLOC-1-deficient cells.
Furthermore, my data show that PI4KIIβ localizes not only to endosomal tubules in melanocytes,
but also to endosomal vacuoles where it might contribute to the pool of PtdIns4P marking the site
for cargo exit to the plasma membrane. In addition, PI4KIIβ has been found to associate with
clathrin-coated vesicles (Li et al., 2012), and endosome-derived clathrin-coated vesicles have been
shown to be at least in part responsible for cargo recycling from endosomes to the plasma
membrane (van Dam and Stoorvogel, 2002). Therefore, PI4KIIβ may be involved in clathrinmediated recycling pathway. Taken together, it would be interesting to test whether depletion of
PI4KIIβ impacts the endosome-to-plasma membrane route in melanocytes by assaying for TYRP1
and TfR recycling in cells depleted of PI4KIIβ.

3) Depletion of type II PtdIns-4-kinase might impair endosome-to-Golgi trafficking.
Retrograde trafficking from endosomes to the Golgi is mediated by the coordinated action of the
SNX6-retromer with dynein; the release of SNX6-retromer-associated cargos at the TGN requires
PtdIns4P to promote the dissociation SNX6 from the p150Glued subunit of the dynein-dynactin
complex (Niu et al., 2013). Depletion of PtdIns4P by PI4KIIα knockdown or inhibition of PtdIns-4kinase activity increases the protein-protein interaction between SNX6 and p150Glued and blocks
cargo release at the TGN, resulting in cargo accumulation in the peri-Golgi region (Niu et al., 2013).
This suggests that PI4KIIα (and perhaps also PI4KIIβ, which localizes at steady state largely to the
Golgi complex) contributes to generating the PtdIns4P pool that functions in cargo release at the
TGN. Moreover, SNX6 preferentially binds to PtdIns4P in vitro and associates with PtdIns4Penriched compartments in cells (Niu et al., 2013); this suggests that the SNX6-retromer potentially
initiates tubule formation from PtdIns4P-positive endosomal domains. These PtdIns4P-enriched
endosomal domains are likely produced by PI4KIIα and PI4KIIβ, and depletion of PtdIns4P by
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PI4KIIα or PI4KIIβ inhibition may impair the association of SNX6 with endosomal membranes. Thus,
I predict that PI4KIIα and PI4KIIβ may influence the SNX6-mediated endosome-to-Golgi trafficking
route. It would be of interest to test this directly using photobleaching approaches to assess how
PI4KIIα or PI4KIIβ depletion might impact cargo transport to the Golgi.

Indeed, our data could be interpreted to suggest that the endosome-to-Golgi trafficking route may
be impaired by depletion of PI4KIIα or PI4KIIβ in melanocytes. In BLOC-2-deficient melanocytes –
in which the functions of PI4KIIα and PI4KIIβ are intact – the BLOC-1-dependent tubules are short
and ineffective to contact melanosomes, much like in cells depleted of PI4KIIα or PI4KIIβ. However,
the BLOC-1-dependent cargo TYRP1 in BLOC-2-deficient cells undergoes accelerated recycling
from endosomes both to the plasma membrane (as in BLOC-1-deficient cells) and to the Golgi,
which is not observed in BLOC-1-deficient cells (Dennis et al., 2015). The mistargeting of TYRP1
to the Golgi likely reflects a normal endosome-to-Golgi trafficking route in BLOC-2-deficient cells
and indicates that the ineffective short endosome-derived tubules in these cells facilitate cargo
transport to the Golgi instead of to melanosomes. By contrast, whereas depletion of PI4KIIα or
PI4KIIβ in my study also results in the generation of ineffective short tubules, these tubules deliver
cargos to late endosomes and lysosomes, suggesting that TYRP1 trafficking to the Golgi as
observed in BLOC-2-deficient cells is potentially blocked. To test whether type II PtdIns-4-kinases
play a role in TYRP1 transport between endosomes and the Golgi, I would perform Fluorescence
Recovery After Photobleaching (FRAP) experiments as described in (Dennis et al., 2015) on cells
depleted of PI4KIIα, PI4KIIβ or both and treated with a protein synthesis inhibitor to monitor the
dynamics of fluorescently labeled TYRP1 relative to the Golgi. I would then compare the rate of
TYRP1 recovery in the Golgi in these cells relative to control cells. Additionally, to determine if
TYRP1 transport to the Golgi in BLOC-2-deficient cells as seen in (Dennis et al., 2015) is a
consequence of PI4KIIα and/or PI4KIIβ-mediated process but not a subsidiary process caused by
the loss of BLOC-2, I would also use the FRAP approach in BLOC-2-deficient cells depleted of
PI4KIIα, PI4KIIβ or both. If PI4KIIα and/or PI4KIIβ indeed regulate(s) TYRP1 recycling from
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endosomes to the Golgi, the FRAP results would show that depletion of PI4KIIα, PI4KIIβ or both
reduces the fluorescence recovery of TYRP1 to the photobleached Golgi. If this is the case, I would
further examine whether PI4KIIα and/or PI4KIIβ support(s) SNX6-retromer-mediated endosometo-Golgi trafficking. To test this idea, I would compare the rate of TYRP1 recovery to the Golgi in
WT and BLOC-2-deficient cells depleted of SNX6, PI4KIIα, PI4KIIβ, or both PI4KIIα and PI4KIIβ. If
the rates from SNX6-depled cells were comparable to those from PI4KIIα and/or PI4KIIβ-depleted
cells, then a) the SNX6-retromer complex might regulate TYRP1 recycling to the Golgi and b) the
SNX6-retromer complex might collaborate with PI4KIIα and/or PI4KIIβ to effect endosome-to-Golgi
cargo transport.

These considerations suggest that PtdIns4P generated by endosomal type II PtdIns-4-kinases
might influence multiple cargo trafficking routes from early endosomes to other compartments. This
raises the question of how PtdIns4P and the type II PtdIns-4 kinases are distributed among cargo
carriers for different routes. There might exist a mechanism that simultaneously orchestrates and
discriminates distinct PtdIns4P-associated molecular machineries to ensure that each cargo is
assigned with its own cohort of PtdIns4P to reach its specific destination. In this context, it is
interesting that I found that, at steady state, both PI4KIIα and PI4KIIβ localized to only a small
subset of STX13- and TfR-containing early endosomes. This suggests that type II PtdIns-4 kinases
might be recruited only to those endosomes actively involved in generating cargo carriers destined
for specific routes, perhaps in a manner dependent on cargo. It would be of interest to use superresolution microscopy approaches to test if a) melanosome cargos are associated with PtdIns4P
on endosomes; b) overexpression of melanosome cargos increases the fraction of endosomes that
recruit type II PtdIns-4-kinases; and 3) overexpression of melanosomes cargos affects endosomal
PtdIns4P distribution.

4) Depletion of type II PtdIns-4-kinase might impair Golgi-to-plasma membrane trafficking.
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Our live-cell imaging data show that the total number of tubules labeled by GFP-P4C (i.e., that
contain PtdIns4P) is reduced in cells depleted of PI4KIIα or PI4KIIβ; this included endosomal
tubules that were labeled by mCherry-STX13 as well as non-endosomal tubules that were not
labeled by mCherry-STX13, and in data not shown I found that both populations were reduced by
a similar percentage. Assuming that most of the mCherry-STX13-negative tubules were secretory
carriers (see section 1.3.2a), these data suggest that the number of PtdIns4P-positive secretory
tubular carriers might also be reduced by depletion of either PI4KIIα or PI4KIIβ. Thus, type II PtdIns4-kinases may affect the Golgi-to-plasma membrane trafficking route by generating PtdIns4P to
contribute to the formation of PtdIns4P-positive secretory tubular transport carriers.

While the role of type III PtdIns-4-kinases in generating PtdIns4P at the Golgi has been wellestablished, how type II PtdIns-4-kinases might regulate Golgi-to-plasma membrane secretory
trafficking has not been well studied. However, Golgi PtdIns4P has been proposed to promote a
“Rab cascade” that orders sequential events in secretory trafficking (Mizuno-Yamasaki et al., 2010;
Ortiz et al., 2002). In the yeast S. cerevisiae, Golgi-associated PtdIns4P and GTP-bound Ypt32
(Rab11 in mammals) work together to recruit Sec2 (Rabin8 in mammals), a GEF for Sec4 (Rab8
in mammals), to the newly formed secretory carriers. Sec2 subsequently activates Sec4, which
then binds to effectors such as the exocyt (a complex that tethers exocytic vesicles to PM and
facilitates membrane fusion) to promote exocytosis (Feng et al., 2012; Knodler et al., 2010; MizunoYamasaki et al., 2010; Ortiz et al., 2002). Although PI4KIIIβ activity is the major contributor to the
Golgi PtdIns4P pool (Mizuno-Yamasaki et al., 2010), PI4KIIα and PI4KIIβ have been shown to
synthesize separate pools of PtdIns4P on TGN (Alli-Balogun et al., 2016). Thus, PI4KIIα and
PI4KIIβ may have a direct contribution to the Golgi-to-plasma membrane secretory pathway by
supplying PtdIns4P.

Type II PtdIns-4-kinases may also indirectly influence Golgi-to-plasma membrane traffic. PtdIns4P
at the TGN is needed to recruit AP-1 for TGN-to-endosomal trafficking, and loss of TGN-localized
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PtdIns4P impacts this trafficking route (Wang et al., 2003). For example, depletion of either PI4KIIα
or PI4KIIβ leads to a significant reduction in colocalization between PtdIns4P and AP-1 cargo; this
impact is more pronounced in cells depleted of PI4KIIβ (Wieffer et al., 2013), which directly interacts
with AP-1 (Wieffer et al., 2013). Endosomal compartments can serve as intermediates during
transport from the Golgi to the plasma membrane for some exocytic cargos, such as β1 integrin
(Ketel et al., 2016) and VSVG (Ang et al., 2004), and thus interfering with TGN-to-endosome
trafficking would impair the plasma membrane transport of these cargos. Additionally, inhibiting the
conversion from PtdIns3P to PtdIns4P or silencing PI4KIIα to reduce endosomal PtdIns4P impairs
the recruitment of exocyst to promote exocytosis (Ketel et al., 2016). It would be of value to assess
TGN to plasma membrane trafficking in melanocytes depleted of PI4KIIα or PI4KIIβ, as this might
impact signaling for melanogenesis – for example by impairing the surface expression of MC1R,
signals from which are important for upregulating melanogenesis.

3.2 How do type II PtdIns-4-kinases affect melanosome maturation?
1) Type II PtdIns-4-kinases do not likely regulate stage I and II melanosome maturation.
As mentioned in section 1.1.1e, early-stage melanosomes emerge from maturing early endosomes
and characterized by the progressive remodeling of PMEL into amyloid fibrils that laterally
assemble into sheets (Watt et al., 2013). The PMEL remodeling is processed by proteolytic
cleavage that requires lysosomal proteases (Watt et al., 2013). The acquisition of lysosomal
proteases needs the transient interactions of stage I melanosomes with lysosomes (Bissig et al.,
2019), which regulates the efficiency of assembly of amyloid fibrous sheets. Although PtdIns4P
generated by type II PtdIns-4-kinases can modulate lysosome fusion with other LROs, such as
phagosomes (Jeschke and Haas, 2018), there is no evidence that PtdIns4P is required for fusion
of lysosomes with stage I melanosomes or for PMEL cleavage and maturation. Instead, this
transient interaction is controlled by PIKfyve, a lipid kinase responsible for generating
phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) from PtdIns3P on maturing endosomes (Jin
et al., 2008; Sbrissa et al., 2007). PtdIns(3,5)P2 is required for membrane dynamics on late
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endosomes and lysosomes and for stimulating lysosomal function (Dong et al., 2010). Thus, the
inter-organellar interaction between early-stage melanosomes and lysosomes appears to be
mediated by PtdIns(3,5)P2 and not likely by PtdIns4P. To test this idea, I would exploit live-cell
imaging on PI4KIIα- and/or PI4KIIβ-depleted cells that express the fluorescently tagged lipid probe
2XFYVE-GFP, which labels PtdIns3P-containing endosomal compartments including stage I
melanosomes, and that are loaded overnight with fluorescent dextran, which reliably marks
lysosomes. I would then visualize the interaction between compartments labeled by 2XFYVE-GFP
and dextran. This experiment could also be used to determine whether membrane fusion occurs
between stage I melanosomes and lysosomes. If PtdIns4P mediates the inter-organellar interaction
and/or fusion, then both kiss-and-run interactions and Dextran transfer to 2XFYVE-GFP
compartments as seen in (Bissig et al., 2019) would be blocked. A further EM analysis on earlystage melanosomes in melanocytes depleted of PI4KIIα, PI4KIIβ or both would be needed to
validate whether PtdIns4P and type II PtdIns-4-kinases regulate stage I and II melanosome
maturation.

Our live-cell imaging results indicate that depletion of either PI4KIIα or PI4KIIβ does not impact
either the distribution or the number of GFP-PtdIns3P-containing endosomal compartments labeled
by 2XFYVE-GFP, which correspond to the stage I melanosomes in which PMEL fibrils begin to
form. In addition, my preliminary IFM results show that labeling for PMEL with an antibody that
detects the mature form present in fibrils is comparable in control cells and in cells depleted of
either PI4KIIα or PI4KIIβ, suggesting that stage II and/or I melanosomes continue to be generated
in cells depleted of type II PtdIns-4-kinases. While these data suggest that PtdIns4P and type II
PtdIns-4-kinases are not likely involved in stage I melanosome maturation, further experiments are
needed to definitively test the idea. For example, we can assess whether the failure to remove
cargo from early endosomes/ stage I melanosomes by BLOC-1- and PtdIns4P-dependent tubule
formation impacts stage II melanosome morphology by electron microscopy or the proteolytic
processing of PMEL by immunoblotting of cell lysates.
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2) Type II PtdIns-4-kinases participate in stage III and/or IV melanosome maturation.
Melanin synthesis and deposition take place on PMEL fibril sheets upon delivery of enzymes and
transporters to melanosomes, marking the transition to stage III melanosomes. Stage III
melanosomes continue to synthesize melanin pigments, maturing to stage IV. Our study indicates
that melanin production is impaired by depletion of either PI4KIIα or PI4KIIβ, suggesting that
maturation of stage III and/or IV melanosomes is restricted. This restriction minimally reflects
impaired delivery of specific cargoes such as TYRP1 and OCA2 via the BLOC-1-dependent tubular
pathway. For example, TYRP1 functions to stabilize TYR (Kobayashi et al., 1998) and might also
have enzymatic activity in the polymerization of the melanin intermediate, dihydroxyindole
carboxylic acid (Simon et al., 2009); its absence would thus reduce melanin production and might
alter melanosome morphology (Hirobe et al., 2014). The failure to efficiently deliver OCA2 to
melanosomes is expected to impair the neutralization of melanosomes required for optimal TYR
activity (Bellono et al., 2014). Importantly, impaired transport of melanosome-destined VAMP7 will
impair fusion of cargo carriers with melanosomes, further reducing delivery of TYRP1 and OCA2
to maturing melanosomes. However, whether stage III or IV or both stages are affected by PI4KIIα
or PI4KIIβ deficiency is not clear. Quantitative electron microscopy analysis of cells depleted of
PI4KIIα and PI4KIIβ are needed to answer these questions, as well as to address whether stage II
melanosome morphology is impacted.

While my thesis work focuses on the function of type II PtdIns-4-kinases and PtdIns4P in the BLOC1-dependent pathway of melanosome cargo transport, I have not studied in detail whether these
kinases or PtdIns4P also play a role in AP-3-dependent vesicular trafficking of TYR from early
endosomes to melanosomes or of Rab6-dependent transport of DCT from the TGN to
melanosomes. This can be tested by assessing the localization of these cargoes in cells depleted
of PI4KIIα or PI4KIIβ. Given the importance of PtdIns4P in endosomal and TGN dynamics, I
suspect that these pathways might also be disrupted upon type II PtdIns4-kinase depletion,
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although whether either PI4KIIα or PI4KIIβ play a direct role in these pathways will need to be
determined by live cell imaging.

3.3 How do type II PtdIns-4-kinases mechanistically influence BLOC-1-dependent tubule
formation?
My data presented in Chapter 2 definitively show that both PI4KIIα and PI4KIIβ contribute to the
stability and/or extension of BLOC-1-dependent tubules during melanosome biogenesis. PtdIns4P
is also present throughout the lifetime of the BLOC-1-dependent tubules over their entire length,
and the tubular pool of PtdIns4P is reduced by depletion of either PI4KIIα or PI4KIIβ. The data
suggest that PI4KIIα and PI4KIIβ together are responsible for the entire pool of PtdIns4P on BLOC1-dependent endosomal tubules. Moreover, since depletion of either PI4KIIα or PI4KIIβ impairs
tubule dynamics, the continuous PtdIns4P generation by both PI4KIIα and PI4KIIβ must be
necessary for tubule extension and stabilization. Our imaging results from rescue experiments
document the requirement of the kinase activities of both kinases for their function in cargo
trafficking, indicating that PtdIns4P itself is critical for BLOC-1-dependent tubular transport.

What mechanism might underlie this function? Because the extension of BLOC-1-dependent
tubules is driven by the motor protein KIF13A (Delevoye et al., 2016), I hypothesize that there exists
a connection between KIF13A and type II PtdIns-4-kinases. In melanocytes, BLOC-1 and the
kinesin-3 microtubule motor heavy chain KIF13A are required to generate membrane tubules of
unusually long length and lifetime that facilitate transport of selected cargoes to melanosomes
(Delevoye et al., 2016; Delevoye et al., 2009; Dennis et al., 2016; Dennis et al., 2015). In order to
be maintained, these tubules likely require a stable association with KIF13A or other microtubuleassociated proteins that link the membrane tubule to the microtubule (Roux et al., 2002). BLOC-1
co-immunoprecipitates with KIF13A (Delevoye et al., 2016), and in other systems cooperates with
PI4KIIα in endosomal cargo trafficking (Gokhale et al., 2012; Larimore et al., 2011; Salazar et al.,
2009). Taken together with the data presented in Chapter 2, it is reasonable to hypothesize that
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type II PtdIns-4-kinases function together with BLOC-1 and KIF13A in cargo trafficking. Our livecell imaging results document that the presence of PI4KIIα and/or of PI4KIIβ on the tubule
correlates with tubule extension and stabilization over time, and that depletion of PI4KIIα or PI4KIIβ
impairs both the number and length of tubules. PI4KIIβ directly interacts with AP-1 (Wieffer et al.,
2013); given that KIF13A recruitment to endosomes and activity in pulling endosomal tubules
require AP-1 (Delevoye et al., 2009; Nakagawa et al., 2000), perhaps AP-1 simultaneously recruits
both KIF13A and PI4KIIβ to the endosomal tubule and brings PI4KIIβ in proximity to KIF13A.
Additionally, published evidence suggests that PtdIns4P is necessary for the recruitment of AP-1
to endosomal membranes (Wang et al., 2003). Thus, PtdIns4P generated by PI4KIIα or PI4KIIβ
might function to stabilize AP-1, and hence KIF13A, on tubular membranes Stabilizing the AP-1
association with membranes might require a certain amount of PtdIns4P. To test this prediction,
liposome co-sedimentation and co-flotation assays could be used to examine the AP-1 binding
affinity to liposomes that contain different concentrations of PtdIns4P. If PtdIns4P contributes to
stabilizing AP-1 to membranes, liposome with higher concentration of PtdIns4P might bind more
AP-1. Alternatively, PtdIns4P might function directly to cluster KIF13A on tubules in much the same
way that PtdIns(4,5)P2 functions in clustering KIF1A and KIF5B to drive membrane transport and
tubulation (Du et al., 2016; Klopfenstein et al., 2002). To discover if PtdIns4P can directly recruit
KIF13A, the liposome co-sedimentation and co-flotation assays could be conducted using purified
KIF13A protein and synthetic liposomes with or without PtdIns4P.

While the role of KIF13A in BLOC-1-dependent transport is clear, and while a body of literature
documents engagement of the minus-end-directed microtubule motor dynein in melanosome
movement (Aktary et al., 2021; Barral and Seabra, 2004), any role for dynein in BLOC-1-dependent
transport for melanosome biogenesis is not clear. Most of the tubules that we observe in
melancoytes extend outward along microtubules from the pericentriolar region, consistent with
kinesin-dependent motility. Nevertheless, some studies have suggested that snapin, a shared
subunit of BLOC-1 and BORC, can recruit dynein to regulate endosomal transport (Cai et al., 2010;
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Cheng et al., 2015; Zhou et al., 2012); this would seemingly contradict the known roles of BLOC-1
and BORC in engaging kinesins. How can these data be reconciled? PtdIns4P might play a role in
ensuring that KIF13A, and not dynein, is engaged for BLOC-1-dependent tubule motility. For
example, the association of the dynein–dynactin motor complex with one binding partner, the
retromer complex, is negatively regulated by local PtdIns4P pools generated at least in part by
PI4KIIα (Niu et al., 2013). The association of PI4KIIα with BLOC-1 (Salazar et al., 2009) at sites of
BLOC-1-dependent tubule formation might thereby introduce sufficient PtdIns4P to promote the
dissociation of BLOC-1 from dynein and allow for BLOC-1 association with KIF13A. The continuous
PtdIns4P generation by PI4KIIα and PI4KIIβ as the tubules grow might continue to inhibit the
interaction between BLOC-1 and dynein, consequently bolstering KIF13A-driven BLOC-1dependent tubular cargo transport to melanosomes. Thus, type II PtdIns-4-kinases might not only
positively influence KIF13A activity, but might have a negative impact on dynein recruitment to
BLOC-1-dependent tubules. This prediction can be tested by introducing either a wild-type form or
a PtdIns4P-insensitive mutant of p150Glued subunit of the dynein-dynactin complex into cells
depleted of endogenous p150Glued and expressing fluorescent STX13, and assessing the impact
on tubule elongation; this hypothesis would be supported if tubules are shorter in cells expressing
the PtdIns4P-insensitive mutant relative to the wild-type form.

3.4 Why is the localization of type II PtdIns-4-kinases to early endosomes and derived
tubules important?
1) PI4KIIα and PI4KIIβ together are needed in a likely redundant manner to initiate BLOC-1dependent tubule formation.
In HeLa cells, BLOC-1-depedent recycling endosome tubule initiation from endosomal vacuoles
requires a pool of PtdIns4P that is dependent on the combined activities of PI4KIIα and PI4KIIβ
(Jani et al., 2021). Knockdown of both PI4KIIα and PI4KIIβ by siRNA (siPI4KII) or inhibition of their
kinase activity by phenylarsine oxide (PAO) treatment drastically reduces tubule number and length
as determined by fluorescence microscopy approaches, and the formation of stable buds on early
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endosomal vacuoles by electron microscopy analysis (Jani et al., 2021). Both phenotypes are
comparable in impact to that of BLOC-1 depletion (Delevoye et al., 2016). Thus, in HeLa cells, the
impact of loss of both type II PtdIns-4-kinase activities on tubule formation is comparable to that of
BLOC-1 deficiency. In contrast, our results show that single knockdown of either PI4KIIα or PI4KIIβ
does not inhibit tubule initiation and tubule profiles to the same extent as BLOC-1 depletion. Tubule
length and number were more dramatically impaired in BLOC-1-deficient cells (Delevoye et al.,
2016) and upon BLOC-1 knockdown in wild-type cells than upon depletion of either PI4KIIα or
PI4KIIβ. Moreover, loss of pigmentation and cargo mislocalization were not as severe in cells
individually depleted of either PI4KIIα or PI4KIIβ than in cells depleted of BLOC-1. How do we
reconcile these data? We suspect that the requirement for PtdIns4P in BLOC-1 tubule initiation is
conserved in HeLa cells and melanocytes, but that PtdIns4P levels produced by either of the two
type II PtdIns-4-kinases on early endosomal vacuoles may be sufficient for BLOC-1 to associate
with a membrane bud to allow for tubule initiation to occur. Consistently, in our study, single
knockdown of either PI4KIIα or PI4KIIβ does not affect BLOC-1 association with membranes.
Therefore, PI4KIIα and PI4KIIβ likely play a redundant role in BLOC-1 recruitment for tubule
initiation. How do we directly test whether PtdIns4P is requires for BLOC-1 association with
membranes for tubule initiation in melanocytes? One way is to deplete both isoforms
simultaneously and test to see if BLOC-1 membrane association is impaired. Alternatively, the in
vivo membrane association of BLOC-1 could be assayed by subcellular fractionation using cells
treated with the PtdIns-4-kinase inhibitor PAO. Although PAO is not specific to type II PtdIns-4kinases, it allows us to assess the general impact of PtdIns4P on BLOC-1 interaction with
membranes. Our efforts to deplete both enzymes in melanocytes by shRNAs were unsuccessful,
but future studies using CRISPR knockout/knockdown approaches might be helpful to validate
whether there is an early requirement for endosomal PtdIns4P in BLOC-1 recruitment in
melanocytes. Another way is to use rapamycin-induced FKBP−FRB dimerization (Inobe and
Nukina, 2016) to specifically introduce a PtdIns4P phosphatase, e.g. Sac1, to endosomal
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compartments to remove PtdIns4P and then to visualize the change in the dynamics of BLOC-1dependent endosomal tubules.

2) Once PI4KIIα and PI4KIIβ are recruited onto the BLOC-1-dependent tubule, they are both
required in a non-redundant and sequential fashion for extension and/or stability of the same tubule.
As discussed in section 2.4, PI4KIIα and PI4KIIβ likely function redundantly in engaging BLOC-1
for tubule initiation but non-redundantly in the maintenance and extension of the tubules by
sequentially generating local PtdIns4P. The functional non-redundancy and sequence is supported
by the data that 1) both type II PtdIns-4-kinase and PtdIns4P localize to the tubule, and especially
PtdIns4P is present on the whole tubule throughout its lifetime; 2) PI4KIIα is recruited earlier and
PI4KIIβ later to the tubule; 3) depletion of either PI4KIIα or PI4KIIβ reduces the endosomal pool of
PtdIns4P, particularly on the tubules, and consequently the number and length of endosomal
tubules are reduced and melanosome cargo transport is impaired; 3) tubules are shorter upon
depletion of PI4KIIα than upon depletion of PI4KIIβ, which likely reflects an earlier engagement of
PI4KIIα than of PI4KIIβ in the tubule elongation. Of note, the requirement for PtdIns4P in tubule
extension following BLOC-1-dependent tubule initiation is consistent with the live-cell imaging data
in Jani et al (Jani et al., 2021). Together, these data suggest that PI4KIIα and PI4KIIβ act
sequentially and non-redundantly to ensure that PtdIns4P levels are maintained throughout tubule
elongation. Rapamycin-induced FKBP−FRB dimerization (Inobe and Nukina, 2016) could be used
to help test the requirement of both PI4KIIα and PI4KIIβ for PtdIns4P maintenance by inducibly
linking phosphatase Sac1 to either PI4KIIα or PI4KIIβ. We would then assess whether endosomal
PtdIns4P was altered by assaying for the localization of the fluorescently labeled lipid probe P4C
when the activity of either type II PtdIns-4-kinases was counteracted by its linked phosphatase.

How can one explain the earlier function for PI4KIIα acts than PI4KIIβ on the tubule? The data
show that PI4KIIα function and localization require its determinant for binding to AP-3. Therefore, I
speculate that PI4KIIα is recruited by AP-3 on budding regions of vacuolar endosomes, where a
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BLOC-1-AP-3 super-complex (Di Pietro et al., 2006; Salazar et al., 2006; Salazar et al., 2009)
facilitates tubule initiation and sorts SNARE and cargos into the nascent tubules (Bowman et al.,
2021). Similarly, PI4KIIβ function and localization required its determinant for binding AP-1; thus, I
further hypothesize that PI4KIIβ is recruited to the growing tubule by AP-1 bound to KIF13A as
KIF13A extends the tubule along microtubules (Campagne et al., 2018; Delevoye et al., 2016;
Delevoye et al., 2009; Delevoye et al., 2014). The sequential recruitment of PI4KIIα first and then
PI4KIIβ by AP-3 and AP1, respectively, could be tested by swapping their sorting motifs and using
dual-view live-cell microscopy to assess whether their order of association with the tubule is
accordingly swapped.

3) The presence of both PI4KIIα and PI4KIIβ is necessary to form effective tubules that are likely
specifically targeted to and contact with melanosomes.
Previous data have documented that BLOC-1-dependent cargo transport is mediated by long
dynamic tubules, predominantly greater than 1 μm in length, that transiently fuse with melanosomes
in a process requiring the vSNARE, VAMP7 to deliver their cargo (Bowman et al., 2021; Delevoye
et al., 2016; Delevoye et al., 2009; Dennis et al., 2016; Dennis et al., 2015). Depletion of BLOC-1
results in retention of BLOC-1-dependent cargoes largely in early endosomes via continual
recycling to the plasma membrane and endocytosis (Setty et al., 2007). The data in Chapter 2 show
that depletion of PI4KIIα or PI4KIIβ results in (a) specific reduction in the number of tubules that
are longer than 1 μm, (b) impaired delivery of BLOC-1-dependent cargo and VAMP7 to
melanosomes, and (c) mistargeting of cargos largely to late endosomes/ lysosomes. Together,
these data indicate that short tubules that form in the absence of PI4KIIα or PI4KIIβ and that are
loaded with cargo and VAMP7 are largely insufficient to support effective cargo delivery to
melanosomes. Thus, the length of tubule and/or its continued association with microtubules appear
to be critical for ultimate contact and fusion with melanosomes and cargo delivery (Delevoye et al.,
2009). How are the short tubules formed in PI4KIIα or PI4KIIβ-depleted cells? Considering our
observations that the general membrane association of BLOC-1 and AP-1 is not impaired by
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depletion of either PI4KIIα or PI4KIIβ alone, it is likely that the remaining pool of PtdIns4P generated
by PI4KIIα or PI4KIIβ is sufficient for binding a cohort of AP-1 (Wang et al., 2003) to recruit KIF13A
(Delevoye et al., 2009) and sort cargo such as TYRP1 (Delevoye et al., 2009; Theos et al., 2005a),
as well as a cohort of BLOC-1 (Jani et al., 2021) to coordinate with KIF13A for initial tubule
extension and sorting of VAMP7 into them (Bowman et al., 2021; Delevoye et al., 2016). Given that
the cargo accumulates primarily in early and late endosomes and lysosomes, we predict that the
VAMP7 that is sorted into these structures can facilitate fusion with other endosomes and with
lysosomes (Pryor et al., 2004) that may be more proximal to their site of origin than the maturing
melanosomes. Our unpublished data indicate that VAMP7 indeed accumulates in early endosomes
more in cells depleted of either PI4KIIα or PI4KIIβ than in control cells (Fig. 3.1). This suggests that
the “extra” VAMP7 might promote endosome fusion with late endosomes and lysosomes.
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Figure 3.1

Figure 3.1 GFP-VAMP7 is mislocalized to early endosomes in melanocytes depleted of either
PI4KIIα or PI4KIIβ.
WT melan-Ink4a melanocytes were transduced with lentiviruses expressing the indicated shRNAs
to PI4KIIα, PI4KIIβ, or control non-coding shRNA (shNC) and selected for 7 to 9 d. (A) After shRNA
transduction, cells were transiently transfected with GFP-VAMP7 and analyzed for GFP-VAMP7
(green) and endogenous STX13 (magenta) by IFM. White arrows, examples of non-overlap
between STX13 and GFP-VAMP7; yellow arrowheads, examples of GFP-VAMP7 overlap with
STX13. Boxed regions are magnified 5-fold in the insets. Scale bars: main panels, 10 μm; insets,
2 μm. (B) Quantification of the overlap of GFP-VAMP7 with STX13 in cells treated with the indicated
shRNAs. Data from three independent experiments were analyzed by Kruskal-Wallis test. ****,
p<0.0001; ns, not significant.

131

Long tubules reflect a need for long-distance trafficking, and it is plausible that PtdIns4P is generally
needed to maintain such long tubules; for example, the known transport secretory carriers that
deliver cargo from the Golgi to the plasma membrane contain PtdIns4P and are also very long
(Dowler et al., 2000; Godi et al., 2004). In the case of the BLOC-1-dependent tubules, the long
length must favor cargo transport from centrally localized endosomes to distant melanosomes.
Maturing melanosomes have been shown to move back and forth along microtubule tracks (Wu et
al., 1998), whereas fully melanized mature melanosomes are transferred to sub-cortical actin
filaments beneath the plasma membrane for ultimate release (Barral and Seabra, 2004). If the
endosomal tubules and melanosomes move along different microtubules, then it is possible that
endosomes generate the long tubules to reach migrating melanosomes at microtubule junctions to
deliver their cargos. This would be consistent with casual observations in the Marks lab by live cell
imaging that those melanosomes with which the tubules interact migrate prior to and after tubule
contact but not during tubule contact. To validate this model, these data would require quantification
and analysis relative to labeled microtubules.

The tubule profiles in PI4KIIα or PI4KIIβ-depleted cells look similar to BLOC-2-deficient cells where
most tubules are less than 1 μm in length and contact melanosomes less efficiently (Dennis et al.,
2015). This leads us to hypothesize that there may be a connection between type II PtdIns-4kinases (or PtdIns4P) and BLOC-2. In unpublished data using subcellular fractionation of wild-type
melanocytes, I found that BLOC-2 membrane association was significantly increased upon PI4KIIβ
depletion and trended towards an increase upon PI4KIIα depletion (Fig. 3.2). These data suggest
that PI4KIIα or PI4KIIβ deficiency may cause BLOC-2 to accumulate on inappropriate membrane
compartments where it is ineffective in cargo transport, resulting in a loss of BLOC-2-dependent
tubule contact with melanosomes. Thus, the presence of PtdIns4P on the tubules might support
the localization and/or function of BLOC-2 to ensure that the cargo carriers are specified for fusion
with melanosomes and not with late endosomes or lysosomes. This will be discussed further in
Section 3.3.1.
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Figure 3.2

Figure 3.2 BLOC-2 membrane association
Melan-Ink4a melanocytes were transduced with lentiviruses to express shNC, shPI4KIIα, or
shPI4KIIβ for 7 to 9 d. Indicated cells were homogenized and fractionated to yield post-nuclear
membrane (M) and cytosolic (C) fractions. Identical cell equivalents of membrane and cytosolic
fractions were fractionated by SDS-PAGE and analyzed by immunoblotting using an antibody to
the HPS6 subunit of BLOC-2. (A) Representative blots. Left, positions of molecular weight (MW)
markers. (B) Quantification of the percentage (mean ± SD of 3 independent experiments) of HPS6
associated with the membrane fraction relative to the total cellular content. Analysis, ordinary oneway ANOVA. ns, not significant.
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4) Local PtdIns4P generation on endosomal tubules by PI4KIIα and PI4KIIβ may contribute to
maintaining highly curved membranes.
Our live-cell and fixed-cell imaging all indicate that PI4KIIα and PI4KIIβ are largely localized to early
endosomes in melanocytes, consistent with observations in other cell types (Balla et al., 2002;
Craige et al., 2008; Jovic et al., 2014; Ma et al., 2020; Wieffer et al., 2013), and are detected both
on the vacuolar regions and the tubular membranes. PI4KIIα and PI4KIIβ on vacuolar early
endosomes can produce local PtdIns4P that likely plays a role in facilitating membrane bud
generation. As mentioned previously in sections 1.3.1a and 1.3.2a, PtdIns4P on the cytoplasmic
leaflet of endosomal vacuoles, generated by PI4KIIα and PI4KIIβ, might induce bilayer asymmetry
and reduce the rigidity of the membrane. Moreover, due to the addition of the phosphate group,
PtdIns4P possesses a larger polar head group than PtdIns and other glycerophospholipids such
as phosphatidylethanolamine (PE) and phosphatidic acid (PA) (Dickey and Faller, 2008; Son and
London, 2013); thus, a PtdIns4P-enriched area might intrinsically favor membrane bending. The
two physical alterations — leaflet asymmetry and local enrichment of lipids with a large head group
— could together reduce the and rigidity and energy cost for deforming the membrane and allow
for the generation of spontaneous membrane curvature. This mechanism could complement the
PtdIns4P-dependent recruitment of additional components, such as BLOC-1 and AP-1/KIF13A, to
further enhance membrane deformation. An optical trapping experiment using synthetic
membranes could be conducted to test whether PtdIns4P-enrichment reduces membrane rigidity
to favor membrane deformation. A series of giant unilamellar vesicles (GUVs) could be made with
a gradient concentration of PtdIns4P or lipid that is known to have low bending rigidity, such as 1,2Dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Doktorova et al., 2017). GUVs would be aspirated
into micropipettes and simultaneously attached to small beads as in (Karimi et al., 2018; Prevost
et al., 2017). An optical tweezer would then be used to exert a local force on the bead, thereby
pulling out a membrane tubule from the vesicle. This assay would allow us to measure the
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spontaneous curvature and the bending rigidity of GUVs in the absence of or presence of PtdIns4P
in different concentrations.
.
PtdIns4P might also facilitate tubule extension or stability via its function as a platform to recruit
proteins for driving tubulation and for stabilizing the curved membrane (Kitamata et al., 2020).
Several documented or predicted membrane bending proteins have been shown to bind to
PtdIns4P, including BLOC-1 (Jani et al., 2021), EHD1 (Jovic et al., 2009), and DRG2 (Mani et al.,
2017), and these or others might play a role in stabilizing the BLOC-1-dependent tubules; indeed,
the Drosophila EHD orthologue, Past1, is recruited to the PI4KII-positive tubules in the Drosophila
salivary gland (Ma et al., 2020). It would be interesting to determine whether EHD1 participates in
BLOC-1-dependent tubule formation. To test this, I would first assess EHD1 localization relative to
endosomal tubules to see if EHD1 decorates the tubules. If it does, I would then deplete EHD1 in
WT melanocytes and assess the dynamics of BLOC-1 tubules and melanosomal localization of
BLOC-1-dependent cargos relative to control cells. If EHD1 participates in BLOC-1-dependent
tubule formation or stabilization, I would observe impaired tubule dynamics and reduced TYRP1 or
OCA2 localization to melanosomes as in cells depleted of type II PtdIns-4-kinases. If so, then the
effect of PtdIns4P on EHD1 recruitment would be further examined. The most direct way is to use
the FRB–FKBP dimerization system (Inobe and Nukina, 2016) to introduce the PtdIns4P
phosphatase Sac1 to endosomal compartments to dephosphorylate PtdIns4P and to test whether
EHD1 localization to endosomal tubules is impaired. BLOC-1 seems less likely than the others to
function in coating the entire tubule since it is not very abundant in cells, but live cell imaging
analysis with a fluorescent BLOC-1 fusion protein would be necessary to test for this.

3.5 How is PtdIns4P removed from endosomal tubules?
PtdIns4P metabolism primarily relies on specific Ptdins-4 kinases (type II and type III) to generate
PtdIns4P and phosphatases (Sac1 and Sac2) to consume it. Coordination between lipid kinases
and phosphatases balances the production and consumption of PtdIns4P to control its homeostasis
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on the cytosolic leaflet of membranes of various organelles, including the Golgi, endosomes,
lysosomes, and transport carriers derived from these organelles (Balla, 2013). The endosomal
PtdIns4P pool is mostly generated by type II PtdIns-4-kinases as shown in our data and other
studies (Balla et al., 2002; Craige et al., 2008; Jovic et al., 2014; Ma et al., 2020; Tan and Brill,
2014; Wieffer et al., 2013), but how the PtdIns4P on BLOC-1-dependent endosomal tubules is
ultimately consumed is not clear. Intriguingly, the inositol 4-phosphatase Sac2 has been shown in
other cell types to localize to early endosomes where type II PtdIns-4-kinases are also localized
(Hsu et al., 2015; Nakatsu et al., 2015). Therefore, Sac2 could potentially counteract type II PtdIns4-kinase activity and play a role in clearance of PtdIns4P from early endosomes and derived
tubules that engage in melanosomal cargo trafficking. This could provide a mechanism for tubule
retraction following cargo delivery to melanosomes, as observed by live imaging (Dennis 2015).
Sac2 might also limit the site of PtdIns4P generation on endosomal vacuoles to ensure tubule
formation from specific sites on the membrane. Another possible mechanism for PtdIns4P
clearance is through membrane contact sites between the tubules and melanosomes. Contacts
between endosomal tubules and the endoplasmic reticulum (ER) generate a steep PtdIns4P
concentration gradient, which enable PtdIns4P transference from endosome to ER, and PtdIns4P
is then hydrolyzed by Sac1 on the ER membrane (Dong et al., 2016). Indeed, during
phagolysosome resolution, PtdIns4P on phagolysosomes is degraded by ER-localized Sac1 to
regulate tubule growth and resorption (Levin-Konigsberg et al., 2019). This PtdIns4P depletion is
achieved by phagolysosome/ ER contact sites that are dependent on oxysterol-binding proteinrelated protein 1L (ORP1L); ORP1L forms discrete patches between the PtdIns4P-rich
phagolysosome and the ER, and transfers PtdIns4P to the ER where PtdIns4P is then
dephosphorylated by Sac1. In melanocytes, known contact sites between the ER and
melanosomes (Hurbain et al., 2008) might play a similar role in the removal of PtdIns4P upon
contact of the membrane tubules with melanosomes.
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PtdIns4P is a crucial metabolic intermediate in the synthesis of other phosphoinositides. One of
those phosphoinositides is PtdIns(4,5)P2, which is considered as not only an important signaling
lipid but also a regulator of actin dynamics for membrane remodeling. As mentioned previously in
section 1.2.2b, AnxA2, an activator to WASH complex, is required to stabilize the BLOC-1associated tubules by promoting the Arp2/3-dependent polymerization of branched actin filaments
on the tubule membrane (Delevoye et al., 2016). AnxA2 function requires its binding to membranes,
and AnxA2 has a particularly high affinity for PtdIns(4,5)P2 (Gokhale et al., 2005; Hayes et al., 2004;
Hayes et al., 2009; Rescher et al., 2004). Thus, the recruitment of AnxA2 to BLOC-1-associated
tubules may require PtdIns(4,5)P2. If this is the case, there may exist a conversion of PtdIns4P to
PtdIns(4,5)P2 that allows the binding of AnxA2 to the BLOC-1-associated tubule membrane; this
conversion would provide another mechanism to consume PtdIns4P at budding regions of the
vacuolar endosome. In preliminary data, we assessed PtdIns(4,5)P2 distribution in melanocytes
using the GFP-PHPLCδ biosensor (Stauffer et al., 1998); as expected, most PtdIns(4,5)P2 was
detected at the plasma membrane, and we were unable to reproducibly detect internal structures
labeled by the biosensor. Moreover, we did not detect a drastic change of intracellular PtdIns(4,5)P 2
in cells depleted of PI4KIIα or PI4KIIβ. However, these negative data do not exclude the possibility
that the endosomal pool of PtdIns(4,5)P2 might decrease due to the reduced PtdIns4P level caused
by loss of PI4KIIα or PI4KIIβ. A more sensitive lipid probe or a distinct approach to expressing it
might be needed to help visualize the endosomal PtdIns(4,5)P2 pool.

3.6 Are type II PtdIns-4-kinases localized to melanosomes?
In our IFM analysis of fixed cells, we found that a pool of endogenous PI4KIIα and PI4KIIβ localized
to melanosomes at steady state (Fig. 3.3A). For both, quantification showed that less than 25% of
the total pool of kinase localized to melanosomes – a small but significant fraction (Fig. 3.3B).
When PI4KIIα and PI4KIIβ was detected on melanosomes, they localized in a discrete punctate
pattern on the exterior pigment granules (Fig. 3.3A and 3.3C, yellow arrowheads), unlike the
smooth “donut” pattern surrounding pigment granules observed for TYRP1 or the cytoplasmic
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domain of TYR. This pattern was also observed in cells overexpressing GFP-tagged PI4KIIα and
PI4KIIβ (Fig 3.3C and 3.3D). Notably, some remaining tubule-like structures of both endogenous
and overexpressed type II PtdIns-4-kinases are detected in association with pigment granules in
fixed cells (Fig. 3.3A and 3.3C, white arrows); these appear to correspond to the GFP-tagged
PI4KIIα- and PI4KIIβ-labeling endosomal tubules visualized by live-cell confocal microscopy.
These data suggest that PI4KIIα and PI4KIIβ themselves may be delivered to melanosomes for
temporary residence. Their sorting is likely mediated by AP-3 and AP-1, respectively, as it is for
cargo.

The discrete punctate appearance of type II PtdIns-4-kinases on melanosomal membranes
suggests that these kinases are likely confined within a “microdomain”. What function might PI4KIIα
or PI4KIIβ have on the melanosomal membrane? As previously described in 1.2.2c, VAMP7 and
other cargoes are retrieved from melanosomes by retrograde transport in tubular transport carriers
(Dennis et al., 2016), and type II PtdIns-4-kinases might be involved in this retrograde transport
pathway. Ripoll et al., showed that release of the retrograde carriers from melanosomes requires
branched actin polymerized by Arp2/3 and the WASH complex (Ripoll et al., 2018) — the latter is
activated through interaction with PtdIns4P (Dong et al., 2016). Our preliminary results from livecell imaging performed on melanocytes expressing PtdIns4P probe GFP-P4C show that GFP-P4C
forms a small patch on the melanosomal membrane, suggesting the existence of a melanosomal
PtdIn4P “microdomain” likely generated by type II PtdIns-4-kinases. Thus, the melanosomal type
II PtdIns-4-kinases may participate in the release of retrograde tubular carriers by providing
PtdIns4P to activate WASH complex for actin branching. This would support the intriguing notion
that anterograde transport mediated by the BLOC-1-dependent tubules may be coordinated with
retrograde transport in a PtdIns4P-dependent manner.
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Figure 3.3

Figure 3.3 A pool of endogenous and GFP-tagged PI4KIIα and PI4KIIβ localize to
melanosomes.
(A-D) Melan-Ink4a cells that were untransfected (A, B) or that stably expressed PI4KIIα-GFP or
PI4KIIβ-GFP (C, D) were fixed and analyzed by IFM for either PI4KIIα and PI4KIIβ (A, B) or GFPtagged PI4KIIα or PI4KIIβ (C, D), and by bright field microscopy (BF) for pigment granules. White
arrows, tubule-like structures; yellow arrowheads, pigment granules decorated by PI4KIIα, PI4KIIβ,
PI4KIIα-GFP or PI4KIIβ-GFP. Shown are representative individual and merged images (A, C) and
quantification of the percentage of overlap either endogenous (B) or GFP-tagged (D) type II PtdIns4-kinases with melanosomes relative to the total area labeled by either protein alone (mean ± SD
from three experiments).
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3.3 Future directions
My data, combined with other published research and unpublished work from our lab, raise a
number of interesting questions that I would love to answer if I were to continue working on this
project. Here, I present three questions that I find particularly intriguing based on the discussion
above.

3.3.1 Do type II PtdIns-4-kinases and PtdIns4P affect BLOC-2 function?
Published data from the Marks lab shows that BLOC-2 in melanocytes is required for the stability
of BLOC-1-dependent tubules, targeting tubules to maturing melanosomes, and subsequent
delivery of melanosome cargoes (Dennis et al., 2016; Dennis et al., 2015), but how BLOC-2
mediates these functions remains unclear. My preliminary subcellular fractionation results (Fig. 3.2
in section 3.2) show that BLOC-2 association with cellular membranes tends to increase in cells
depleted of PI4KIIα or PI4KIIβ. This suggests that PtdIns4P on endosomes or endosomal tubules
may impact BLOC-2 function. One future area of focus would be to better understand how PtdIns4P
and BLOC-2 interact and how they coordinate tubule dynamics.

Preliminary data in our lab show that in BLOC-2-deficient (BLOC-2-/-) melanocytes, endosomal
tubules associate less stably with microtubules. If confirmed, these data would support the
conclusion that BLOC-2 functions to secure the endosomal tubules to microtubules. The KIF13A
kinesin-3 motor drives tubule extension along microtubules (Delevoye et al., 2016), and a previous
studying suggests that there may be a physical interaction between KIF13A and BLOC-2 (Shakya
et al., 2018) (although this study lacked a necessary negative control). Thus, BLOC-2 might act a
stabilizer or activator of the KIF13A motor, and this mechanism might require PtdIns4P. To test the
relationship between BLOC-2 and PtdIns4P, I would first validate whether BLOC-2 and KIF13A
indeed interact in melanocytes with proper negative controls. I would then determine if the
interaction of BLOC-2 with KIF13A requires PtdIns4P. One method to test this is by using coimmunoprecipitation to detect the interaction between tagged BLOC-2 and tagged KIF13A
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expressed in cells depleted of PI4KIIα or PI4KIIβ. Tagged forms of intact KIF13A or a truncated
form lacking its motor domain have been successfully used in a number of studies to assess
interactions with the tail and stalk domains that regulate localization (refs). Of note, to ensure that
the tagged BLOC-2 complex is functional, I would express a tagged HPS3 subunit in Hps3-/- melancoa melanocytes and ensure by immunoblotting that the whole complex is restored (e.g. that the
HPS5 and HPS6 subunits are stabilized and/or associate with the tagged HPS3 subunit). Moreover,
cells expressing the tagged HPS3 subunit should restore pigmentation and melanosome cargo
localization. A live cell imaging approach would also provide insightful information about the spatial
relationship between BLOC-2 and KIF13A in the presence or absence of PtdIns4P.

The increased membrane association of BLOC-2 in cells depleted of PI4KIIα or PI4KIIβ suggests
that BLOC-2 may be mislocalized to other membrane compartments, and thus that endosomal
PtdIns4P may be necessary to secure BLOC-2 to its functional location. To test for BLOC-2
localization, I would generate a fluorescent form of BLOC-2 to visualize the dynamics and
localization of BLOC-2 relative to other organelles such as early endosomes and melanosomes in
the presence or absence of type II PtdIns-4-kinases. This would allow us to understand where
BLOC-2 is localized to exert its functions. Indeed, preliminary data in the lab suggest that HPS3
fused at either the C- or N-terminus to HaloTag retains functionality and can be used for this
approach. To test whether PtdIns4P on endosomal tubules is required for BLOC-2 localization
rather than the type II PtdIns-4-kinases themselves, the rapamycin-induced FKBP−FRB
dimerization technique (Inobe and Nukina, 2016) can be used to introduce PI4KIIIβ to endosomes
in an inducible manner in cells already depleted of PI4KIIα or PI4KIIβ. This would allow for PtdIns4P
generation independently of type II PtdIns-4-kinases and assess whether PtdIns4P itself is
sufficient to ensure BLOC-2 localization.
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3.3.2 Do type II PtdIns-4-kinases and PtdIns4P play a role in retrograde transport from
melanosomes?
As discussed above in section 3.6, my data show that a fraction of type II PtdIns-4-kinases localize
to melanosomes at steady state and that these kinases likely generate PtdIns4P patch(es) on the
melanosome membrane. Thus, the kinases and/or PtdIns4P itself may participate in retrograde
transport. I hypothesize that they function in the recruitment and/or activation of the WASH complex
(Dong et al., 2016) for release of the retrograde carriers from melanosomes (Ripoll et al., 2018).

To determine if PI4KIIα and PI4KIIβ are involved in WASH-mediated retrograde transport, I would
use live-cell imaging to visualize the melanosome-derived retrograde tubules in cells depleted of
PI4KIIα or PI4KIIβ or both. I would then compare the tubule phenotype to cells depleted of WASH
subunits. To visualize the tubules, I would use GFP-conjugated to Rab38, which is present on the
retrograde tubules and serves as a convenient marker for them (Dennis et al., 2016). If depletion
of type II PtdIns-4-kinase phenocopies WASH deficiency, then they may function in a same process,
and I would assess WASH recruitment to melanosomes in cells depleted of PI4KIIα or PI4KIIβ.
Alternatively, PtdIns4P might play a role in regulating the association of the retrograde tubules with
SNX6, which is part of the retromer complex that has been shown by the Raposo lab in unpublished
data to also be required for generating the retrograde tubules. This can also be assessed by live
cell imaging of SNX1, SNX2, or SNX6 relative to Rab38. If defects in retrograde trafficking are not
observed, I would conclude that type II PtdIns-4-kinases and PtdIns4P may have other functions
on melanosomes. One potential function is that PtdIns4P and both type II PtdIns-4-kinases may
contribute to establish the ER-melanosome membrane contact site as observed in a previous study
(Hurbain et al., 2008), given that both PtdIns4P and WASH have known roles in endosome/
endoplasmic reticulum membrane contact sites (Dong et al., 2016).
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3.3.3 Do type II PtdIns-4-kinases and PtdIns4P affect Rab6-dependent cargo transport to
melanosomes?
As discussed above in sections 1.3.1a and 1.3.2a, PtdIns4P is enriched on the outer leaflet of the
TGN membrane and plays a role in membrane curvature to promote post-Golgi vesicle formation
and exit from the Golgi (Waugh, 2019). A fraction of type II PtdIns-4-kinases generates a pool of
Golgi PtdIns4P and thus contributes to the biogenesis of Golgi-derived vesicles (Anitei and Hoflack,
2011; von Blume and Hausser, 2019). Notably, Rab6 decorates post-Golgi vesicles and regulates
both their release from the Golgi and their trafficking to their ultimate destinations (Fourriere et al.,
2019; Grigoriev et al., 2007; Miserey-Lenkei et al., 2017). Most importantly in the context of this
thesis, Rab6 is required for targeting DCT and MART-1 to melanosomes (Patwardhan et al., 2017)
(see section 1.2.1). Thus, type II PtdIns-4-kinases and PtdIns4P may play a role in Rab6-dependent
cargo transport to melanosomes by mediating the formation Rab6-positive post-Golgi vesicles.

To test whether if PI4KIIα and PI4KIIβ are involved in Rab6-dependent cargo transport, I would use
IFM to assess melanosomal localization of DCT and MART-1 in cells depleted of PI4KIIα or PI4KIIβ
or both and then compare the localization phenotype to cells depleted of Rab6 or its effector ELKS.
If cells depleted of either type II PtdIns-4-kinase and cells depleted of Rab6 or its effector ELKS
display comparable defects in melanosomal localization of DCT and MART-1, then they might
function in the same process.

If the results were to support an effect of PI4KIIα or PI4KIIβ on the Golgi-to-melanosome pathway,
I would then further probe how they do so. I propose three interesting questions for future studies:
a) Do type II PtdIns-4-kinases affect Rab6 recruitment to the Golgi for vesicle formation? b) Is cargo
incorporation into Rab6-positive cargos mediated by type II PtdIns-4-kinases? c) Do type II PtdIns4-kinases function in release of Rab6-positive vesicles from Golgi? Addressing these questions
would help gain a comprehensive understanding of the role of type II PtdIns-4-kinases in
melanosome biogenesis.
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APPENDIX

Appendix Figure 1
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Appendix Figure 1. Binding of either AP-3δ to VAMP7 or Pldn to STX13 is required for BLOC1–dependent VAMP7 localization to melanosomes.
(A–E) Ap3d1−/−/ Pldn−/− melanocytes that were untransduced (A) or stably transduced with the
indicated WT (black text) or SNARE binding mutant (magenta text) AP-3δ and Pldn variants (B–E)
were transiently transfected with GFP-VAMP7, fixed, immunolabeled for STX13, and analyzed by
deconvolution IFM and brightfield (BF) microscopy. Shown are corresponding BF images (left),
individual labels for GFP-VAMP7 and STX13, merged images of GFP-VAMP7 and STX13, and
overlap of GFP-VAMP7 with pigment granules (if any) pseudocolored magenta from the BF image
(right). Boxed regions are magnified sevenfold in the insets. White arrows, overlap of GFP-VAMP7
with STX13; cyan arrows, overlap of GFP-VAMP7 with pigment granules; white arrowheads, lack
of overlap of GFP-VAMP7 with STX13. The cell outline is shown in the BF images in A and E. Scale
bar, 10 μm; inset scale bar, 1 μm. (F) Quantification (mean ± SEM) of percentage GFP-VAMP7
overlap with STX13 across 18 cells for each sample over three separate experiments. ****, P <
0.0001; n.s., not significant. Figure copied with permission from Figure 4 in (Bowman et al., 2021).

(This figure has been published as Fig. 4 in a peer-reviewed article titled “A BLOC-1–AP-3 supercomplex sorts a cis-SNARE complex into endosome-derived tubular transport carriers” by Shanna
L. Bowman, Linh Le, Yueyao Zhu, Dawn C. Harper, Anand Sitaram, Alexander C. Theos, Elena V.
Sviderskaya, Dorothy C. Bennett, Graça Raposo-Benedetti, David J. Owen, Megan K. Dennis, and
Michael S. Marks. Journal of Cell Biology, 2021. DOI: 10.1083/jcb.202005173. Yueyao Zhu
contributed to experimental design, performed experiments, analyzed data, and assembled part of
Fig. 4 and associated text.)
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Bissig, C., P. Croisé, X. Heiligenstein, I. Hurbain, G.M. Lenk, E. Kaufman, R. Sannerud,
W. Annaert, M.H. Meisler, L.S. Weisman, G. Raposo, and G. van Niel. 2019. The
PIKfyve complex regulates the early melanosome homeostasis required for
physiological amyloid formation. J. Cell Sci. 132:jcs.229500.
Biyasheva, A., T.V. Do, Y. Lu, M. Vaskova, and A.J. Andres. 2001. Glue secretion in the
Drosophila salivary gland: a model for steroid-regulated exocytosis. Dev Biol.
231:234-251.
Blasius, A.L., C.N. Arnold, P. Georgel, S. Rutschmann, Y. Xia, P. Lin, C. Ross, X. Li, N.G.
Smart, and B. Beutler. 2010. Slc15a4, AP-3, and Hermansky-Pudlak syndrome
proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells.
Proc. Natl. Acad. Sci. U.S.A. 107:19973-19978.
Bonifacino, J.S., and B.S. Glick. 2004. The mechanisms of vesicle budding and fusion.
Cell. 116:153-166.
Bonifacino, J.S., and R. Rojas. 2006. Retrograde transport from endosomes to the transGolgi network. Nat. Rev. Mol. Cell Biol. 7:568-579.
Boucrot, E., A.P. Ferreira, L. Almeida-Souza, S. Debard, Y. Vallis, G. Howard, L. Bertot,
N. Sauvonnet, and H.T. McMahon. 2015. Endophilin marks and controls a clathrinindependent endocytic pathway. Nature. 517:460-465.
Bowman, S.L., J. Bi-Karchin, L. Le, and M.S. Marks. 2019. The road to LROs: insights into
lysosome-related organelles from Hermansky-Pudlak syndrome and other rare
diseases. Traffic. 20:404-435.
147

Bowman, S.L., L. Le, Y. Zhu, D.C. Harper, A. Sitaram, A.C. Theos, E.V. Sviderskaya, D.C.
Bennett, G. Raposo, D.J. Owen, M.K. Dennis, and M.S. Marks. 2021. A BLOC-1AP-3 super-complex sorts a cis-SNARE complex into endosome-derived tubular
transport carriers. J. Cell Biol. 220:e202005173.
Briken, V., R.M. Jackman, S. Dasgupta, S. Höning, and S.A. Porcelli. 2002. Intracellular
trafficking pathway of newly synthesized CD1b molecules. EMBO J. 21:825-834.
Brown, F.D., A.L. Rozelle, H.L. Yin, T. Balla, and J.G. Donaldson. 2001a.
Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell
Biol. 154:1007-1017.
Brown, M.F., R.L. Thurmond, S.W. Dodd, D. Otten, and K. Beyer. 2001b. Composite
membrane deformation on the mesoscopic length scale. Phys Rev E Stat Nonlin
Soft Matter Phys. 64:010901.
Brown, M.F., R.L. Thurmond, S.W. Dodd, D.r. Otten, and K. Beyer. 2002. Elastic
Deformation of Membrane Bilayers Probed by Deuterium NMR Relaxation. Journal
of the American Chemical Society. 124:8471-8484.
Bruce Alberts, Alexander Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts,
and P. Walter. 2014. Molecular Biology of the Cell, Sixth edition. W. W. Norton &
Company, Garland Science.
Bryan, M.M., N.J. Tolman, K.L. Simon, M. Huizing, R.B. Hufnagel, B.P. Brooks, V.
Speransky, J.C. Mullikin, W.A. Gahl, M.C. Malicdan, and B.R. Gochuico. 2017.
Clinical and molecular phenotyping of a child with Hermansky-Pudlak syndrome7, an uncommon genetic type of HPS. Mol. Genet. Metab. 120:378-383.
Bultema, J.J., A.L. Ambrosio, C.L. Burek, and S.M. Di Pietro. 2012. BLOC-2, AP-3, and
AP-1 function in concert with Rab38 and Rab32 to mediate protein trafficking to
lysosome-related organelles. J. Biol. Chem. 287:19550-19563.
Burd, C., and P.J. Cullen. 2014. Retromer: a master conductor of endosome sorting. Cold
Spring Harb Perspect Biol. 6.
Burger, K.N. 2000. Greasing membrane fusion and fission machineries. Traffic. 1:605-613.
Burgess, J., L.M. Del Bel, C.I. Ma, B. Barylko, G. Polevoy, J. Rollins, J.P. Albanesi, H.
Krämer, and J.A. Brill. 2012. Type II phosphatidylinositol 4-kinase regulates
trafficking of secretory granule proteins in Drosophila. Development. 139:30403050.
Burgess, J., M. Jauregui, J. Tan, J. Rollins, S. Lallet, P.A. Leventis, G.L. Boulianne, H.C.
Chang, R. Le Borgne, H. Krämer, and J.A. Brill. 2011. AP-1 and clathrin are
essential for secretory granule biogenesis in Drosophila. Mol. Biol. Cell. 22:20942105.
Busch, D.J., J.R. Houser, C.C. Hayden, M.B. Sherman, E.M. Lafer, and J.C. Stachowiak.
2015. Intrinsically disordered proteins drive membrane curvature. Nat Commun.
6:7875.
Cai, Q., L. Lu, J.H. Tian, Y.B. Zhu, H. Qiao, and Z.H. Sheng. 2010. Snapin-regulated late
endosomal transport is critical for efficient autophagy-lysosomal function in
neurons. Neuron. 68:73-86.
Caltagarone, J., S. Ma, and A. Sorkin. 2015. Dopamine transporter is enriched in filopodia
and induces filopodia formation. Mol Cell Neurosci. 68:120-130.
Campagne, C., L. Ripoll, F. Gilles-Marsens, G. Raposo, and C. Delevoye. 2018. AP1/KIF13A blocking peptides impair melanosome maturation and melanin synthesis.
Int. J. Mol. Sci. 19:568.

148

Cao, H., S. Weller, J.D. Orth, J. Chen, B. Huang, J.L. Chen, M. Stamnes, and M.A.
McNiven. 2005. Actin and Arf1-dependent recruitment of a cortactin-dynamin
complex to the Golgi regulates post-Golgi transport. Nat Cell Biol. 7:483-492.
Cao, X., U. Coskun, M. Rossle, S.B. Buschhorn, M. Grzybek, T.R. Dafforn, M. Lenoir, M.
Overduin, and K. Simons. 2009. Golgi protein FAPP2 tubulates membranes. Proc
Natl Acad Sci U S A. 106:21121-21125.
Carlton, J., M. Bujny, B.J. Peter, V.M. Oorschot, A. Rutherford, H. Mellor, J. Klumperman,
H.T. McMahon, and P.J. Cullen. 2004. Sorting nexin-1 mediates tubular
endosome-to-TGN transport through coincidence sensing of high- curvature
membranes and 3-phosphoinositides. Curr Biol. 14:1791-1800.
Cernadas, M., M. Sugita, N. van der Wel, X. Cao, J.E. Gumperz, S. Maltsev, G.S. Besra,
S.M. Behar, P.J. Peters, and M.B. Brenner. 2003. Lysosomal localization of murine
CD1d mediated by AP-3 is necessary for NK T cell development. J Immunol.
171:4149-4155.
Chandra, M., Y.K. Chin, C. Mas, J.R. Feathers, B. Paul, S. Datta, K.E. Chen, X. Jia, Z.
Yang, S.J. Norwood, B. Mohanty, A. Bugarcic, R.D. Teasdale, W.M. Henne, M.
Mobli, and B.M. Collins. 2019. Classification of the human phox homology (PX)
domains based on their phosphoinositide binding specificities. Nat Commun.
10:1528.
Chen, D., C.B. Uhl, S.C. Bryant, M. Krumwiede, R.L. Barness, M.C. Olson, S.C. Gossman,
S. Erdogan Damgard, S.I. Gamb, L.A. Cummins, J.E. Charlesworth, C.M. WoodWentz, J.L. Salisbury, E.A. Plumhoff, E.M. Van Cott, R. He, D.M. Warad, R.K.
Pruthi, J.A. Heit, W.L. Nichols, and J.G. White. 2018. Diagnostic laboratory
standardization and validation of platelet transmission electron microscopy.
Platelets. 29:574-582.
Cheng, X.T., B. Zhou, M.Y. Lin, Q. Cai, and Z.H. Sheng. 2015. Axonal autophagosomes
recruit dynein for retrograde transport through fusion with late endosomes. J Cell
Biol. 209:377-386.
Chernomordik, L. 1996. Non-bilayer lipids and biological fusion intermediates. Chem Phys
Lipids. 81:203-213.
Chiang, P.-W., N. Oiso, R. Gautam, R.T. Swank, and R.A. Spritz. 2003. The HermanskyPudlak syndrome 1 (HPS1) and HPS4 proteins are components of two complexes,
BLOC-3 and BLOC-4, involved in the biogenesis of lysosome-related organelles.
J. Biol. Chem. 278:20332-20337.
Chiang, P.-W., E. Spector, M. Thomas, and M. Frei-Jones. 2010. Novel mutation causing
Hermansky–Pudlak Syndrome Type 2. Pediatric Blood & Cancer. 55:1438.
Chintala, S., J. Tan, R. Gautam, M.E. Rusiniak, X. Guo, W. Li, W.A. Gahl, M. Huizing, R.A.
Spritz, S. Hutton, E.K. Novak, and R.T. Swank. 2007. The Slc35d3 gene, encoding
an orphan nucleotide sugar transporter, regulates platelet dense granules. Blood.
109:1533-1540.
Clark, R.H., J.C. Stinchcombe, A. Day, E. Blott, S. Booth, G. Bossi, T. Hamblin, E.G.
Davies, and G.M. Griffiths. 2003. Adaptor protein 3–dependent microtubulemediated movement of lytic granules to the immunological synapse. Nature
Immunol. 4:1111-1120.
Collins, A., A. Warrington, K.A. Taylor, and T. Svitkina. 2011. Structural organization of
the actin cytoskeleton at sites of clathrin-mediated endocytosis. Curr Biol. 21:11671175.
Costin, G.E., and V.J. Hearing. 2007. Human skin pigmentation: melanocytes modulate
skin color in response to stress. FASEB J. 21:976-994.
149

Craige, B., G. Salazar, and V. Faundez. 2008. Phosphatidylinositol-4-kinase type II alpha
contains an AP-3 sorting motif and a kinase domain that are both required for
endosome traffic. Mol. Biol. Cell. 19:1415-1426.
Cullinane, A.R., J.A. Curry, C. Carmona-Rivera, C.G. Summers, C. Ciccone, N.D. Cardillo,
H. Dorward, R.A. Hess, J.G. White, D. Adams, M. Huizing, and W.A. Gahl. 2011.
A BLOC-1 mutations screen reveals that PLDN is mutated in Hermansky-Pudlak
syndrome type 9. Am. J. Human Genet. 88:778-787.
Cullinane, A.R., J.A. Curry, G. Golas, J. Pan, C. Carmona-Rivera, R.A. Hess, J.G. White,
M. Huizing, and W.A. Gahl. 2012. A BLOC-1 mutation screen reveals a novel
BLOC1S3 mutation in Hermansky–Pudlak Syndrome type 8. Pigment Cell
Melanoma Res. 25:584–591.
Cullinane, A.R., A.A. Schäffer, and M. Huizing. 2013. The BEACH is hot: a LYST of
emerging roles for BEACH-domain containing proteins
in human disease. Traffic. 14:749-766.
D'Angelo, G., M. Vicinanza, A. Di Campli, and M.A. De Matteis. 2008. The multiple roles
of PtdIns(4)P -- not just the precursor of PtdIns(4,5)P2. J. Cell Sci. 121:1955-1963.
Danglot, L., and T. Galli. 2007. What is the function of neuronal AP-3? Biol Cell. 99:349361.
Daumke, O., R. Lundmark, Y. Vallis, S. Martens, P.J. Butler, and H.T. McMahon. 2007.
Architectural and mechanistic insights into an EHD ATPase involved in membrane
remodelling. Nature. 449:923-927.
de Chastellier, C., F. Forquet, A. Gordon, and L. Thilo. 2009. Mycobacterium requires an
all-around closely apposing phagosome membrane to maintain the maturation
block and this apposition is re-established when it rescues itself from
phagolysosomes. Cell Microbiol. 11:1190-1207.
De Jesus Rojas, W., and L.R. Young. 2020. Hermansky-Pudlak Syndrome. Semin. Respir.
Crit. Care Med. 41:238-246.
Dean, G.E., H. Fishkes, P.J. Nelson, and G. Rudnick. 1984. The hydrogen ion-pumping
adenosine triphosphatase of platelet dense granule membrane. Differences from
F1F0- and phosphoenzyme-type ATPases. J. Biol. Chem. 259:9569-9574.
Delevoye, C., X. Heiligenstein, L. Ripoll, F. Gilles-Marsens, M.K. Dennis, R.A. Linares, L.
Derman, A. Gokhale, E. Morel, V. Faundez, M.S. Marks, and G. Raposo. 2016.
BLOC-1 brings together the actin and microtubule cytoskeletons to generate
recycling endosomes. Curr. Biol. 26:1-13.
Delevoye, C., I. Hurbain, D. Tenza, J.-B. Sibarita, S. Uzan-Gafsou, H. Ohno, W.J.C.
Geerts, A.J. Verkleij, J. Salamero, M.S. Marks, and G. Raposo. 2009. AP-1 and
KIF13A coordinate endosomal sorting and positioning during melanosome
biogenesis. J. Cell Biol. 187:247-264.
Delevoye, C., M.S. Marks, and G. Raposo. 2019. Lysosome-related organelles as
functional adaptations of the endolysosomal system. Curr Opin Cell Biol. 59:147158.
Delevoye, C., S. Miserey-Lenkei, G. Montagnac, F. Gilles-Marsens, P. Paul-Gilloteaux, F.
Giordano, F. Waharte, M.S. Marks, B. Goud, and G. Raposo. 2014. Recycling
endosome tubule morphogenesis from sorting endosomes requires the kinesin
motor KIF13A. Cell Rep. 6:445-454.
Dell'Angelica, E.C. 2009. AP-3-dependent trafficking and disease: the first decade. Curr.
Opin. Cell Biol. 21:552-559.
150

Dell'Angelica, E.C., H. Ohno, C.E. Ooi, E. Rabinovich, K.W. Roche, and J.S. Bonifacino.
1997. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J.
16:917-928.
Dell'Angelica, E.C., V. Shotelersuk, R.C. Aguilar, W.A. Gahl, and J.S. Bonifacino. 1999.
Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to
mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell. 3:11-21.
Dennis, M.K., C. Delevoye, A. Acosta-Ruiz, I. Hurbain, M. Romao, G.G. Hesketh, P.S.
Goff, E.V. Sviderskaya, D.C. Bennett, J.P. Luzio, T. Galli, D.J. Owen, G. Raposo,
and M.S. Marks. 2016. BLOC-1 and BLOC-3 regulate VAMP7 cycling to and from
melanosomes via distinct tubular transport carriers. J. Cell Biol. 214:293-308.
Dennis, M.K., A.R. Mantegazza, O.L. Snir, D. Tenza, A. Acosta-Ruiz, C. Délevoye, R.
Zorger, A. Sitaram, W. de Jesus-Rojas, K. Ravichandran, J. Rux, E.V. Sviderskaya,
D.C. Bennett, R. G., M.S. Marks, and S.R.G. Setty. 2015. BLOC-2 targets recycling
endosomal tubules to melanosomes for cargo delivery. J. Cell Biol. 209:563-577.
Deo, R., M.S. Kushwah, S.C. Kamerkar, N.Y. Kadam, S. Dar, K. Babu, A. Srivastava, and
T.J. Pucadyil. 2018. ATP-dependent membrane remodeling links EHD1 functions
to endocytic recycling. Nat Commun. 9:5187.
Di Pietro, S.M., and E.C. Dell'Angelica. 2005. The cell biology of Hermansky-Pudlak
syndrome: recent advances. Traffic. 6:525-533.
Di Pietro, S.M., J.M. Falcon-Perez, and E.C. Dell'Angelica. 2004. Characterization of
BLOC-2, a complex containing the Hermansky-Pudlak syndrome proteins HPS3,
HPS5 and HPS6. Traffic. 5:276-283.
Di Pietro, S.M., J.M. Falcon-Perez, D. Tenza, S.R.G. Setty, M.S. Marks, G. Raposo, and
E.C. Dell'Angelica. 2006. BLOC-1 interacts with BLOC-2 and the AP-3 complex to
facilitate protein trafficking on endosomes. Mol. Biol. Cell. 17:4027-4038.
Dickey, A., and R. Faller. 2008. Examining the contributions of lipid shape and headgroup
charge on bilayer behavior. Biophys J. 95:2636-2646.
Doktorova, M., D. Harries, and G. Khelashvili. 2017. Determination of bending rigidity and
tilt modulus of lipid membranes from real-space fluctuation analysis of molecular
dynamics simulations. Phys Chem Chem Phys. 19:16806-16818.
Dolinsky, S., I. Haneburger, A. Cichy, M. Hannemann, A. Itzen, and H. Hilbi. 2014. The
Legionella longbeachae Icm/Dot substrate SidC selectively binds
phosphatidylinositol 4-phosphate with nanomolar affinity and promotes pathogen
vacuole-endoplasmic reticulum interactions. Infect. Immun. 82:4021-4033.
Domingues, L., A. Ismail, N. Charro, I. Rodriguez-Escudero, D.W. Holden, M. Molina, V.J.
Cid, and L.J. Mota. 2016. The Salmonella effector SteA binds phosphatidylinositol
4-phosphate for subcellular targeting within host cells. Cell. Microbiol. 18:949-969.
Dong, R., Y. Saheki, S. Swarup, L. Lucast, J.W. Harper, and P. De Camilli. 2016.
Endosome-ER contacts control actin nucleation and retromer function through
VAP-dependent regulation of PI4P. Cell. 166:408-423.
Dong, X.P., D. Shen, X. Wang, T. Dawson, X. Li, Q. Zhang, X. Cheng, Y. Zhang, L.S.
Weisman, M. Delling, and H. Xu. 2010. PI(3,5)P(2) controls membrane trafficking
by direct activation of mucolipin Ca(2+) release channels in the endolysosome.
Nat Commun. 1:38.
Dowler, S., R.A. Currie, D.G. Campbell, M. Deak, G. Kular, C.P. Downes, and D.R. Alessi.
2000. Identification of pleckstrin-homology-domain-containing proteins with novel
phosphoinositide-binding specificities. Biochem J. 351:19-31.

151

Du, W., Q.P. Su, Y. Chen, Y. Zhu, D. Jiang, Y. Rong, S. Zhang, Y. Zhang, H. Ren, C.
Zhang, X. Wang, N. Gao, Y. Wang, L. Sun, Y. Sun, and L. Yu. 2016. Kinesin 1
drives autolysosome tubulation. Dev. Cell. 37:326-336.
Elewaut, D., A.P. Lawton, N.A. Nagarajan, E. Maverakis, A. Khurana, S. Höning, C.A.
Benedict, E. Sercarz, O. Bakke, M. Kronenberg, and T.I. Prigozy. 2003. The
adaptor protein AP-3 Is required for CD1d-mediated antigen presentation of
glycosphingolipids and development of Va14i NKT cells. J. Exp. Med. 198:11331146.
Enders, A., B. Zieger, K. Schwarz, A. Yoshimi, C. Speckmann, E.M. Knoepfle, U. Kontny,
C. Muller, A. Nurden, J. Rohr, M. Henschen, U. Pannicke, C. Niemeyer, P. Nurden,
and S. Ehl. 2006. Lethal hemophagocytic lymphohistiocytosis in HermanskyPudlak Syndrome Type II. Blood. 108:81-87.
Escriba, P.V., J.M. Gonzalez-Ros, F.M. Goni, P.K. Kinnunen, L. Vigh, L. SanchezMagraner, A.M. Fernandez, X. Busquets, I. Horvath, and G. Barcelo-Coblijn. 2008.
Membranes: a meeting point for lipids, proteins and therapies. J Cell Mol Med.
12:829-875.
Faigle, W., G. Raposo, D. Tenza, V. Pinet, A.B. Vogt, H. Kropshofer, A. Fischer, G. de
Saint-Basile, and S. Amigorena. 1998. Deficient peptide loading and MHC class II
endosomal sorting in a human genetic immunodeficiency disease: the ChediakHigashi syndrome. J. Cell Biol. 141:1121-1134.
Fairn, G.D., and S. Grinstein. 2012. How nascent phagosomes mature to become
phagolysosomes. Trends Cell Biol. . 33:397-405.
Falcon-Perez, J.M., M. Starcevic, R. Gautam, and E.C. Dell'Angelica. 2002. BLOC-1, a
novel complex containing the pallidin and muted proteins involved in the
biogenesis of melanosomes and platelet dense granules. J. Biol. Chem.
277:28191-28199.
Farge, E., and P.F. Devaux. 1992. Shape changes of giant liposomes induced by an
asymmetric transmembrane distribution of phospholipids. Biophys J. 61:347-357.
Farge, E., D.M. Ojcius, A. Subtil, and A. Dautry-Varsat. 1999. Enhancement of
endocytosis due to aminophospholipid transport across the plasma membrane of
living cells. Am J Physiol. 276:C725-733.
Farsad, K., and P. De Camilli. 2003. Mechanisms of membrane deformation. Curr Opin
Cell Biol. 15:372-381.
Feng, S., A. Knodler, J. Ren, J. Zhang, X. Zhang, Y. Hong, S. Huang, J. Peranen, and W.
Guo. 2012. A Rab8 guanine nucleotide exchange factor-effector interaction
network regulates primary ciliogenesis. J Biol Chem. 287:15602-15609.
Ferraro, F., J. Kriston-Vizi, D.J. Metcalf, B. Martin-Martin, J. Freeman, J.J. Burden, D.
Westmoreland, C.E. Dyer, A.E. Knight, R. Ketteler, and D.F. Cutler. 2014. A twotier Golgi-based control of organelle size underpins the functional plasticity of
endothelial cells. Dev. Cell. 29:292-304.
Ferraro, F., S. Mafalda Lopes da, W. Grimes, H.K. Lee, R. Ketteler, J. Kriston-Vizi, and
D.F. Cutler. 2016. Weibel-Palade body size modulates the adhesive activity of its
von Willebrand Factor cargo in cultured endothelial cells. Sci. Rep. 6:32473.
Fjorback, A.W., M. Seaman, C. Gustafsen, A. Mehmedbasic, S. Gokool, C. Wu, D. Militz,
V. Schmidt, P. Madsen, J.R. Nyengaard, T.E. Willnow, E.I. Christensen, W.B.
Mobley, A. Nykjaer, and O.M. Andersen. 2012. Retromer binds the FANSHY
sorting motif in SorLA to regulate amyloid precursor protein sorting and processing.
J Neurosci. 32:1467-1480.
152

Fontana, S., S. Parolini, W. Vermi, S. Booth, F. Gallo, M. Donini, M. Benassi, F. Gentili,
D. Ferrari, L.D. Notarangelo, P. Cavadini, E. Marcenaro, S. Dusi, M. Cassatella, F.
Facchetti, G.M. Griffiths, A. Moretta, L.D. Notarangelo, and R. Badolato. 2006.
Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood. 107:48574864.
Ford, M.G., I.G. Mills, B.J. Peter, Y. Vallis, G.J. Praefcke, P.R. Evans, and H.T. McMahon.
2002. Curvature of clathrin-coated pits driven by epsin. Nature. 419:361-366.
Fourriere, L., A. Kasri, N. Gareil, S. Bardin, H. Bousquet, D. Pereira, F. Perez, B. Goud,
G. Boncompain, and S. Miserey-Lenkei. 2019. RAB6 and microtubules restrict
protein secretion tofocal adhesions. J. Cell Biol. In press:doi:
10.1083/jcb.201805002.
Fukuda, M., T.S. Kuroda, and K. Mikoshiba. 2002. Slac2-a/melanophilin, the missing link
between Rab27 and myosin Va. Implications of a tripartite protein complex for
melanosome transport. J. Biol. Chem. 277:12432-12436.
Fuller, N., and R.P. Rand. 2001. The influence of lysolipids on the spontaneous curvature
and bending elasticity of phospholipid membranes. Biophys J. 81:243-254.
Gallon, M., and P.J. Cullen. 2015. Retromer and sorting nexins in endosomal sorting.
Biochem Soc Trans. 43:33-47.
Gardner, J.M., S.C. Wildenberg, N.M. Keiper, E.K. Novak, M.E. Rusiniak, R.T. Swank, N.
Puri, J.N. Finger, N. Hagiwara, A.L. Lehman, T.L. Gales, M.E. Bayer, R.A. King,
and M.H. Brilliant. 1997. The mouse pale ear (ep) mutation is the homologue of
human Hermansky-Pudlak syndrome. Proc. Natl. Acad. Sci. USA. 94:9238-9243.
Ge, K., and G.C. Prendergast. 2000. Bin2, a functionally nonredundant member of the
BAR adaptor gene family. Genomics. 67:210-220.
Gerondopoulos, A., L. Langemeyer, J.-R. Liang, A. Linford, and F.A. Barr. 2012. BLOC-3
mutated in Hermansky-Pudlak syndrome is a Rab32/38 guanine nucleotide
exchange factor. Curr. Biol. 22:2135-2139.
Ghiani, C.A., M. Starcevic, I.A. Rodriguez-Fernandez, R. Nazarian, V.T. Cheli, L.N. Chan,
J.S. Malvar, J. de Vellis, C. Sabatti, and E.C. Dell'angelica. 2010. The dysbindincontaining complex (BLOC-1) in brain: developmental regulation, interaction with
SNARE proteins and role in neurite outgrowth. Mol. Psychiatry. 15:204-215.
Gillooly, D.J., I.C. Morrow, M. Lindsay, R. Gould, N.J. Bryant, J.M. Gaullier, R.G. Parton,
and H. Stenmark. 2000. Localization of phosphatidylinositol 3-phosphate in yeast
and mammalian cells. EMBO J. 19:4577-4588.
Godi, A., A. Di Campli, A. Konstantakopoulos, G. Di Tullio, D.R. Alessi, G.S. Kular, T.
Daniele, P. Marra, J.M. Lucocq, and M.A. De Matteis. 2004. FAPPs control Golgito-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat Cell Biol.
6:393-404.
Godi, A., P. Pertile, R. Meyers, P. Marra, G. Di Tullio, C. Iurisci, A. Luini, D. Corda, and
M.A. De Matteis. 1999. ARF mediates recruitment of PtdIns-4-OH kinase-beta and
stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat Cell Biol. 1:280287.
Gokhale, A., J. Larimore, E. Werner, L. So, A. Moreno-De-Luca, C. Lese-Martin, V.V.
Lupashin, Y. Smith, and V. Faundez. 2012. Quantitative proteomic and genetic
analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of
the biogenesis of lysosome-related organelles complex 1. J. Neurosci. 32:36973711.

153

Gokhale, N.A., A. Abraham, M.A. Digman, E. Gratton, and W. Cho. 2005.
Phosphoinositide specificity of and mechanism of lipid domain formation by
annexin A2-p11 heterotetramer. J Biol Chem. 280:42831-42840.
Gokool, S., D. Tattersall, and M.N.J. Seaman. 2007. EHD1 interacts with retromer to
stabilize SNX1 tubules and facilitate endosome-to-Golgi retrieval. Traffic. 8:18731886.
Gomez, T.S., and D.D. Billadeau. 2009. A FAM21-containing WASH complex regulates
retromer-dependent sorting. Dev. Cell. 17:699-711.
Graham, T.R., and C.G. Burd. 2011. Coordination of Golgi functions by
phosphatidylinositol 4-kinases. Trends Cell Biol. 21:113-121.
Grigoriev, I., D. Splinter, N. Keijzer, P.S. Wulf, J. Demmers, T. Ohtsuka, M. Modesti, I.V.
Maly, F. Grosveld, C.C. Hoogenraad, and A. Akhmanova. 2007. Rab6 regulates
transport and targeting of exocytotic carriers. Dev Cell. 13:305-314.
Guo, J., M.R. Wenk, L. Pellegrini, F. Onofri, F. Benfenati, and P. De Camilli. 2003.
Phosphatidylinositol 4-kinase type IIalpha is responsible for the
phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc Natl
Acad Sci U S A. 100:3995-4000.
Gurkan, C., H. Lapp, C. Alory, A.I. Su, J. Hogenesch, and W.E. Balch. 2005. Large-scale
profiling of rab GTPase trafficking networks: the Membrome. Mol. Biol. Cell.
16:3847-3864.
Guttentag, S.H., A. Akhtar, J.Q. Tao, E. Atochina, M.E. Rusiniak, R.T. Swank, and S.R.
Bates. 2005. Defective surfactant secretion in a mouse model of HermanskyPudlak syndrome. Am. J. Respir. Cell Mol. Biol. 33:14-21.
Haddad, E.K., X. Wu, J.A.r. Hammer, and P.A. Henkart. 2001. Defective granule
exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J. Cell Biol.
152:835-842.
Haft, C.R., M. de la Luz Sierra, R. Bafford, M.A. Lesniak, V.A. Barr, and S.I. Taylor. 2000.
Human orthologs of yeast vacuolar protein sorting proteins Vps26, 29, and 35:
assembly into multimeric complexes. Mol Biol Cell. 11:4105-4116.
Hammer, J.A., 3rd., and W. Wagner. 2013. Functions of class V myosins in neurons. J.
Biol. Chem. 288:28428-28434.
Hammond, G.R., M.P. Machner, and T. Balla. 2014. A novel probe for phosphatidylinositol
4-phosphate reveals multiple pools beyond the Golgi. J. Cell Biol. 205:113-126.
Hanby, H. 2017. Platelet Dense Granules Mature Within Late Stages Of Megakaryocyte
Differentiation By Cargo Delivery. Vol. Doctor of Philosophy (PhD). University of
Pennsylvanina, Publicly Accessible Penn Dissertations.
Hanby, H.A., J. Bao, J.-Y. Noh, D. Jarocha, M. Poncz, M.J. Weiss, and M.S. Marks. 2017.
Platelet dense granules begin to selectively accumulate mepacrine during
proplatelet formation. Blood Adv. 1:1478-1490.
Hannah, M.J., R. Williams, J. Kaur, L.J. Hewlett, and D.F. Cutler. 2002. Biogenesis of
Weibel-Palade bodies. Semin Cell Dev Biol. 13:313-324.
Harrison-Lavoie, K.J., G. Michaux, L. Hewlett, J. Kaur, M.J. Hannah, W.W. Lui-Roberts,
K.E. Norman, and D.F. Cutler. 2006. P-selectin and CD63 use different
mechanisms for delivery to Weibel-Palade bodies. Traffic. 7:647-662.
Harrison, M.S., C.S. Hung, T.T. Liu, R. Christiano, T.C. Walther, and C.G. Burd. 2014. A
mechanism for retromer endosomal coat complex assembly with cargo. Proc Natl
Acad Sci U S A. 111:267-272.
Harterink, M., F. Port, M.J. Lorenowicz, I.J. McGough, M. Silhankova, M.C. Betist, J.R.T.
van Weering, R. van Heesbeen, T.C. Middelkoop, K. Basler, P.J. Cullen, and H.C.
154

Korswagen. 2011. A SNX3-dependent retromer pathway mediates retrograde
transport of the Wnt sorting receptor Wntless and is required for Wnt secretion.
Nat Cell Biol. 13:914-923.
Hayes, M.J., C.J. Merrifield, D. Shao, J. Ayala-Sanmartin, C.D. Schorey, T.P. Levine, J.
Proust, J. Curran, M. Bailly, and S.E. Moss. 2004. Annexin 2 binding to
phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the
stress response pathway. J Biol Chem. 279:14157-14164.
Hayes, M.J., D.M. Shao, A. Grieve, T. Levine, M. Bailly, and S.E. Moss. 2009. Annexin A2
at the interface between F-actin and membranes enriched in phosphatidylinositol
4,5,-bisphosphate. Biochim Biophys Acta. 1793:1086-1095.
Helfer, E., M.E. Harbour, V. Henriot, G. Lakisic, C. Sousa-Blin, L. Volceanov, M.N.J.
Seaman, and A. Gautreau. 2013. Endosomal recruitment of the WASH complex:
active sequences and mutations impairing interaction with the retromer. Biol Cell.
105:191-207.
Hengst, M., L. Naehrlich, P. Mahavadi, J. Grosse-Onnebrink, S. Terheggen-Lagro, L.H.
Skanke, L.A. Schuch, F. Brasch, A. Guenther, S. Reu, J. Ley-Zaporozhan, and M.
Griese. 2018. Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung
disease early in childhood. Orphanet. J. Rare Dis. 13:42.
Henmi, Y., Y. Morikawa, N. Oe, N. Ikeda, A. Fujita, K. Takei, S. Minogue, and K. Tanabe.
2016. PtdIns4KIIalpha generates endosomal PtdIns(4)P and is required for
receptor sorting at early endosomes. Mol Biol Cell. 27:990-1001.
Highland, C.M., and J.C. Fromme. 2021. Arf1 directly recruits the Pik1-Frq1 PI4K complex
to regulate the final stages of Golgi maturation. Mol. Biol. Cell. 32:1064-1080.
Hinostroza, F., A. Neely, I. Araya-Duran, V. Maraboli, J. Canan, M. Rojas, D. Aguayo, R.
Latorre, F.D. Gonzalez-Nilo, and A.M. Cardenas. 2020. Dynamin-2 R465W
mutation induces long range perturbation in highly ordered oligomeric structures.
Sci Rep. 10:18151.
Hirobe, T., S. Ito, K. Wakamatsu, Y. Kawa, and H. Abe. 2014. The mouse brown
(b/Tyrp1(b) ) allele does not affect pheomelanin synthesis in mice. Zoolog Sci.
31:53-63.
Ho, T., B. Watt, L.A. Spruce, S.H. Seeholzer, and M.S. Marks. 2016. The Kringle-like
domain facilitates post-endoplasmic reticulum changes to PMEL oligomerization
and disulfide bond configuration and promotes amyloid formation. J. Biol. Chem.
291:3595-3612.
Hoffmann, C., I. Finsel, A. Otto, G. Pfaffinger, E. Rothmeier, M. Hecker, D. Becher, and
H. Hilbi. 2014. Functional analysis of novel Rab GTPases identified in the
proteome of purified Legionella-containing vacuoles from macrophages. Cell
Microbiol. 16:1034-1052.
Holloway, Z.G., A. Velayos-Baeza, G.J. Howell, C. Levecque, S. Ponnambalam, E. Sztul,
and A.P. Monaco. 2013. Trafficking of the Menkes copper transporter ATP7A is
regulated by clathrin-, AP-2-, AP-1-, and Rab22-dependent steps. Mol Biol Cell.
24:1735-1748, S1731-1738.
Hong, Z., Y. Yang, C. Zhang, Y. Niu, K. Li, X. Zhao, and J.J. Liu. 2009. The retromer
component SNX6 interacts with dynactin p150(Glued) and mediates endosometo-TGN transport. Cell Res. 19:1334-1349.
Horazdovsky, B.F., B.A. Davies, M.N. Seaman, S.A. McLaughlin, S. Yoon, and S.D. Emr.
1997. A sorting nexin-1 homologue, Vps5p, forms a complex with Vps17p and is
required for recycling the vacuolar protein-sorting receptor. Mol Biol Cell. 8:15291541.
155

Hsu, F., F. Hu, and Y. Mao. 2015. Spatiotemporal control of phosphatidylinositol 4phosphate by Sac2 regulates endocytic recycling. J. Cell Biol. 209:97-110.
Hsu, V.W., S.Y. Lee, and J.S. Yang. 2009. The evolving understanding of COPI vesicle
formation. Nat Rev Mol Cell Biol. 10:360-364.
Hu, D.N., J.D. Simon, and T. Sarna. 2008. Role of ocular melanin in ophthalmic physiology
and pathology. Photochem Photobiol. 84:639-644.
Huang, L., Y.M. Kuo, and J. Gitschier. 1999. The pallid gene encodes a novel, syntaxin
13-interacting protein involved in platelet storage pool deficiency. Nature Genet.
23:329-332.
Huizing, M., Y. Anikster, D.L. Fitzpatrick, A.B. Jeong, M. D'Souza, M. Rausche, J.R. Toro,
M.I. Kaiser-Kupfer, J.G. White, and W.A. Gahl. 2001a. Hermansky-Pudlak
syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with
hypopigmentation and platelet storage-pool deficiency. Am. J. Hum. Genet.
69:1022-1032.
Huizing, M., A. Helip-Wooley, W. Westbroek, M. Gunay-Aygun, and W.A. Gahl. 2008.
Disorders of lysosome-related organelle biogenesis: clinical and molecular
genetics. Annu. Rev. Genomics Hum. Genet. 9:359-386.
Huizing, M., R. Hess, H. Dorward, D.A. Claassen, A. Helip-Wooley, R. Kleta, M.I. KaiserKupfer, J.G. White, and W.A. Gahl. 2004. Cellular, molecular and clinical
characterization of patients with Hermansky-Pudlak syndrome type 5. Traffic.
5:711-722.
Huizing, M., M.C.V. Malicdan, J.A. Wang, H. Pri-Chen, R.A. Hess, R. Fischer, K.J. O'Brien,
M.A. Merideth, W.A. Gahl, and B.R. Gochuico. 2020. Hermansky-Pudlak
syndrome: Mutation update. Hum Mutat. 41:543-580.
Huizing, M., B. Pederson, R.A. Hess, A. Griffin, A. Helip-Wooley, W. Westbroek, H.
Dorward, K.J. O'Brien, G. Golas, E. Tsilou, J.G. White, and W.A. Gahl. 2009.
Clinical and cellular characterisation of Hermansky-Pudlak syndrome type 6. J.
Med. Genet. 46:803-810.
Huizing, M., R. Sarangarajan, E. Strovel, Y. Zho, W.A. Gahl, and R.E. Boissy. 2001b. AP3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes. Mol. Biol.
Cell. 12:2075-2085.
Huizing, M., C.D. Scher, E. Strovel, D.L. Fitzpatrick, L.M. Hartnell, Y. Anikster, and W.A.
Gahl. 2002. Nonsense mutations in ADTB3A cause complete deficiency of the
beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome
type 2. Pediatric Res. 51:150-158.
Hume, A.N., L.M. Collinson, C.R. Hopkins, M. Strom, D.C. Barral, G. Bossi, G.M. Griffiths,
and M.C. Seabra. 2002. The leaden gene product is required with rab27a to recruit
myosin Va to melanosomes in melanocytes. Traffic. 3:193-202.
Hume, A.N., L.M. Collinson, A. Rapak, A.Q. Gomes, C.R. Hopkins, and M.C. Seabra. 2001.
Rab27a regulates the peripheral distribution of melanosomes in melanocytes. J.
Cell Biol. 152:795-808.
Hume, A.N., A.K. Tarafder, J.S. Ramalho, E.V. Sviderskaya, and M.C. Seabra. 2006. A
coiled-coil Domain of melanophilin Is essential for myosin Va recruitment and
melanosome transport in melanocytes. Mol. Biol. Cell. 17:4720-4735.
Huotari, J., and A. Helenius. 2011. Endosome maturation. EMBO J. 30:3481-3500.
Hurbain, I., W.J.C. Geerts, T. Boudier, S. Marco, A. Verkleij, M.S. Marks, and G. Raposo.
2008. Electron tomography of early melanosomes: implications for melanogenesis
and the generation of fibrillar amyloid sheets. Proc. Natl. Acad. Sci. U.S.A.
105:19726-19731.
156

Inobe, T., and N. Nukina. 2016. Rapamycin-induced oligomer formation system of FRBFKBP fusion proteins. J Biosci Bioeng. 122:40-46.
Ito, S., and K. Wakamatsu. 2003. Quantitative analysis of eumelanin and pheomelanin in
humans, mice, and other animals: a comparative review. Pigment Cell Res.
16:523-531.
Jani, R.A., A. Di Cicco, T. Keren-Kaplan, S. Vale-Costa, D. Hamaoui, I. Hurbain, F.-C.
Tsai, M. Dimarco, A.-S. Macé, Y. Zhu, M.J. Amorim, P. Bassereau, J.S. Bonifacino,
A. Subtil, M.S. Marks, D. Levy, G. Raposo, and C. Delevoye. 2021.
Phosphatidylinositol-4-phosphate initiates endosomal membrane remodeling
through BLOC-1-dependent tubule formation. J. Cell Biol. Submitted.
Jani, R.A., L.K. Purushothaman, S. Rani, P. Bergam, and S.R.G. Setty. 2015. STX13
regulates cargo delivery from recycling endosomes during melanosome
biogenesis. J. Cell Sci. 128:3263-3276.
Janvier, K., and J.S. Bonifacino. 2005. Role of the endocytic machinery in the sorting of
lysosome-associated membrane proteins. Mol. Biol. Cell. 16:4231-4242.
Janvier, K., Y. Kato, M. Boehm, J.R. Rose, J.A. Martina, B.-Y. Kim, S. Venkatesan, and
J.S. Bonifacino. 2003. Recognition of dileucine-based sorting signals from HIV-1
Nef and LIMP-II by the AP-1 g-s1 and AP-3 d-s3 hemicomplexes. J. Cell Biol.
163:1281-1290.
Jarsch, I.K., F. Daste, and J.L. Gallop. 2016. Membrane curvature in cell biology: An
integration of molecular mechanisms. J Cell Biol. 214:375-387.
Jeffery, G. 1998. The retinal pigment epithelium as a developmental regulator of the neural
retina. Eye (Lond). 12 ( Pt 3b):499-503.
Jeschke, A., and A. Haas. 2018. Sequential actions of phosphatidylinositol phosphates
regulate phagosome-lysosome fusion. Mol Biol Cell. 29:452-465.
Jeschke, A., N. Zehethofer, B. Lindner, J. Krupp, D. Schwudke, I. Haneburger, M. Jovic,
J.M. Backer, T. Balla, H. Hilbi, and A. Haas. 2015. Phosphatidylinositol 4phosphate and phosphatidylinositol 3-phosphate regulate phagolysosome
biogenesis. Proc Natl Acad Sci U S A. 112:4636-4641.
Jia, D., T.S. Gomez, D.D. Billadeau, and M.K. Rosen. 2012. Multiple repeat elements
within the FAM21 tail link the WASH actin regulatory complex to the retromer. Mol
Biol Cell. 23:2352-2361.
Jimbow, K., O. Ishida, S. Ito, Y. Hori, J. Witkop C. J., and R.A. King. 1983. Combined
chemical and electron microscopic studies of pheomelanosomes in human red hair.
J. Invest. Dermatol. 81:506-511.
Jin, N., C.Y. Chow, L. Liu, S.N. Zolov, R. Bronson, M. Davisson, J.L. Petersen, Y. Zhang,
S. Park, J.E. Duex, D. Goldowitz, M.H. Meisler, and L.S. Weisman. 2008. VAC14
nucleates a protein complex essential for the acute interconversion of PI3P and
PI(3,5)P(2) in yeast and mouse. EMBO J. 27:3221-3234.
Joshi, S., and S.W. Whiteheart. 2017. The nuts and bolts of the platelet release reaction.
Platelets. 28:129-137.
Jovic, M., M.J. Kean, A. Dubankova, E. Boura, A.C. Gingras, J.A. Brill, and T. Balla. 2014.
Endosomal sorting of VAMP3 is regulated by PI4K2A. J. Cell Sci. 127:3745-3756.
Jovic, M., F. Kieken, N. Naslavsky, P.L. Sorgen, and S. Caplan. 2009. Eps15 homology
domain 1-associated tubules contain phosphatidylinositol-4-phosphate and
phosphatidylinositol-(4,5)-bisphosphate and are required for efficient recycling.
Mol. Biol. Cell. 20:2731-2743.
Jung, J., G. Bohn, A. Allroth, K. Boztug, G. Brandes, I. Sandrock, A.A. Schaffer, C.
Rathinam, I. Kollner, C. Beger, R. Schilke, K. Welte, B. Grimbacher, and C. Klein.
157

2006. Identification of a homozygous deletion in the AP3B1 gene causing
Hermansky-Pudlak syndrome, type 2. Blood. 108:362-369.
Kantheti, P., X. Qiao, M.E. Diaz, A.A. Peden, G.E. Meyer, S.L. Carskadon, D. Kapfhamer,
D. Sufalko, M.S. Robinson, J.L. Noebels, and M. Burmeister. 1998. Mutation in
AP-3d in the mocha mouse links endosomal transport to storage deficiency in
platelets, melanosomes, and synaptic vesicles. Neuron. 21:111-122.
Kaplan, J., I. De Domenico, and D.M. Ward. 2008. Chediak-Higashi syndrome. Curr. Opin.
Hematol. 15:22-29.
Karampini, E., M. Schillemans, M. Hofman, F. van Alphen, M. de Boer, T.W. Kuijpers, M.
van den Biggelaar, J. Voorberg, and R. Bierings. 2019. Defective AP-3-dependent
VAMP8 trafficking impairs Weibel-Palade body exocytosis in Hermansky-Pudlak
Syndrome type 2 blood outgrowth endothelial cells. Haematologica. In press.
Karimi, M., J. Steinkuhler, D. Roy, R. Dasgupta, R. Lipowsky, and R. Dimova. 2018.
Asymmetric Ionic Conditions Generate Large Membrane Curvatures. Nano Lett.
18:7816-7821.
Kelly , B.T., A.J. McCoy, K. Späte, S.E. Miller, P.R. Evans, S. Höning, and D.J. Owen.
2008. A structural explanation for the binding of endocytic dileucine motifs by the
AP2 complex. Nature. 456:976-979.
Kendall, A.K., B. Xie, P. Xu, J. Wang, R. Burcham, M.N. Frazier, E. Binshtein, H. Wei, T.R.
Graham, T. Nakagawa, and L.P. Jackson. 2020. Mammalian Retromer Is an
Adaptable Scaffold for Cargo Sorting from Endosomes. Structure. 28:393-405
e394.
Ketel, K., M. Krauss, A.S. Nicot, D. Puchkov, M. Wieffer, R. Muller, D. Subramanian, C.
Schultz, J. Laporte, and V. Haucke. 2016. A phosphoinositide conversion
mechanism for exit from endosomes. Nature. 529:408-412.
Kinosita, K., Jr., H. Itoh, S. Ishiwata, K. Hirano, T. Nishizaka, and T. Hayakawa. 1991.
Dual-view microscopy with a single camera: real-time imaging of molecular
orientations and calcium. J. Cell Biol. 115:67-73.
Kitamata, M., T. Inaba, and S. Suetsugu. 2020. The roles of the diversity of amphipathic
lipids in shaping membranes by membrane-shaping proteins. Biochem. Soc. Trans.
48:837-851.
Kjeldsen, L., J. Calafat, and N. Borregaard. 1998. Giant granules of neutrophils in
Chediak-Higashi syndrome are derived from azurophil granules but not from
specific and gelatinase granules. J Leukoc Biol. 64:72-77.
Klein, O., A. Roded, N. Zur, N.P. Azouz, O. Pasternak, K. Hirschberg, I. Hammel, P.A.
Roche, A. Yatsu, M. Fukuda, S.J. Galli, and R. Sagi-Eisenberg. 2017. Rab5 is
critical for SNAP23 regulated granule-granule fusion during compound exocytosis.
Sci Rep. 7:15315.
Klopfenstein, D.R., M. Tomishige, N. Stuurman, and R.D. Vale. 2002. Role of
phosphatidylinositol(4,5)bisphosphate organization in membrane transport by the
Unc104 kinesin motor. Cell. 109:347-358.
Klumperman, J., and G. Raposo. 2014. The complex ultrastructure of the endolysosomal
system. Cold Spring Harb. Perspect. Biol. 6:a016857.
Knodler, A., S. Feng, J. Zhang, X. Zhang, A. Das, J. Peranen, and W. Guo. 2010.
Coordination of Rab8 and Rab11 in primary ciliogenesis. Proc Natl Acad Sci U S
A. 107:6346-6351.
Kobayashi, T., G. Imokawa, D.C. Bennett, and V.J. Hearing. 1998. Tyrosinase stabilization
by Tyrp1 (the brown locus protein). J. Biol. Chem. 273:31801-31805.
158

Kovtun, O., N. Leneva, Y.S. Bykov, N. Ariotti, R.D. Teasdale, M. Schaffer, B.D. Engel, D.J.
Owen, J.A.G. Briggs, and B.M. Collins. 2018. Structure of the membraneassembled retromer coat determined by cryo-electron tomography. Nature.
561:561-564.
Krause, M., and A. Gautreau. 2014. Steering cell migration: lamellipodium dynamics and
the regulation of directional persistence. Nat Rev Mol Cell Biol. 15:577-590.
Kvainickas, A., A. Jimenez-Orgaz, H. Nagele, Z. Hu, J. Dengjel, and F. Steinberg. 2017.
Cargo-selective SNX-BAR proteins mediate retromer trimer independent
retrograde transport. J Cell Biol. 216:3677-3693.
Larimore, J., K. Tornieri, P.V. Ryder, A. Gokhale, S.A. Zlatic, B. Craige, J.D. Lee, K. Talbot,
J.-F. Pare, Y. Smith, and V. Faundez. 2011. The schizophrenia susceptibility factor
dysbindin and its associated complex sort cargoes from cell bodies to the synapse.
Mol. Biol. Cell. 22:4854-4867.
Le, L., J. Sires-Campos, G. Raposo, C. Delevoye, and M.S. Marks. 2021. Melanosome
Biogenesis in the Pigmentation of Mammalian Skin. Integr Comp Biol. 61:15171545.
Lee, H.H., D. Nemecek, C. Schindler, W.J. Smith, R. Ghirlando, A.C. Steven, J.S.
Bonifacino, and J.H. Hurley. 2012. Assembly and architecture of Biogenesis of
Lysosome-related Organelles Complex-1 (BLOC-1). J. Biol. Chem. 287:58825890.
Lee, M.C., L. Orci, S. Hamamoto, E. Futai, M. Ravazzola, and R. Schekman. 2005. Sar1p
N-terminal helix initiates membrane curvature and completes the fission of a COPII
vesicle. Cell. 122:605-617.
Lenoir, M., U. Coskun, M. Grzybek, X. Cao, S.B. Buschhorn, J. James, K. Simons, and M.
Overduin. 2010. Structural basis of wedging the Golgi membrane by FAPP
pleckstrin homology domains. EMBO Rep. 11:279-284.
Levin-Konigsberg, R., F. Montaño-Rendón, T. Keren-Kaplan, R. Li, B. Ego, S.
Mylvaganam, J.E. DiCiccio, W.S. Trimble, M.C. Bassik, J.S. Bonifacino, G.D. Fairn,
and S. Grinstein. 2019. Phagolysosome resolution requires contacts with the
endoplasmic reticulum and phosphatidylinositol-4-phosphate signalling. Nature
Cell Biology. 21:1234-1247.
Li, J., B. Barylko, J. Johnson, J.D. Mueller, J.P. Albanesi, and Y. Chen. 2012. Molecular
brightness analysis reveals phosphatidylinositol 4-Kinase IIbeta association with
clathrin-coated vesicles in living cells. Biophys J. 103:1657-1665.
Li, W., C.J. Hao, Z.H. Hao, J. Ma, Q.C. Wang, Y.F. Yuan, J.J. Gong, Y.Y. Chen, J.Y. Yu,
and A.H. Wei. 2022. New insights into the pathogenesis of Hermansky-Pudlak
syndrome. Pigment Cell Melanoma Res.
Li, W., Q. Zhang, N. Oiso, E.K. Novak, R. Gautam, E.P. O'Brien, C.L. Tinsley, D.J. Blake,
R.A. Spritz, N.G. Copeland, N.A. Jenkins, D. Amato, B.A. Roe, M. Starcevic, E.C.
Dell'Angelica, R.W. Elliott, V. Mishra, S.F. Kingsmore, R.E. Paylor, and R.T. Swank.
2003. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin,
a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1).
Nature Genet. 35:84-89.
Liu, A.P., D.L. Richmond, L. Maibaum, S. Pronk, P.L. Geissler, and D.A. Fletcher. 2008.
Membrane-induced bundling of actin filaments. Nat Phys. 4:789-793.
Liu, T.T., T.S. Gomez, B.K. Sackey, D.D. Billadeau, and C.G. Burd. 2012. Rab GTPase
regulation of retromer-mediated cargo export during endosome maturation. Mol
Biol Cell. 23:2505-2515.
159

Lopes da Silva, M., M.N. O'Connor, J. Kriston-Vizi, I.J. White, R. Al-Shawi, J.P. Simons,
J. Mossinger, V. Haucke, and D.F. Cutler. 2016. Type II PI4-kinases control
Weibel-Palade body biogenesis and von Willebrand factor structure in human
endothelial cells. J Cell Sci. 129:2096-2105.
Lopes, V.S., C. Wasmeier, M.C. Seabra, and C.E. Futter. 2007. Melanosome maturation
defect in Rab38-deficient retinal pigment epithelium results in instability of
immature melanosomes during transient melanogenesis. Mol. Biol. Cell. 18:39143927.
López-Haber, C., R. Levin-Konigsberg, Y. Zhu, J. Bi-Karchin, T. Ball, S. Grinstein, M.S.
Marks, and A.R. Mantegazza. 2020a. Phosphatidylinositol-4-kinase IIα licenses
phagosomes for TLR4 signaling and MHC-II presentation in dendritic cells. Proc.
Natl. Acad. Sci. U.S.A. 117:28251-28262.
López-Haber, C., R. Levin-Konigsberg, Y. Zhu, J. Bi-Karchin, T. Balla, S. Grinstein, M.S.
Marks, and A.R. Mantegazza. 2020b. Phosphatidylinositol-4-kinase IIα licenses
phagosomes for TLR4 signaling and MHC-II presentation in dendritic cells.
Proceedings of the National Academy of Sciences. 117:28251.
Lord, S.J., K.B. Velle, R.D. Mullins, and L.K. Fritz-Laylin. 2020. SuperPlots:
Communicating reproducibility and variability in cell biology. J. Cell Biol.
219:e202001064.
Lowe, G.C., I.S. Guiu, O. Chapman, J. Rivera, M. Lordkipanidzé, N. Dovlatova, J. Wilde,
S.P. Watson, N.V. Morgan, and o.b.o.t.U.G. collaborative. 2013. Microsatellite
markers as a rapid approach for autozygosity mapping in Hermansky-Pudlak
syndrome: Identification of the second HPS7 mutation in a patient presenting late in life.
Thromb. Haemost. 109:766-768.
Lu, J., J. Ma, Z. Hao, and W. Li. 2021. HPS6 Regulates the Biogenesis of Weibel-Palade
Body in Endothelial Cells Through Trafficking v-ATPase to Its Limiting Membrane.
Front Cell Dev Biol. 9:743124.
Lui-Roberts, W.W.Y., L.M. Collinson, L.J. Hewlett, G. Michaux, and D.F. Cutler. 2005. An
AP-1/clathrin coat plays a novel and essential role in forming the Weibel-Palade
bodies of endothelial cells. J. Cell Biol. 170:627-636.
Lundmark, R., G.J. Doherty, Y. Vallis, B.J. Peter, and H.T. McMahon. 2008. Arf family
GTP loading is activated by, and generates, positive membrane curvature.
Biochem J. 414:189-194.
Ma, C.J., Y. Yang, T. Kim, C.H. Chen, G. Polevoy, M. Vissa, J. Burgess, and J.A. Brill.
2020. An early endosome-derived retrograde trafficking pathway promotes
secretory granule maturation. J Cell Biol. 219.
Ma, J., Z. Zhang, L. Yang, J. Kriston-Vizi, D.F. Cutler, and W. Li. 2016. BLOC-2 subunit
HPS6 deficiency affects the tubulation and secretion of von Willebrand factor from
mouse endothelial cells. J. Genet. Genomics. 43:686-693.
Mani, M., U.H. Lee, N.A. Yoon, E.H. Yoon, B.J. Lee, W.J. Cho, and J.W. Park. 2017.
Developmentally regulated GTP-binding protein 2 is required for stabilization of
Rac1-positive membrane tubules. Biochem. Biophys. Res. Commun. 493:758-764.
Mantegazza, A.R., S.H. Guttentag, J. El-Benna, M. Sasai, A. Iwasaki, H. Shen, T.M.
Laufer, and M.S. Marks. 2012. Adaptor Protein-3 in dendritic cells facilitates
phagosomal Toll-like receptor signaling and antigen presentation to CD4+ T cells.
Immunity. 36:782-794.
Mantegazza, A.R., A.L. Zajac, A. Twelvetrees, E.L.F. Holzbaur, S. Amigorena, and M.S.
Marks. 2014. TLR-dependent phagosome tubulation in dendritic cells promotes
160

phagosome cross-talk to optimize MHC-II antigen presentation. Proc. Natl. Acad.
Sci. U.S.A. 111:15508-15513.
Marcon, C.R., and M. Maia. 2019. Albinism: epidemiology, genetics, cutaneous
characterization, psychosocial factors. An Bras Dermatol. 94:503-520.
Mardones, G.A., P.V. Burgos, Y. Lin, D.P. Kloer, J.G. Magadan, J.H. Hurley, and J.S.
Bonifacino. 2013. Structural basis for the recognition of Tyrosine-based sorting
signals by the Mu3A subunit of the AP-3 adaptor complex. J. Biol. Chem.
288:9563-9571.
Marks, M.S., H.F.G. Heijnen, and G. Raposo. 2013. Lysosome-related organelles:
unusual compartments become mainstream. Curr. Opin. Cell Biol. 25:495-505.
Martina, J.A., K. Moriyama, and J.S. Bonifacino. 2003. BLOC-3, a protein complex
containing the Hermansky-Pudlak syndrome gene products HPS1 and HPS4. J.
Biol. Chem. 278:29376-29384.
Mártinez-García, M., and L. Montoliu. 2013. Albinism in Europe. J. Dermatol. 40:319-324.
Mattila, P.K., and P. Lappalainen. 2008. Filopodia: molecular architecture and cellular
functions. Nat Rev Mol Cell Biol. 9:446-454.
McGough, I.J., F. Steinberg, D. Jia, P.A. Barbuti, K.J. McMillan, K.J. Heesom, A.L. Whone,
M.A. Caldwell, D.D. Billadeau, M.K. Rosen, and P.J. Cullen. 2014. Retromer
binding to FAM21 and the WASH complex is perturbed by the Parkinson diseaselinked VPS35(D620N) mutation. Curr Biol. 24:1670-1676.
McGrath, M.J., M.J. Eramo, R. Gurung, A. Sriratana, S.M. Gehrig, G.S. Lynch, S.R.
Lourdes, F. Koentgen, S.J. Feeney, M. Lazarou, C.A. McLean, and C.A. Mitchell.
2021. Defective lysosome reformation during autophagy causes skeletal muscle
disease. J. Clin. Invest. 131:e135124.
Ménasché, G., C.H. Ho, O. Sanal, J. Feldmann, I. Tezcan, F. Ersoy, A. Houdusse, A.
Fischer, and G. de Saint Basile. 2003. Griscelli syndrome restricted to
hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon
deletion (GS1). J. Clin. Invest. 112:450-456.
Ménasché, G., E. Pastural, J. Feldmann, S. Certain, F. Ersoy, S. Dupuis, N. Wulffraat, D.
Bianchi, A. Fischer, F. Le Deist, and G. de Saint Basile. 2000. Mutations in
RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.
Nature Genet. 25:173 - 176.
Meng, R., R. Bridgman, M. Toivio-Kinnucan, G.P. Niemeyer, W. Vernau, T. Hock, and C.D.
Lothrop, Jr. 2010. Neutrophil elastase processing defect in cyclic hematopoietic
dogs. Exp. Hematol. 38:104-115.
Meng, R., Y. Wang, Y. Yao, Z. Zhang, D.C. Harper, H.F.G. Heijnen, A. Sitaram, W. Li, G.
Raposo, M.J. Weiss, M. Poncz, and M.S. Marks. 2012. SLC35D3 delivery from
megakaryocyte early endosomes is required for platelet dense granule biogenesis
and differentially defective in Hermansky-Pudlak syndrome models. Blood.
120:404-414.
Meng, R., J. Wu, D.C. Harper, Y. Wang, M.A. Kowalska, C.S. Abrams, L.F. Brass, M.
Poncz, T.J. Stalker, and M.S. Marks. 2015. Defective release of a granule and
lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models.
Blood. 125:1623-1632.
Minogue, S. 2018. The many roles of type II phosphatidylinositol 4-kinases in membrane
trafficking: new tricks for old dogs. Bioessays. 40:1700145.
Minogue, S., M.G. Waugh, M.A. De Matteis, D.J. Stephens, F. Berditchevski, and J.J.
Hsuan. 2006. Phosphatidylinositol 4-kinase is required for endosomal trafficking
and degradation of the EGF receptor. J Cell Sci. 119:571-581.
161

Miserey-Lenkei, S., H. Bousquet, O. Pylypenko, S. Bardin, A. Dimitrov, G. Bressanelli, R.
Bonifay, V. Fraisier, C. Guillou, C. Bougeret, A. Houdusse, A. Echard, and B. Goud.
2017. Coupling fission and exit of RAB6 vesicles at Golgi hotspots through kinesinmyosin interactions. Nat Commun. 8:1254.
Mizuno-Yamasaki, E., M. Medkova, J. Coleman, and P. Novick. 2010. Phosphatidylinositol
4-phosphate controls both membrane recruitment and a regulatory switch of the
Rab GEF Sec2p. Dev Cell. 18:828-840.
Mizuno, K., T. Tolmachova, D.S. Ushakov, M. Romao, M. Abrink, M.A. Ferenczi, G.
Raposo, and M.C. Seabra. 2007. Rab27b regulates mast cell granule dynamics
and secretion. Traffic. 8:883-892.
Mohammed, M., N. Al-Hashmi, S. Al-Rashdi, N. Al-Sukaiti, K. Al-Adawi, M. Al-Riyami, and
A. Al-Maawali. 2019. Biallelic mutations in AP3D1 cause Hermansky-Pudlak
syndrome type 10 associated with immunodeficiency and seizure disorder. Eur. J.
Med. Genet. 62:103583.
Montoliu, L., K. Grønskov, A.H. Wei, M. Martínez-García, A. Fernández, B. Arveiler, F.
Morice-Picard, S. Riazuddin, T. Suzuki, Z.M. Ahmed, T. Rosenberg, and W. Li.
2014. Increasing the complexity: new genes and new types of albinism. Pigment
Cell Melanoma Res. 27:11-18.
Morgan, N.V., S. Pasha, C.A. Johnson, J.R. Ainsworth, R.A.J. Eady, B. Dawood, C.
McKeown, R.C. Trembath, J. Wilde, S.P. Watson, and E.R. Maher. 2006. A
germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of
Hermansky-Pudlak Syndrome (HPS8). Am. J. Hum. Genet. 78:160-166.
Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for
transient packaging of retroviruses. Gene Ther. 7:1063-1066.
Moriyama, K., and J.S. Bonifacino. 2002. Pallidin is a component of a multi-protein
complex involved in the biogenesis of lysosome-related organelles. Traffic. 3:666677.
Morlot, S., V. Galli, M. Klein, N. Chiaruttini, J. Manzi, F. Humbert, L. Dinis, M. Lenz, G.
Cappello, and A. Roux. 2012. Membrane shape at the edge of the dynamin helix
sets location and duration of the fission reaction. Cell. 151:619-629.
Moyer, F.H. 1966. Genetic variations in the fine structure and ontogeny of mouse melanin
granules. Am. Zoologist. 6:43-66.
Nakagawa, T., M. Setou, D. Seog, K. Ogasawara, N. Dohmae, K. Takio, and N. Hirokawa.
2000. A novel motor, KIF13A, transports mannose-6-phosphate receptor to
plasma membrane through direct interaction with AP-1 complex. Cell. 103:537540.
Nakatsu, F., M. Messa, R. Nández, H. Czapla, Y. Zou, S.M. Strittmatter, and P. De Camilli.
2015. Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic
pathway. J. Cell Biol. 209:85-95.
Nakatsu, F., M. Okada, F. Mori, N. Kumazawa, H. Iwasa, G. Zhu, Y. Kasagi, H. Kamiya,
A. Harada, K. Nishimura, A. Takeuchi, T. Miyazaki, M. Watanabe, S. Yuasa, T.
Manabe, K. Wakabayashi, S. Kaneko, T. Saito, and H. Ohno. 2004. Defective
function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin
adaptor. J. Cell Biol. 167:293-302.
Nass, J., J. Terglane, and V. Gerke. 2021. Weibel Palade Bodies: Unique Secretory
Organelles of Endothelial Cells that Control Blood Vessel Homeostasis. Front Cell
Dev Biol. 9:813995.
Nazarian, R., J.M. Falcón-Pérez, and E.C. Dell'Angelica. 2003. Biogenesis of lysosomerelated organelles complex 3 (BLOC-3): A complex containing the Hermansky162

Pudlak syndrome (HPS) proteins HPS1 and HPS4. Proc. Natl. Acad. Sci. U.S.A.
100:8770-8775.
Newell-Litwa, K., G. Salazar, Y. Smith, and V. Faundez. 2009. Roles of BLOC-1 and
adaptor protein-3 complexes in cargo sorting to synaptic vesicles. Mol. Biol. Cell.
20:1441-1453.
Newell-Litwa, K., E. Seong, M. Burmeister, and V. Faundez. 2007. Neuronal and nonneuronal functions of the AP-3 sorting machinery. J Cell Sci. 120:531-541.
Nguyen, J.A., and R.M. Yates. 2021. Better Together: Current Insights Into PhagosomeLysosome Fusion. Front Immunol. 12:636078.
Nguyen, T., E.K. Novak, M. Kermani, J. Fluhr, L.L. Peters, R.T. Swank, and M.L. Wei.
2002. Melanosome morphologies in murine models of Hermansky-Pudlak
syndrome reflect blocks in organelle development. J. Invest. Dermatol. 119:11561164.
Nguyen, T., and M.L. Wei. 2007. Hermansky-Pudlak HPS1/pale ear gene regulates
epidermal and dermal melanocyte development. J. Invest. Dermatol. 127:421-428.
Nisar, S., E. Kelly, P.J. Cullen, and S.J. Mundell. 2010. Regulation of P2Y1 receptor traffic
by sorting Nexin 1 is retromer independent. Traffic. 11:508-519.
Niu, Y., C. Zhang, Z. Sun, Z. Hong, K. Li, D. Sun, Y. Yang, C. Tian, W. Gong, and J.J. Liu.
2013. PtdIns(4)P regulates retromer-motor interaction to facilitate dynein-cargo
dissociation at the trans-Golgi network. Nat Cell Biol. 15:417-429.
Nossal, R. 2001. Energetics of clathrin basket assembly. Traffic. 2:138-147.
Nothwehr, S.F., S.A. Ha, and P. Bruinsma. 2000. Sorting of yeast membrane proteins into
an endosome-to-Golgi pathway involves direct interaction of their cytosolic
domains with Vps35p. J Cell Biol. 151:297-310.
Novak, E.K., S.W. Hui, and R.T. Swank. 1984. Platelet storage pool deficiency in mouse
pigment mutations associated with seven distinct genetic loci. Blood. 63:536-544.
Novikoff, A.B., A. Albala, and L. Biempica. 1968. Ultrastructural and cytochemical
observations on B-16 and Harding-Passey mouse melanomas. The origin of
premelanosomes and compound melanosomes. J. Histochem. Cytochem. 16:299319.
Ohno, H., R.C. Aguilar, D. Yeh, D. Taura, T. Saito, and J.S. Bonifacino. 1998. The medium
subunits of adaptor complexes recognize distinct but overlapping sets of tyrosinebased sorting signals. J. Biol. Chem. 273:25915-25921.
Oiso, N., S.R. Riddle, T. Serikawa, T. Kuramoto, and R.A. Spritz. 2004. The rat Ruby ( R)
locus is Rab38: identical mutations in Fawn-hooded and Tester-Moriyama rats
derived from an ancestral Long Evans rat sub-strain. Mamm. Genome. 15:307314.
Orlow, S.J. 1995. Melanosomes are specialized members of the lysosomal lineage of
organelles. J. Invest. Dermatol. 105:3-7.
Ortiz, D., M. Medkova, C. Walch-Solimena, and P. Novick. 2002. Ypt32 recruits the Sec4p
guanine nucleotide exchange factor, Sec2p, to secretory vesicles; evidence for a
Rab cascade in yeast. J Cell Biol. 157:1005-1015.
Osanai, K., J. Higuchi, R. Oikawa, M. Kobayashi, K. Tsuchihara, M. Iguchi, J. Huang, D.R.
Voelker, and H. Toga. 2010. Altered lung surfactant system in a Rab38-deficient
rat model of Hermansky-Pudlak syndrome. Am. J. Lung Cell Mol. Physiol.
298:L243-L251.
Osanai, K., R. Oikawa, J. Higuchi, M. Kobayashi, K. Tsuchihara, M. Iguchi, H. Jongsu, H.
Toga, and D.R. Voelker. 2008. A mutation in Rab38 small GTPase causes
163

abnormal lung surfactant homeostasis and aberrant alveolar structure in mice. Am.
J. Pathol. 173:1265-1274.
Park, S.Y., and X. Guo. 2014. Adaptor protein complexes and intracellular transport.
Biosci Rep. 34.
Pastural, E., F.J. Barrat, R. Dufourcq-Lagelouse, S. Certain, O. Sanal, N. Jabado, R.
Seger, C. Griscelli, A. Fischer, and G. de Saint Basile. 1997. Griscelli disease
maps to chromosome 15q21 and is associated with mutations in the Myosin-Va
gene. Nature Genet. 16:289-292.
Patwardhan, A., S. Bardin, S. Miserey-Lenkei, L. Larue, B. Goud, G. Raposo, and C.
Delevoye. 2017. Routing of the RAB6 secretory pathway towards the lysosome
related organelle of melanocytes. Nat. Commun. 8:15835.
Penmatsa, A., K.H. Wang, and E. Gouaux. 2013. X-ray structure of dopamine transporter
elucidates antidepressant mechanism. Nature. 503:85-90.
Pennamen, P., L. Le, A. Tingaud-Sequeira, M. Fiore, A. Bauters, N. Van Duong Beatrice,
V. Coste, J.C. Bordet, C. Plaisant, M. Diallo, V. Michaud, A. Trimouille, D. Lacombe,
E. Lasseaux, C. Delevoye, F.M. Picard, B. Delobel, M.S. Marks, and B. Arveiler.
2020a. BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak
syndrome. Genet. Med. 22:1613-1622.
Pennamen, P., A. Tingaud-Sequeira, I. Gazova, M. Keighren, L. McKie, S. Marlin, S.G.
Halem, J. Kaplan, C. Delevoye, D. Lacombe, C. Plaisant, V. Michaud, E. Lasseaux,
S. Javerzat, I. Jackson, and B. Arveiler. 2020b. Dopachrome tautomerase variants
in patients with oculocutenous albinism. Genet. Med. In press.
Peter, B.J., H.M. Kent, I.G. Mills, Y. Vallis, P.J. Butler, P.R. Evans, and H.T. McMahon.
2004. BAR domains as sensors of membrane curvature: the amphiphysin BAR
structure. Science. 303:495-499.
Pfitzner, A.K., J. Moser von Filseck, and A. Roux. 2021. Principles of membrane
remodeling by dynamic ESCRT-III polymers. Trends Cell Biol. 31:856-868.
Polishchuk, E.V., A. Di Pentima, A. Luini, and R.S. Polishchuk. 2003. Mechanism of
constitutive export from the golgi: bulk flow via the formation, protrusion, and en
bloc cleavage of large trans-golgi network tubular domains. Mol Biol Cell. 14:44704485.
Polishchuk, R.S., M. Capestrano, and E.V. Polishchuk. 2009. Shaping tubular carriers for
intracellular membrane transport. FEBS Lett. 583:3847-3856.
Prevost, C., F.C. Tsai, P. Bassereau, and M. Simunovic. 2017. Pulling Membrane
Nanotubes from Giant Unilamellar Vesicles. J Vis Exp.
Prosser, D.C., D. Tran, A. Schooley, B. Wendland, and J.K. Ngsee. 2010. A novel,
retromer-independent role for sorting nexins 1 and 2 in RhoG-dependent
membrane remodeling. Traffic. 11:1347-1362.
Provance, D.W.J., T.L. James, and J.A. Mercer. 2002. Melanophilin, the product of the
leaden locus, is required for targeting of myosin-Va to melanosomes. Traffic.
3:124-.
Pryor, P.R., B.M. Mullock, N.A. Bright, M.R. Lindsay, S.R. Gray, S.C. Richardson, A.
Stewart, D.E. James, R.C. Piper, and J.P. Luzio. 2004. Combinatorial SNARE
complexes with VAMP7 or VAMP8 define different late endocytic fusion events.
EMBO Reports. 5:590-595.
Pu, J., C. Schindler, R. Jia, M. Jarnik, P. Backlund, and J.S. Bonifacino. 2015. BORC, a
multisubunit complex that regulates lysosome positioning. Dev. Cell. 33:176-188.
Purushothaman, K.K., H. Arlt, A. Kuhlee, S. Raunser, and C. Ungermann. 2017.
Retromer-driven membrane tubulation separates endosomal recycling from
164

Rab7/Ypt7-dependent fusion. Mol. Biol. Cell. In press:10.1091/mbcE1016-10080582.
Puthenveedu, M.A., B. Lauffer, P. Temkin, R. Vistein, P. Carlton, K. Thorn, J. Taunton,
O.D. Weiner, R.G. Parton, and M. von Zastrow. 2010. Sequence-dependent
sorting of recycling proteins by actin-stabilized endosomal microdomains. Cell.
143:761-773.
Rahajeng, J., R.S. Kuna, S.L. Makowski, T.T.T. Tran, M.D. Buschman, S. Li, N. Cheng,
M.M. Ng, and S.J. Field. 2019. Efficient Golgi Forward Trafficking Requires
GOLPH3-Driven, PI4P-Dependent Membrane Curvature. Dev Cell. 50:573-585
e575.
Raposo, G., and M.S. Marks. 2007. Melanosomes - dark organelles enlighten endosomal
membrane transport. Nat. Rev. Mol. Cell Biol. 8:786-798.
Raposo, G., M.S. Marks, and D.F. Cutler. 2007. Lysosome-related organelles: driving
post-golgi compartments into specialisation. Curr. Opin. Cell Biol. 19:394-401.
Raposo, G., D. Tenza, D.M. Murphy, J.F. Berson, and M.S. Marks. 2001. Distinct protein
sorting and localization to premelanosomes, melanosomes, and lysosomes in
pigmented melanocytic cells. J. Cell Biol. 152:809-823.
Rescher, U., D. Ruhe, C. Ludwig, N. Zobiack, and V. Gerke. 2004. Annexin 2 is a
phosphatidylinositol (4,5)-bisphosphate binding protein recruited to actin assembly
sites at cellular membranes. J Cell Sci. 117:3473-3480.
Ringeisen, A.L., L.A. Schimmenti, J.G. White, C. Schoonveld, and C.G. Summers. 2013.
Hermansky-Pudlak syndrome (HPS5) in a nonagenarian. J AAPOS. 17:334-336.
Ripoll, L., X. Heiligenstein, I. Hurbain, L. Domingues, F. Figon, K.J. Petersen, M.K. Dennis,
A. Houdusse, M.S. Marks, G. Raposo, and C. Delevoye. 2018. Myosin VI and
branched actin filaments mediate membrane constriction and fission of
melanosomal tubule carriers. J. Cell Biol. 217:2709-2726.
Rizk, A., G. Paul, P. Incardona, M. Bugarski, M. Mansouri, A. Niemann, U. Ziegler, P.
Berger, and I.F. Sbalzarini. 2014. Segmentation and quantification of subcellular
structures in fluorescence microscopy images using Squassh. Nat Protoc. 9:586596.
Robila, V., M. Ostankovitch, M.L. Altrich-Vanlith, A.C. Theos, S. Drover, M.S. Marks, N.
Restifo, and V.H. Engelhard. 2008. MHC class II presentation of gp100 epitopes
in melanoma cells requires the function of conventional endosomes and is
influenced by melanosomes. J. Immunol. 181:7843-7852.
Rojas, R., T. van Vlijmen, G.A. Mardones, Y. Prabhu, A.L. Rojas, S. Mohammed, A.J.
Heck, G. Raposo, P. van der Sluijs, and J.S. Bonifacino. 2008. Regulation of
retromer recruitment to endosomes by sequential action of Rab5 and Rab7. J Cell
Biol. 183:513-526.
Romer, W., L. Berland, V. Chambon, K. Gaus, B. Windschiegl, D. Tenza, M.R. Aly, V.
Fraisier, J.C. Florent, D. Perrais, C. Lamaze, G. Raposo, C. Steinem, P. Sens, P.
Bassereau, and L. Johannes. 2007. Shiga toxin induces tubular membrane
invaginations for its uptake into cells. Nature. 450:670-675.
Roux, A., G. Cappello, J. Cartaud, J. Prost, B. Goud, and P. Bassereau. 2002. A minimal
system allowing tubulation with molecular motors pulling on giant liposomes. Proc
Natl Acad Sci U S A. 99:5394-5399.
Ryder, P.V., R. Vistein, A. Gokhale, M.N. Seaman, M. Puthenveedu, and V. Faundez.
2013. The WASH complex, and endosomal Arp2/3 activator, interacts with the
Hermansky-Pudlak syndrome complex BLOC-1 and its cargo phosphatidylinositol4 kinase type II alpha. Mol. Biol. Cell. 24:2269-2284.
165

Saftig, P., and J. Klumperman. 2009. Lysosome biogenesis and lysosomal membrane
proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10:623-635.
Salazar, G., B. Craige, M.L. Styers, K.A. Newell-Litwa, M.M. Doucette, B.H. Wainer, J.M.
Falcon-Perez, E.C. Dell’Angelica, A.A. Peden, E. E. Werner, and V. Faundez.
2006. BLOC-1 complex deficiency alters the targeting of Adaptor Protein complex3 cargoes. Mol. Biol. Cell. 17:4014-4026.
Salazar, G., B. Craige, B.H. Wainer, J. Guo, P. De Camilli, and V. Faundez. 2005.
Phosphatidylinositol-4-kinase type II a is a component of AP-3-derived vesicles.
Mol. Biol. Cell. 16:3692-3704.
Salazar, G., R. Love, E. Werner, M.M. Doucette, S. Cheng, A. Levey, and V. Faundez.
2004. The zinc transporter ZnT3 interacts with AP-3 and it is preferentially targeted
to a distinct synaptic vesicle subpopulation. Mol. Biol. Cell. 15:575-587.
Salazar, G., S. Zlatic, B. Craige, A.A. Peden, J. Pohl, and V. Faundez. 2009. Hermanskypudlak syndrome protein complexes associate with phosphatidylinositol-4-kinase
type II alpha in neuronal and non-neuronal cells. J. Biol. Chem. 284:1790-1802.
Sasai, M., M.M. Linehan, and A. Iwasaki. 2010. Bifurcation of Toll-Like Receptor 9
signaling by Adaptor Protein 3. Science. 329:1530-1534.
Sbrissa, D., O.C. Ikonomov, Z. Fu, T. Ijuin, J. Gruenberg, T. Takenawa, and A. Shisheva.
2007. Core protein machinery for mammalian phosphatidylinositol 3,5bisphosphate synthesis and turnover that regulates the progression of endosomal
transport: novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J. Biol.
Chem. 282:23878-23891.
Schneider, C.A., W.S. Rasband, and K.W. Eliceiri. 2012. NIH Image to ImageJ: 25 years
of image analysis. Nat. Methods. 9:671-675.
Schneier, A.J., and A.B. Fulton. 2013. The hermansky-pudlak syndrome: clinical features
and imperatives from an ophthalmic perspective. Semin Ophthalmol. 28:387-391.
Seabra, M.C., and E. Coudrier. 2004. Rab GTPases and myosin motors in organelle
motility. Traffic. 5:393-399.
Seabra, M.C., E.H. Mules, and A.N. Hume. 2002. Rab GTPases, intracellular traffic and
disease. Trends Mol. Med. 8:23-30.
Seaman, M.N., A. Gautreau, and D.D. Billadeau. 2013. Retromer-mediated endosomal
protein sorting: all WASHed up! Trends Cell Biol. 23:522-528.
Seaman, M.N., M.E. Harbour, D. Tattersall, E. Read, and N. Bright. 2009. Membrane
recruitment of the cargo-selective retromer subcomplex is catalysed by the small
GTPase Rab7 and inhibited by the Rab-GAP TBC1D5. J Cell Sci. 122:2371-2382.
Seaman, M.N., E.G. Marcusson, J.L. Cereghino, and S.D. Emr. 1997. Endosome to Golgi
retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of
the VPS29, VPS30, and VPS35 gene products. J Cell Biol. 137:79-92.
Seaman, M.N., J.M. McCaffery, and S.D. Emr. 1998. A membrane coat complex essential
for endosome-to-Golgi retrograde transport in yeast. J Cell Biol. 142:665-681.
Seiji, M., T.B. Fitzpatrick, and M.S.C. Birbeck. 1961. The melanosome: a distinctive
subcellular particle of mammalian melanocytes and the site of melanogenesis. J.
Invest. Dermatol. 36:243-252.
Seto, S., K. Tsujimura, and Y. Koide. 2011. Rab GTPases regulating phagosome
maturation are differentially recruited to mycobacterial phagosomes. Traffic.
12:407-420.
Setty, S.R.G., D. Tenza, E.V. Sviderskaya, D.C. Bennett, G. Raposo, and M.S. Marks.
2008. Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity
in melanosomes. Nature. 454:1142-1146.
166

Setty, S.R.G., D. Tenza, S.T. Truschel, E. Chou, E.V. Sviderskaya, A.C. Theos, M.L.
Lamoreux, S.M. Di Pietro, M. Starcevic, D.C. Bennett, E.C. Dell'Angelica, G.
Raposo, and M.S. Marks. 2007. BLOC-1 is required for cargo-specific sorting from
vacuolar early endosomes toward lysosome-related organelles. Mol. Biol. Cell.
18:768-780.
Seward, S.L., Jr., and W.A. Gahl. 2013. Hermansky-Pudlak syndrome: health care
throughout life. Pediatrics. 132:153-160.
Shakya, S., P. Sharma, A.M. Bhatt, R.A. Jani, C. Delevoye, and S.R. Setty. 2018. Rab22A
recruits BLOC-1 and BLOC-2 to promote the biogenesis of recycling endosomes.
EMBO Rep. 19:e45918.
Sharda, A., and R. Flaumenhaft. 2018. The life cycle of platelet granules. F1000Res.
7:236.
Sharda, A., S.H. Kim, R. Jasuja, S. Gopal, R. Flaumenhaft, B.C. Furie, and B. Furie. 2015.
Defective PDI release from platelets and endothelial cells impairs thrombus
formation in Hermansky-Pudlak syndrome. Blood. 125:1633-1642.
Sharda, A.V., A.M. Barr, J.A. Harrison, A.R. Wilkie, C. Fang, L.M. Mendez, I.C. Ghiran,
J.E. Italiano, and R. Flaumenhaft. 2020. VWF maturation and release are
controlled by 2 regulators of Weibel-Palade body biogenesis: exocyst and BLOC2. Blood. 136:2824-2837.
Simon, J.D., D. Peles, K. Wakamatsu, and S. Ito. 2009. Current challenges in
understanding melanogenesis: bridging chemistry, biological control, morphology
and function. Pigment Cell Melanoma Res. 22:563-579.
Simonetti, B., C.M. Danson, K.J. Heesom, and P.J. Cullen. 2017. Sequence-dependent
cargo recognition by SNX-BARs mediates retromer-independent transport of CIMPR. J Cell Biol. 216:3695-3712.
Simunovic, M., G.A. Voth, A. Callan-Jones, and P. Bassereau. 2015. When Physics Takes
Over: BAR Proteins and Membrane Curvature. Trends Cell Biol. 25:780-792.
Singer, S.J., and G.L. Nicolson. 1972. The fluid mosaic model of the structure of cell
membranes. Science. 175:720-731.
Sirkis, D.W., R.H. Edwards, and C.S. Asensio. 2013. Widespread dysregulation of peptide
hormone release in mice lacking adaptor protein AP-3. PLoS Genet. 9:e1003812.
Sitaram, A., M.K. Dennis, R. Chaudhuri, W. De Jesus-Rojas, D. Tenza, S.R.G. Setty, C.S.
Wood, E.V. Sviderskaya, D.C. Bennett, G. Raposo, J.S. Bonifacino, and M.S.
Marks. 2012. Differential recognition of a dileucine-based sorting signal by AP-1
and AP-3 reveals a requirement for both BLOC-1 and AP-3 in delivery of OCA2 to
melanosomes. Mol. Biol. Cell. 23:3178-3192.
Sitaram, A., and M.S. Marks. 2012. Mechanisms of protein delivery to melanosomes in
pigment cells. Physiology. 27:85-99.
Sitaram, A., R. Piccirillo, I. Palmisano, D.C. Harper, E.C. Dell’Angelica, M.V. Schiaffino,
and M.S. Marks. 2009. Localization to mature melanosomes by virtue of
cytoplasmic dileucine motifs is required for human OCA2 function. Mol. Biol. Cell.
20:1464-1477.
Snead, W.T., and J.C. Stachowiak. 2018. Structure Versus Stochasticity-The Role of
Molecular Crowding and Intrinsic Disorder in Membrane Fission. J Mol Biol.
430:2293-2308.
Son, M., and E. London. 2013. The dependence of lipid asymmetry upon polar headgroup
structure. J Lipid Res. 54:3385-3393.
Spano, S., and J.E. Galan. 2012. A Rab32-dependent pathway contributes to Salmonella
typhi host restriction. Science. 338:960-963.
167

Spicer, S.S., A. Sato, R. Vincent, M. Eguchi, and K.C. Poon. 1981. Lysosome enlargement
in the Chediak-Higashi syndrome. Fed Proc. 40:1451-1455.
Springer, T.A. 2014. von Willebrand factor, Jedi knight of the bloodstream. Blood.
124:1412-1425.
Stachowiak, J.C., E.M. Schmid, C.J. Ryan, H.S. Ann, D.Y. Sasaki, M.B. Sherman, P.L.
Geissler, D.A. Fletcher, and C.C. Hayden. 2012. Membrane bending by proteinprotein crowding. Nat Cell Biol. 14:944-949.
Stalder, D., and D.C. Gershlick. 2020. Direct trafficking pathways from the Golgi apparatus
to the plasma membrane. Semin. Cell Dev. Biol. 107:112-125.
Starcevic, M., and E.C. Dell'Angelica. 2004. Identification of snapin and three novel
proteins (BLOS1, BLOS2 and BLOS3/reduced pigmentation) as subunits of
biogenesis of lysosome-related organelles complex-1 (BLOC-1). J. Biol. Chem.
279:28393-28401.
Stauffer, T.P., S. Ahn, and T. Meyer. 1998. Receptor-induced transient reduction in
plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr Biol.
8:343-346.
Stephen, J., T. Yokoyama, N.J. Tolman, K.J. O'Brien, E.R. Nicoli, B.P. Brooks, L. Huryn,
S.A. Titus, D.R. Adams, D. Chen, W.A. Gahl, B.R. Gochuico, and M.C. Malicdan.
2017. Cellular and molecular defects in a patient with Hermansky-Pudlak
syndrome type 5. PLoS One. 12:e0173682.
Stephens, D.J., and R. Pepperkok. 2001. Illuminating the secretory pathway: when do we
need vesicles? J Cell Sci. 114:1053-1059.
Stinchcombe, J.C., D.C. Barral, E.H. Mules, S. Booth, A.N. Hume, L.M. Machesky, M.C.
Seabra, and G.M. Griffiths. 2001. Rab27a is required for regulated secretion in
cytotoxic T lymphocytes. J. Cell Biol. 152:825-834.
Strochlic, T.I., T.G. Setty, A. Sitaram, and C.G. Burd. 2007. Grd19/Snx3p functions as a
cargo-specific adapter for retromer-dependent endocytic recycling. J Cell Biol.
177:115-125.
Strom, M., A.N. Hume, A.K. Tarafder, E. Barkagianni, and M.C. Seabra. 2002. A family of
Rab27-binding proteins: Melanophilin links Rab27a and myosin Va function in
melanosome transport. J. Biol. Chem. 277:25423-25430.
Suckow, A.T., B. Craige, V. Faundez, W.J. Cain, and S.D. Chessler. 2010. An AP-3dependent mechanism drives synaptic-like microvesicle biogenesis in pancreatic
islet beta-cells. Am. J. Physiol. Endocrinol. Metab. 299:E23-E32.
Suetsugu, S., S. Kurisu, and T. Takenawa. 2014. Dynamic shaping of cellular membranes
by phospholipids and membrane-deforming proteins. Physiol. Rev. 94:1219-1248.
Sugita, M., X. Cao, G.F.M. Watts, R.A. Rogers, J.S. Bonifacino, and M.B. Brenner. 2002.
Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells.
Immunity. 16:697-706.
Summers, C.G., W.H. Knobloch, C.J. Witkop, Jr., and R.A. King. 1988. Hermansky-Pudlak
syndrome. Ophthalmic findings. Ophthalmology. 95:545-554.
Sun-Wada, G.H., H. Tabata, N. Kawamura, M. Aoyama, and Y. Wada. 2009. Direct
recruitment of H+-ATPase from lysosomes for phagosomal acidification. J Cell Sci.
122:2504-2513.
Sun, Y., A.C. Martin, and D.G. Drubin. 2006. Endocytic internalization in budding yeast
requires coordinated actin nucleation and myosin motor activity. Dev Cell. 11:3346.
Suzuki, T., W. Li, Q. Zhang, A. Karim, E.K. Novak, E.V. Sviderskaya, S.P. Hill, D.C.
Bennett, A.V. Levin, H. Nieuwenhuis, K., C.-T. Fong, C. Castellan, B. Miterski, R.T.
168

Swank, and R.A. Spritz. 2002. Hermansky-Pudlak syndrome is caused by
mutations in HPS4, the human homolog of the mouse light-ear gene. Nature Genet.
30:321-324.
Sviderskaya, E.V., S.P. Hill, T.J. Evans-Whipp, L. Chin, S.J. Orlow, D.J. Easty, S.C.
Cheong, D. Beach, R.A. DePinho, and D.C. Bennett. 2002. p16Ink4a in
melanocyte senescence and differentiation. J. Natl. Cancer Inst. 94:446-454.
Swanson, J.A. 2008. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol.
Cell Biol. 9:639-649.
Swarbrick, J.D., D.J. Shaw, S. Chhabra, R. Ghai, E. Valkov, S.J. Norwood, M.N. Seaman,
and B.M. Collins. 2011. VPS29 is not an active metallo-phosphatase but is a rigid
scaffold required for retromer interaction with accessory proteins. PLoS One.
6:e20420.
Takats, S., P. Nagy, A. Varga, K. Pircs, M. Karpati, K. Varga, A.L. Kovacs, K. Hegedus,
and G. Juhasz. 2013. Autophagosomal Syntaxin17-dependent lysosomal
degradation maintains neuronal function in Drosophila. J Cell Biol. 201:531-539.
Tamura, K., N. Ohbayashi, K. Ishibashi, and M. Fukuda. 2011. Structure-function analysis
of VPS9-ankyrin-repeat protein (Varp) in the trafficking of tyrosinase-related
protein 1 in melanocytes. J. Biol. Chem. 286:7507-7521.
Tamura, K., N. Ohbayashi, Y. Maruta, E. Kanno, T. Itoh, and M. Fukuda. 2009. Varp is a
novel Rab32/38-binding protein that regulates Tyrp1 trafficking in melanocytes.
Mol. Biol. Cell. 20:2900-2908.
Tan, J., and J.A. Brill. 2014. Cinderella story: PI4P goes from precursor to key signaling
molecule. Crit. Rev. Biochem. Mol. Biol. 49:33-58.
Theos, A.C., J.F. Berson, S.C. Theos, K.E. Herman, D.C. Harper, D. Tenza, E.V.
Sviderskaya, M.L. Lamoreux, D.C. Bennett, G. Raposo, and M.S. Marks. 2006a.
Dual loss of ER export and endocytic signals with altered melanosome morphology
in the silver mutation of Pmel17. Mol. Biol. Cell. 17:3598-3612.
Theos, A.C., D. Tenza, J.A. Martina, I. Hurbain, A.A. Peden, E.V. Sviderskaya, A. Stewart,
M.S. Robinson, D.C. Bennett, D.F. Cutler, J.S. Bonifacino, M.S. Marks, and G.
Raposo. 2005a. Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting
from endosomes to melanosomes. Mol Biol Cell. 16:5356-5372.
Theos, A.C., D. Tenza, J.A. Martina, I. Hurbain, A.A. Peden, E.V. Sviderskaya, A. Stewart,
M.S. Robinson, D.C. Bennett, D.F. Cutler, J.S. Bonifacino, M.S. Marks, and G.
Raposo. 2005b. Functions of AP-3 and AP-1 in tyrosinase sorting from endosomes
to melanosomes. Mol. Biol. Cell. 16:5356-5372.
Theos, A.C., S.T. Truschel, D. Tenza, I. Hurbain, D.C. Harper, J.F. Berson, P.C. Thomas,
G. Raposo, and M.S. Marks. 2006b. A lumenal domain-dependent pathway for
sorting to intralumenal vesicles of multivesicular endosomes involved in organelle
morphogenesis. Dev. Cell. 10:343-354.
Truschel, S.T., S. SImoes, S.R.G. Setty, D.C. Harper, D. Tenza, P.C. Thomas, K.E.
Herman, S.D. Sackett, D.C. Cowan, A.C. Theos, G. Raposo, and M.S. Marks.
2009. ESCRT-1 function is required for Tyrp1 transport from early endosomes to
the melanosome limiting membrane. Traffic. 10:1318-1336.
Valentijn, K.M., J.A. Valentijn, K.A. Jansen, and A.J. Koster. 2008. A new look at WeibelPalade body structure in endothelial cells using electron tomography. J. Struct.
Biol. 161:447-458.
van Dam, E.M., and W. Stoorvogel. 2002. Dynamin dependent transferrin receptor
recycling by endosome-derived clathrin-coated vesicles. Mol. Biol. Cell. 13:169182.
169

Van Gele, M., P. Dynoodt, and J. Lambert. 2009. Griscelli syndrome: a model system to
study vesicular trafficking. Pigment Cell Melanoma Res. 22:268-282.
van Niel, G., S. Charrin, S. Simoes, M. Romao, L. Rochin, P. Saftig, M.S. Marks, E.
Rubinstein, and G. Raposo. 2011. The Tetraspanin CD63 integrates ESCRTindependent and dependent sorting at a common endosome. Dev. Cell. 21:708721.
van Weering, J.R., R.B. Sessions, C.J. Traer, D.P. Kloer, V.K. Bhatia, D. Stamou, S.R.
Carlsson, J.H. Hurley, and P.J. Cullen. 2012. Molecular basis for SNX-BARmediated assembly of distinct endosomal sorting tubules. EMBO J. 31:4466-4480.
van Weering, J.R., P. Verkade, and P.J. Cullen. 2010. SNX-BAR proteins in
phosphoinositide-mediated, tubular-based endosomal sorting. Semin Cell Dev Biol.
21:371-380.
Vijayasaradhi, S., Y.Q. Xu , B. Bouchard, and A.N. Houghton. 1995. Intracellular sorting
and targeting of melanosomal membrane proteins: identification of signals for
sorting of the human brown locus protein, gp75. J. Cell Biol. 130:807-820.
von Blume, J., and A. Hausser. 2019. Lipid-dependent coupling of secretory cargo sorting
and trafficking at the trans-Golgi network. FEBS Lett. 593:2412-2427.
Wagner, D.D., S. Saffaripour, R. Bonfanti, J.E. Sadler, E.M. Cramer, B. Chapman, and
T.N. Mayadas. 1991. Induction of specific storage organelles by von Willebrand
factor propolypeptide. Cell. 64:403-413.
Wang, H., H.Q. Sun, X. Zhu, L. Zhang, J. Albanesi, B. Levine, and H. Yin. 2015.
GABARAPs regulate PI4P-dependent autophagosome:lysosome fusion. Proc Natl
Acad Sci U S A. 112:7015-7020.
Wang, Y.J., J. Wang, H.Q. Sun, M. Martinez, Y.X. Sun, E. Macia, T. Kirchhausen, J.P.
Albanesi, M.G. Roth, and H.L. Yin. 2003. Phosphatidylinositol 4 phosphate
regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell. 114:299310.
Ward, D.M., J. Pevsner, M.A. Scullion, M. Vaughn, and J. Kaplan. 2000. Syntaxin 7 and
VAMP-7 are soluble N-ethylmaleimide-sensitive factor attachment protein
receptors required for late endosome-lysosome and homotypic lysosome fusion in
alveolar macrophages. Mol Biol Cell. 11:2327-2333.
Wasmeier, C., M. Romao, L. Plowright, D.C. Bennett, G. Raposo, and M.C. Seabra. 2006.
Rab38 an Rab32 control early post-Golgi trafficking of melanogenic enzymes. J.
Cell Biol. 175:271-281.
Wassmer, T., N. Attar, M. Harterink, J.R. van Weering, C.J. Traer, J. Oakley, B. Goud,
D.J. Stephens, P. Verkade, H.C. Korswagen, and P.J. Cullen. 2009. The retromer
coat complex coordinates endosomal sorting and dynein-mediated transport, with
carrier recognition by the trans-Golgi network. Dev Cell. 17:110-122.
Watt, B., G. van Niel, G. Raposo, and M.S. Marks. 2013. PMEL: A pigment cell-specific
model for functional amyloid formation. Pigment Cell Melanoma Res. 26:300-315.
Waugh, M.G. 2019. The Great Escape: how phosphatidylinositol 4-kinases and PI4P
promote vesicle exit from the Golgi (and drive cancer). Biochem J. 476:2321-2346.
Weaver, A.M., A.V. Karginov, A.W. Kinley, S.A. Weed, Y. Li, J.T. Parsons, and J.A.
Cooper. 2001. Cortactin promotes and stabilizes Arp2/3-induced actin filament
network formation. Curr Biol. 11:370-374.
Weber, S., B. Steiner, A. Welin, and H. Hilbi. 2018. Legionella-containing vacuoles capture
PtdIns(4)P-rich vesicles derived from the Golgi apparatus. mBio. 9:e02420-02418.
Weber, S., M. Wagner, and H. Hilbi. 2014. Live-cell imaging of phosphoinositide dynamics
and membrane architecture during Legionella infection. mBio. 5:e00839-00813.
170

Wenham, M., S. Grieve, M. Cummins, M.L. Jones, S. Booth, R. Kilner, P.J. Ancliff, G.M.
Griffiths, and A.D. Mumford. 2010. Two patients with Hermansky Pudlak syndrome
type 2 and novel mutations in AP3B1. Haematologica. 95:333-337.
Wieffer, M., E. Cibrian Uhalte, Y. Posor, C. Otten, K. Branz, I. Schutz, J. Mossinger, P.
Schu, S. Abdelilah-Seyfried, M. Krauss, and V. Haucke. 2013. PI4K2beta/AP-1based TGN-endosomal sorting regulates Wnt signaling. Curr. Biol. 23:2185-2190.
Wigge, P., K. Kohler, Y. Vallis, C.A. Doyle, D. Owen, S.P. Hunt, and H.T. McMahon. 1997.
Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol
Biol Cell. 8:2003-2015.
Wu, X., B. Bowers, K. Rao, Q. Wei, and J.A. Hammer, 3rd. 1998. Visualization of
melanosome dynamics within wild-type and dilute melanocytes suggests a
paradigm for myosin V function in vivo. J. Cell Biol. 143:1899-1918.
Wu, X., K. Rao, M.B. Bowers, N.G. Copeland, N.A. Jenkins, and J.A. Hammer. 2001.
Rab27a enables myosin Va-dependent melanosome capture by recruiting the
myosin to the organelle. J. Cell Sci. 114:1091-1100.
Wu, X., F. Wang, K. Rao, J.R. Sellers, and J.A. Hammer, III. 2002a. Rab27a is an essential
component of melanosome receptor for myosin Va. Mol. Biol. Cell. 13:1735-1749.
Wu, X.S., K. Rao, H. Zhang, F. Wang, J.R. Sellers, L.E. Matesic, N.G. Copeland, N.A.
Jenkins, and J.A.r. Hammer. 2002b. Identification of an organelle receptor for
myosin-Va. Nature Cell Biol. 4:271-278.
Yi, L., and S.G. Kaler. 2015. Direct interactions of adaptor protein complexes 1 and 2 with
the copper transporter ATP7A mediate its anterograde and retrograde trafficking.
Hum Mol Genet. 24:2411-2425.
Yong, X., L. Zhao, W. Deng, H. Sun, X. Zhou, L. Mao, W. Hu, X. Shen, Q. Sun, D.D.
Billadeau, Y. Xue, and D. Jia. 2020. Mechanism of cargo recognition by retromerlinked SNX-BAR proteins. PLoS Biol. 18:e3000631.
Young, L.R., P.M. Gulleman, J.P. Bridges, T.E. Weaver, G.H. Deutsch, T.S. Blackwell,
and F.X. McCormack. 2012. The alveolar epithelium determines susceptibility to
lung fibrosis in Hermansky-Pudlak syndrome. Am. J. Respir. Crit. Care Med.
186:1014-1024.
Young, L.R., R. Pasula, P.M. Gulleman, G.H. Deutsch, and F.X. McCormack. 2007.
Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell
apoptosis and fibrosis. Am. J. Respir. Cell Mol. Biol. 37:67-74.
Youssefian, T., and E.M. Cramer. 2000. Megakaryocyte dense granule components are
sorted in multivesicular bodies. Blood. 95:4004-4007.
Yuan, F., H. Alimohamadi, B. Bakka, A.N. Trementozzi, K.J. Day, N.L. Fawzi, P.
Rangamani, and J.C. Stachowiak. 2021. Membrane bending by protein phase
separation. Proc Natl Acad Sci U S A. 118.
Zhang, Q., B. Zhao, W. Li, N. Oiso, E.K. Novak, M.E. Rusiniak, R. Gautam, S. Chintala,
E.P. O'Brien, Y. Zhang, B.A. Roe, R.W. Elliott, E.M. Eicher, P. Liang, C. Kratz, E.
Legius, R.A. Spritz, T.N. O'Sullivan, N.G. Copeland, N.A. Jenkins, and R.T. Swank.
2003. Ru2 and Ru encode mouse orthologs of the genes mutated in human
Hermansky-Pudlak syndrome types 5 and 6. Nature Genet. 33:145-153.
Zhao, H., Y.L. Boissy, Z. Abdel-Malek, R.A. King, J.J. Nordlund, and R.E. Boissy. 1994.
On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects
expressed by cultured melanocytes. Lab Invest. 71:25-34.
Zhou, B., Q. Cai, Y. Xie, and Z.H. Sheng. 2012. Snapin recruits dynein to BDNF-TrkB
signaling endosomes for retrograde axonal transport and is essential for dendrite
growth of cortical neurons. Cell Rep. 2:42-51.
171

